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ABSTRACT 
 
Lauren K. Slevin: A structural study of conserved centriole duplication machinery 
(Under the direction of Kevin C. Slep) 
 
 
 Centrioles are microtubule-based cylindrical structures that act within organelles 
responsible for nucleating polarized microtubule networks. Centrioles have an inherent nine-
fold radial symmetry with species-dependent dimensions. Despite the fact that centrioles 
have been described by biologists for over a century, the process by which cells license and 
assemble nascent centrioles has only recently started to come to light. It is now known that 
centrioles, like DNA, duplicate via a cell cycle-regulated mechanism, and that a core set of 
five conserved proteins is necessary for centriole duplication. Polo-like Kinase 4 (Plk4) is a 
highly conserved serine/threonine kinase required for centriole duplication licensing. Plk4, 
along with all other Plk family members, contains arrayed Polo Box (PB) domains, a motif 
that undergoes hetero- or homo-dimerization to bind targets, localize to subcellular 
structures, and regulate kinase activity; however, the mechanism by which Plk4 employs its 
PBs to license centriole duplication has been unclear. Here, we harness x-ray 
crystallography, biochemistry, and cell biology to show that Drosophila melanogaster Plk4 
contains three complete PB domains with distinct functions. The first two, PB1-PB2, form a 
homodimer in trans in both crystallographic form and in solution. We use in vitro pulldowns 
to demonstrate that PB1-PB2 are collectively needed to bind Asterless, a centriole 
scaffolding protein that localizes FL Plk4 to centrioles. Additionally, the PB1-PB2 
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homodimer is required for downregulation of the FL molecule, limiting centriole duplication. 
Finally, we use D.m. S2 cells to show that PB1-PB2 localizes to centrioles via conserved 
electrostatic interactions. The C-terminal PB domain, PB3, also forms a canonical PB fold, 
yet it shows species-dependent architecture and oligomerization states, demonstrating that 
PB3 is a structurally variable domain with species-dependent functions. Further work 
examines the role of a dynein light chain (LC8) in oligomerizing Anastral-2 (Ana2), a 
downstream centriole component that is a candidate for Plk4 phosphorylation. LC8-based 
Ana2 tetramerization has further implications for the role of Ana2 during centriole 
duplication. Collectively, our work delineates novel domains and interactions in the 
fundamental centriole licensing and assembly proteins Plk4 and Ana2, and implicates 
conserved mechanisms in centriole biogenesis. 
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PREFACE 
 
 Chapter 2 is a published manuscript describing work done in collaboration with the 
lab of Gregory Rogers (University of Arizona). This work was published in Structure in 
November 2012. Jonathan Nye carried out centriole count assays while Dan Buster 
completed all pull-down experiments and Western Blots (both from the Rogers lab). Derek 
Pinkerton (an undergraduate in the Slep lab) assisted with centriole localization experiments.  
I purified Plk4 PB1-PB2, obtained crystals, and assisted Kevin Slep with structure 
refinement, as well as designed, cloned, and performed the centriole localization assay (as 
well as the basic patch mutant assay, unpublished; described in detail in Chapter 6). Kevin 
Slep, Gregory Rogers and I designed experiments and drafted the manuscript.  
Slevin, L.K., Nye, J., Pinkerton, D.C., Buster, D.W., Rogers, G.C., and Slep, K.C. (2012). 
The structure of the Plk4 cryptic polo box reveals two tandem polo boxes required for 
centriole duplication. Structure. 20, 1905-1917. 
 
 Chapter 3 describes an ongoing project that is a collaborative effort between Kevin 
Slep and me to define the role of Plk4’s C-terminal PB3 in centriole duplication. I designed 
the constructs, collected diffraction data on the D.m. PB3 crystals, processed the data, built, 
and refined the structure, while Kevin Slep crystallized the protein and solved the structure. I 
designed, cloned, and performed all microscopy work to determine the localization and 
centriole phenotype of PB3 in both D.m. S2 cells and H.s. RPEI cells. A manuscript detailing 
this work is currently being drafted for publication.  
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 Chapter 5 is a published manuscript co-authored by Erin Romes, a former Slep lab 
graduate student, and me. This work was published in The Journal of Biological Chemistry in 
August 2014. Erin Romes cloned LC8, designed Ana2 peptides, purified proteins for 
crystallization trials, crystallized LC8-Ana2 pep1, and assisted with ITC. I performed ITC, 
solved both structures as presented, analyzed comparative LC8 binding targets, and designed 
and carried out the SEC-MALS assays. Mary Dandulakis (a Slep lab undergraduate student) 
crystallized the LC8-Ana2 pep2 complex. I drafted all figures and wrote the manuscript. 
Kevin Slep designated the proposed LC8 binding sites within Ana2 and oversaw 
experimental design. 
Slevin, L.K.,* Romes, E.M.,* Dandulakis, M.G., and Slep, K.C. (2014). The mechanism 
of dynein light chain LC8-mediated oligomerization of the Ana2 centriole duplication 
factor. Journal of Biological Chemistry. 289, 20727-20739. *indicates equal 
contributions 
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CHAPTER 1: INTRODUCTION  
 
 
Centrioles are microtubule-based cylindrical structures essential in nucleating 
polarized microtubule networks 
 
Centrioles are cylindrical subcellular structures observed in nearly all metazoans. 
Centrioles take species- and cell type-specific dimensions; human somatic cells undergoing 
mitotic divisions typically have centrioles 250 nm in diameter and 500 nm long (Winey and 
O’Toole, 2014). Centriolar structure consists of a cartwheel-like formation with 9 spokes that 
emanate radially (Figure 1.1). This cartwheel forms the basis of the 9-fold radial symmetry of 
the microtubule triplet blades (van Breugel et al., 2011; Kitagawa et al., 2011), which 
decorate the length of the centriolar barrel and are evident in electron microscopic images of 
centrioles (Guichard et al., 2013; Li et al., 2012). Centrioles play critical roles in centrosomes 
and cilia, organelles that nucleate and organize dynamic polarized microtubule networks 
(Figure 1.1).  
In cells that have exited the cell cycle (in G0), centrioles are recruited to the cell 
cortex, where they become modified centrioles called basal bodies. Basal bodies then 
nucleate either a single cilium (called a primary cilium) or many cilia (motile cilia), 
depending on the tissue type and centriole number (Scholey and Anderson, 2006). The 
primary cilium emanates from the cell in a finger-like projection, and employs its extended 
surface area to sense environmental cues and facilitate cell-to-cell communication. The 
formation of the primary cilium requires exactly two centrioles, which form the physical base 
of the single cilium in each cell. In other contexts, many centrioles are needed to nucleate 
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formation of multiple motile cilia, which aid in various tissues (including the fallopian tubes, 
airway, and brain of human cells (Bylander et al., 2013)) to create movement and propagate 
signals.  
In actively dividing cells, however, centrioles play an important role in forming the 
centrosome, an organelle that nucleates and organizes the bipolar mitotic spindle (Figure 
1.1). Centrosomal centrioles play a key role in regulating these activities in most vertebrate 
somatic cells, though centrioles are interestingly absent in higher fungi, higher plants, and 
many oocyte types (Carvalho-Santos et al., 2010), in which acentriolar structures govern 
mitotic spindle formation. While centrioles themselves do not nucleate microtubule growth, 
data from several labs in recent years suggest that centrioles are central in recruiting, 
stabilizing, and spatially organizing the pericentriolar material complex (PCM), which 
contains such microtubule nucleators as the γ-TuRC complex (Mennella et al., 2012). A 
centrosome consists of a pair of centrioles and their associated shells of PCM components. 
The centriole pair is connected orthogonally, forming an “L” shape between an older 
(“mother”) centriole and a nascent (“daughter”) centriole (Rodrigues-Martins et al., 2007). 
The centrioles maintain a physical connection, with proteinaceous tethers including C-Nap1, 
LRRC45 and Rootletin, within the mature centrosome through mitosis (Bornens et al., 1987; 
He et al., 2013). The centrosome seeds growth of the microtubule polymers, and maintains 
secure connections with the minus ends of microtubules (both astral and spindle 
microtubules), while the plus ends extend towards the kinetochores. During mitosis, exactly 
two centrosomes (and therefore a total of exactly four centrioles) form the bipolar mitotic 
spindle. Supernumerary centrosomes have been implicated in forming multi-polar spindles, a 
situation that leads to aneuploidy, a hallmark of tumorigenesis (Godinho and Pellman, 2014). 
 Misregulated centriole duplication is also associated with diseases including dwarfism, male 
sterility, and primary microcephaly 
Dias et al., 2011), underlining the importance of learning how cells
and regulate their biogenesis.
          
Figure 1.1. Centrioles form the basis of centrosomes and cilia.
the proximal end of a centriole (see Figure 1.3 for greater molecular detail). Microtubule 
triplet blades are depicted in green, surrounding the inner barrel. (B) Side view of a 
vertebrate centriole. Microtubules are depicted as single green tubes for simplicity. (C) 
Mother-daughter centriole pairs (shown as connected green barrels) form the basis of 
centrosomes (cycling cells) or cilia (G
and an associated ordered cloud of PCM components (yellow), and nucleate the mitotic 
spindle to accurately segregate sister chromatids (magenta) during 
employ centrioles to nucleate inner microtubules of various lengths and multiplicity (purple) 
to form a finger-like protrusion from the cell.
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(Chavali et al., 2014; Nigg and Raff, 2009; Bettencourt
 “count” their centrioles 
 
 (A) Cross
0). Top, centrosomes consist of two centrioles (green) 
cell division. Bottom, cilia 
 
 
-
 
-section view of 
either 
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Centrioles undergo duplication in a cell-cycle- and Plk4-dependent manner 
 Despite the fact that cell biologists have studied centrioles for more than a century 
(Boveri 1909), the manner by which cells create their centrioles has only recently begun to 
come to light. Using microscopic and molecular techniques, researchers have discovered a 
couple of mechanisms by which cells undertake centriole biogenesis. In the less understood 
de novo mechanism, nascent, unconnected centrioles are made in the cytoplasm due to the 
presence of excessive duplication components. The de novo mechanism has largely been 
described in oocyte systems (Rodrigues-Martins et al., 2007; Peel et al., 2007; Eckerdt et al., 
2011), in which ectopic overexpression of key components leads to the formation of nascent 
centrioles incapable of PCM recruitment. De novo centriole biogenesis is thought to play a 
biological role in cells that have exited the cell cycle, differentiated, and require motile cilia 
(Zhao et al., 2013). To meet this requirement, the cell must make hundreds of modified 
centrioles to undergo multiciliogenesis; thus, the de novo pathway is an important 
mechanism through which differentiated cells create centrioles. However, it is not the 
dominant pathway through which most centrioles are made in dividing cells; therefore, I will 
focus herein on the axiomatic “templating” duplication mechanism. 
 In the canonical templating mechanism, a nascent centriole must grow orthogonally 
to a preexisting centriole; thus, the new (daughter) centriole templates from an older (mother) 
centriole (Figure 1.2). The mother and daughter centrioles are connected by the physical 
tether proteins which includes Rootletin; this physical connection is thought to play an 
important role in limiting the number of daughters able to nucleate from a single mother 
centriole (Tsou and Stearns, 2006). As a cell exits from cytokinesis, it contains one complete 
centrosome: a connected mother-daughter pair surrounded by PCM components. As the cell 
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enters G1, the cell-cycle-dependent enzyme Separase and signaling kinase Plk1 function to 
sever the connection between mother and daughter centrioles. The loss of physical 
connection “resets” the identities of the centrioles, making both new mothers to begin 
centriole duplication anew. 
 By the end of G1, the kinase Plk4 (Polo-like Kinase 4) is recruited to the site of 
centriole duplication to act as the “master licenser” of centriole duplication. While little is 
known about its mechanism of action, Plk4 is known to be required for centriole duplication; 
additionally, its licensing activity requires its catalytic activity (Bettencourt-Dias et al., 
2005). After Plk4 licenses centriole duplication by its unknown mechanism, daughter 
centrioles begin to grow orthogonally to their respective mother centrioles. The formation of 
the initial structures is commensurate with DNA replication during S phase (Figure 1.2). As 
the cell progresses through G2 and prepares for mitotic entry, the daughter centriole 
completes elongation and the two mature mother-daughter pairs each finish recruiting the 
PCM components required to build and organize the mitotic spindle. The cell undergoes 
mitosis, and each new cell undergoes the process again.  
 
 
Centriole duplication is driven by a conserved set of proteins 
 As aforementioned, centrioles are not present in higher fungi and higher plants; 
however, it is of important note that centrioles are present in basal fungi and plants, 
suggesting that centrioles were present in common eukaryotic ancestors (Carvalho-Santos et 
al., 2010; Firat-Karalar and Stearns, 2014). Accordingly, the components responsible for 
centriole duplication are largely conserved, functionally if not through primary sequence,  
                           
 
Figure 1.2. Canonical centriole duplicatio
mother centriole templating.
and four centrioles; when it completes cytokinesis, each resulting (daughter) cell receives one 
centrosome and two centrioles 
Separase (red)  and Plk1 (not shown) 
centrioles, resetting the identity of both to “mother” 
Plk4 (blue) licenses centriole duplication. During Synthesis phase, nascent daughter 
centrioles (chartreuse) begin to grow orthogonally to their respective mothers (forest green). 
As the cell completes G2 and prepares for mitosis, the daughter centrioles elongate, ar
capped to pre-determined lengths, and the mother
PCM proteins (yellow). As the cell builds the mitotic spindle, the two mature centrosomes 
are separated on opposite sides, and the cyclical process begins again.
 
 
within centriolar eukaryotes. Shown in Figure 1.3 (A) is a comparative list of the components
required for centriole duplication 
melanogaster (D.m.), humans (
elegans (C.e.). While many more proteins contribute to procentriole assembly, elongation, 
and capping (length determination), shown in Figure 1.3 (A) are the five basic players 
necessary for centriole duplication.
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  While Plk4 (also known as SAK/ZY
the “master licenser” of centriole duplication (
2009), it requires centriole scaffolding components to localize to the site of nascent 
centrioles. In D.m., Asterless is the scaffolding protein responsible for binding and recruiting 
Plk4 to nascent centrioles (Dzhindzhev et al., 2010
redundant system to recruit Plk4 to centrioles, presumably due to its essential function in
centriole duplication; in humans, either Cep152 (the Asterless homolog) or Cep192 (the 
SPD-2 homolog) is sufficient for Plk4 localization 
2010). Interestingly, C.e. have lost the Asterless homolog, and make use of 
recruit Plk4, indicative that the 
specific interactions (Shimanovskaya et al., 2014
 
             
Figure 1.3. Centriole duplication requires a set of proteins functionally and s
conserved across species. (A) Schematic pathway of conserved components. Three species 
are compared: Drosophila melanogaster 
elegans (C.e.), with the resulting structures shown to the left. See text 
components as they are known to localize to the cartwheel structure (omitting Asl for clarity 
and Plk4, which is transient). Sas
cartwheel (shown in dark (N-
is unknown, but its N-terminus binds Sas
2013) and its C-terminus binds Sas
7 
G-1 in D.m. and C.e., respectively) is considered 
Cunha-Ferreira et al., 2009; Rogers et al., 
). However, humans have developed a 
(Hatch et al., 2010; Cizmecioglu et al., 
C.e. Plk4 and SPD-2 proteins have coevolved to form their 
).   
(D.m.), Homo sapiens (H.s.), and 
for details. (B) Map of 
-6 oligomerizes into an 18-mer and builds the central 
terminus) and light (C-terminus) blue. The localization of Ana2 
-4 (highlighted in top orange box, Cottee et al., 
-6 (highlighted in bottom orange box
 
 
SPD-2 alone to 
 
patially 
Caenorhabditis 
, Stevens et al., 
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2010a). Sas-4 (red) forms a scaffold along the outer wall of the centriole to recruit and 
stabilize the triplet microtubule blades (Cottee et al., 2013).  
 
 It remains unknown exactly what Plk4’s function is at the centriole after its 
recruitment; it is only known that centriole duplication requires catalytically active Plk4, 
though recent evidence suggests that a direct interaction between Plk4 and Sas-6 is sufficient 
to recruit Sas-6 to the site of the nascent centriole (Lettman et al., 2013).  
 The first structure observed through cryotomography in the emerging daughter 
centriole is the cartwheel with 9-fold symmetry. Structural breakthroughs occurred in 2011, 
when several labs demonstrated that a higher-order oligomer of the conserved Sas-6 (spindle-
assembly abnormal-6 (Leidel et al., 2005)) creates cartwheels with an inherent 9-fold radial 
symmetry in vitro (van Breugel et al., 2011; Kitagawa et al., 2011). It has since been shown 
(van Breugel et al., 2014) that 18 Sas-6 protomers associate in two ways to create the 9-
spoked cartwheel: first, the helical region at the Sas-6 C-terminus interacts with other 
protomers to form a high-affinity coiled-coil dimer. Second, the globular Sas-6 N-terminus 
interacts weakly and laterally with the same domain in other protomers, forming the hub of 
the cartwheel; the coiled-coil regions emanate out from the hub, forming the spokes of the 
wheel (Figure 1.3 B, shown in blue).   
 Another component, called Anastral Spindle 2 (Ana2/STIL/SAS-5 in D.m./H.s./C.e., 
respectively (Stevens et al., 2010a)), is recruited at the same time as Sas-6 and is required for 
duplication. However, much less is known about the role of Ana2 in centriole duplication. In 
D.m. cells, overexpressed Sas-6 and Ana2 assemble into tubules reminiscent of Sas-6 
cartwheels (Stevens et al., 2010b), a phenotype that requires Plk4 as a permissive cue. 
Furthermore, Sas-6 N-terminal globular domains have a weak affinity for each other (~110 
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µM in C.e. (Kitagawa et al., 2011)). Thus, while Ana2 likely promotes Sas-6-based cartwheel 
structures, the mechanism by which Ana2 does so remains unknown. Ana2 does contain 
several known binding motifs (presented in greater detail in Chapter 5), including a Sas-6- 
and a Sas-4-binding domain, each of which has been mapped using biochemical techniques 
and yeast two-hybrid screens (Stevens et al., 2010a; Cottee et al., 2013). The presumptive 
binding sites between Ana2 and its partners Sas-6 and Sas-4 are mapped in Figure 1.3 B, as 
well as all currently known protein positions relative to the daughter cartwheel (Guichard et 
al., 2013; Mennella et al., 2012). 
 Finally, Sas-4 aids in elongating the nascent centriole, mostly through recruiting 
additional PCM components required for building the surrounding microtubule triplet blades 
(Pelletier et al., 2006; Dammermann et al., 2008; Gopalakrishnan et al., 2011; Cottee et al., 
2013). At the distal end of the centriole, further components including Poc5, CP110 and 
Klp10A cooperate to regulate centriole length and prevent centrosomal centrioles from 
converting to basal bodies (Azimzadeh et al., 2009; Delgehyr et al., 2012).  
 
The Plk4 phosphorylation targets include itself, cell cycle regulator proteins, and 
unknown centriole components  
 
 Plk4 is a conserved serine/threonine kinase that plays a critical role in centriole 
duplication. Initial experiments in 2005 determined that Plk4 is required for centriole 
duplication in both D.m. and H.s. systems (Habedanck et al., 2005; Bettencourt-Dias et al., 
2005; Kleylein-Sohn et al., 2007). Further work established that Plk4’s phosphorylation 
activity is paramount to its licensing activity (Guderian et al., 2010). Plk4 has been shown to 
autophosphorylate (Rogers et al., 2009; Cunha-Ferreira et al., 2009; Holland et al., 2010; 
Sillibourne et al., 2010) in addition to phosphorylating FBXW5 (Puklowski et al., 2011; 
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Pagan and Pagano, 2011) and Chk2 (Petrinac et al., 2009), though loss of either of these 
targets has no direct effect on centriole number in D.m. (Rogers et al., 2009). In C.e., earlier 
experiments indicated that SAS-6 is a phosphorylation target of the Plk4 ortholog ZYG-1 
(Kitagawa et al., 2009), though further work demonstrated that ZYG-1 directly binds SAS-6 
for its recruitment to nascent centrioles in a phosphorylation-independent manner (Lettman et 
al., 2013). Thus, the identity of the direct Plk4 phosphorylation target(s) remains unknown 
and contested. Of specific interest to the field is whether Plk4 even directly targets a centriole 
duplication player, or whether Plk4 indirectly licenses centriole duplication by preventing 
degradation of daughter centriole components (Puklowski et al., 2011; Pagan and Pagano, 
2011). 
  
Plk4 is a divergent member of the Polo-like family of kinases 
 Plk4 is a member of the widely conserved Polo-like family of serine/threonine 
kinases (Figure 1.4), which collectively regulate cell cycle progression and proliferation 
(Park et al., 2010). The most widely studied member of the Plk family, Plk1 is a ubiquitous 
kinase in cycling cells with roles in mitotic entry and exit, centrosome maturation, spindle 
assembly, chromatin segregation and cytokinesis, and oncogenic transformation (Xu et al., 
2013; Park et al., 2010). Plk2/Snk, Plk3/Prk/Fnk, and Plk5 are less studied, though each is 
known to have distinct functions. Plk2, though not essential, is associated with centriole 
maintenance and avoiding mitotic catastrophe (van de Weerdt et al., 2008; de Carcer et al., 
2011). Plk3 is required for S phase entry and cyclin E production (Zimmerman and Erikson, 
2007). Interestingly, Plk5 is the only member of the Plk family that has lost catalytic activity, 
as a premature stop codon prevents expression of the kinase domain in the human protein 
 (Figure 1.4); furthermore, it is only
central nervous system, underlining its evolutionary departure from the other Plk’s roles in 
proliferative tissues (de Carcer et al., 2011
though in different measures: its kinase domain more closely resembles that of the Aurora 
family of kinases than the Plk family (
Oegema), and unlike all other Plk members, Plk4 contains three structurally defined Polo 
Box (PB) domains rather than two 
throughout embryonic development and in adult proliferative tissues in humans, i
bone marrow and the male testis 
 
 
Figure 1.4. The architectural map of the Plk family of kinases highlights the divergence 
of Plk4. Each Homo sapiens 
All Plks share an N-terminal kinase domain (black), though Plk4’s kinase domain more 
closely resembles Aurora kinases. Plks 1, 2, 3, and 5 share a C
domains (PB1-PB2, light and dark purple) that generally regulate the activity and targe
the full-length molecule (see the following sections for in
function). Plk1 contains an inter
cis to inhibit kinase activity in a PB1
a downstream regulatory element (DRE, green) immediately C
used to regulate protein levels preceding centriole duplication (see the following section for 
in-depth discussion of the DRE). Plk4 al
terminal array of three distinct PB domains 
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 expressed in fully differentiated tissue types including the 
). Plk4 is likewise divergent from the Plk4 family, 
personal communication, Yao Liang Wong and Karen 
(Slevin et al., 2012). Plk4, like Plk1, is largely expressed 
(de Carcer et al., 2011). 
major isoform is shown here, with each cartoon drawn to scale. 
-terminal pair of Polo Box 
-depth discussion regarding PB 
-domain linker (IDL, tan) that binds Plk1’s kinase domain in 
-PB2-dependent fashion (Xu et al., 2013
-terminal to its kinase domain, 
so differs from the Plk family by containing a C
(Slevin et al., 2012; Park et al., 2014; 
 
ncluding 
 
ting of 
). Plk4 contains 
-
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Shimanovskaya et al., 2014).  PB1-PB2 (red and orange) collectively bind scaffolding 
proteins, localizing Plk4 to its centriolar targets, and homodimerize in trans to afford DRE-
dependent polyubiquitination (Dzhindzhev et al., 2010; Slevin et al., 2012). *Plk5’s kinase 
domain is truncated and non-functional, followed by another start site that initiates the 
remainder of the Plk5 polypeptide. 
 
 
 
The mechanism of Plk4’s licensing activity followed by swift degradation is conserved 
among opisthokonts  
 
 Despite the lack of conservation between Plk4 and the other Plk family members, 
Plk4 remains an essential centriole duplication component within all animals and most 
eukaryotes, excluding higher plants and fungi (Shimanovskaya et al., 2014). It has been 
hypothesized that Plk1, present in the last eukaryotic common ancestor, was once responsible 
for many more cell cycle functions, including centriole duplication (Carvalho-Santos et al., 
2010). Over several gene duplication events, Plk1 eventually gave rise to Plks 2, 3, 4, and 5, 
a hypothesis supported by the fact that heterokonts, alveolates, higher plants and amoebozoa 
still rely on Plk1 for functions supported by the collective Plk family in animals. This gene 
duplication event allowed for uncoupling between centriole duplication and mitotic 
functions; such uncoupling and differentiation events are thought to be an integral part of 
creating higher-complexity organisms throughout evolution (Carvalho-Santos et al., 2010; 
Ohno, 1970). Plk4 has been widely studied in human, mouse, and fly homologs, with a 
tentative ortholog in C. elegans called ZYG-1. Although ZYG-1 lacks apparent sequence 
homology with all other Plk4 homologs, it is also a kinase that regulates centriole assembly 
in nematodes (Dammermann et al., 2004; Pelletier et al., 2006; Delattre et al., 2006). 
However, recent work using x-ray crystallography has demonstrated that ZYG-1 contains a 
pair of tandem Polo Box (PB) domains, a feature common to all Plk4 homologs 
(Shimanovskaya et al., 2014). These new data suggest that, contrary to former belief, ZYG-1 
 represents a new class of bona fide 
 Biochemical and structural techniques as well as functional studies in cell culture 
have revealed the architecture and modules within both human and 
et al., 2002; Habedanck et al., 2005; Dzhindzhev et a
al., 2013; Shimanovskaya et al., 2014
domain is the downstream regulatory element (DRE) (Figure 1.5), a phospho
region with important roles in down
al., 2009; Rogers et al., 2009
region for F-box binding (β-TrCP in 
degradation. This degradation event is essential to limit Plk4 levels in cells, as ectopic Plk4 
constructs that are phosphorylation
leading to centriole amplification 
al., 2010).  
 
 
Figure 1.5. Plk4 is functionally conserved and maintains specific structural modules. 
architectural comparison of the functional Plk4 orthologs reveals conservation within the 
domain architecture. H.s., Homo sapiens 
Drosophila melanogaster (fruit fly);
homologs share a similar N-terminal kinase domain (black), while most orthologs (excluding 
C.e. ZYG-1) share the DRE (green), a region u
central pair of PB domains (PB1
degradation of the FL molecule. The function of the C
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Plk4 orthologs. 
Drosophila 
l., 2010; Slevin et al., 2012; Sonnen et 
). Immediately C-terminal to the conserved kinase 
-regulating the full-length molecule (Cunha
). Active Plk4 autophosphorylates the DRE in trans, 
H.s.; Slimb in D.m.), polyubiquitination, and proteolytic 
-resistant in both H.s. and D.m. cells become stabilized, 
(Cunha-Ferreira et al., 2009; Rogers et al., 2009; H
(human); M.m., Mus musculus 
 C.e., Caenorhabditis elegans (nematode). All Plk4 
sed to regulate FL protein stabilization. A 
-PB2, red and orange) collectively regulate localization and 
-terminal PB3 (blue) remains debated 
 
Plk4 (Leung 
-regulated 
-Ferreira et 
priming the 
olland et 
 
An 
(mouse); D.m., 
 and undefined. *Asterisks indi
similarity, but not structurally verified as PB domains. The other PB structures and their 
references are as follows: (H.s. 
D.m. PB1-PB2: Slevin et al., 2012 and Shimanovskaya et al., 2014; 
data, unpublished; C.e. PB1-PB2: Shimanovskaya et al., 2014
                        
 The C-terminus of Plk4 comprises an array of three PBs. PB1
orange, respectively, in Figure 1.5) together bind Asterless (Asl), affording localization of the 
full-length molecule to the site of daughter centriole assembly 
Shimanovskaya et al., 2014). Additional work from our lab has shown that PB
homodimer in trans, effectively dimerizing the full
binding and, ultimately, polyubiquitination and degradation (Figure 1.6) 
The PB1-PB2 cassette is a conserved feature of Plk4s ac
(shown in Figure 1.5). Unique to Plk4 is the presence of the C
unknown function in the context of the FL molecule. Early work determined that the 
PB3 also forms a dimer; however, work from 
PB3 is not sufficient for robust centriole localization 
The role of PB3 in Plk4 function remains unclear.
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Figure 1.6. Plk4 depends on the PB1-PB2 homodimerization interface to 
autophosphorylate in trans and bind F-box proteins for its degradation. (A) Active Plk4 
(activity notated by a yellow star in the kinase domain) dimerizes via a strong 
homodimerization interface between PB1-PB2 cassettes in two protomers (Slevin et al., 
2012), allowing for phosphorylation of the DRE in trans. (B) Schematic of the FL molecules 
following dual phosphorylation events in trans. The phosphorylated DRE region is able to 
then bind an F-box protein (Slimb in D.m., purple; β-TrCP in H.s.) for its degradation 
mechanism. Note that 1) both diagrams refer to information gleaned in D.m. Plk4, 2) the 
molecules are translated horizontally relative to each other in (B), and 3) the oligomerization 
state of PB3 remains contested in D.m. The author’s unpublished data suggest that PB3 is a 
monomer in D.m., thus the schematic presents a monomeric form. 
 
 
The Polo Box (PB) domain is used to regulate Plk activity and subcellular targeting by 
employing a structurally defined fold 
 
 The PB domain takes a conserved, simple structural fold: a 6-stranded anti-parallel β-
sheet packed perpendicularly against a single α-helix (Figure 1.7 A and B). Though the 
sequences and binding partners vary greatly among Plks (Yun et al., 2009; Slevin et al., 
2012; Xu et al., 2013; Park et al., 2014; Shimanovskaya et al., 2014), serial structural 
alignments of single PB domains reveal little structural divergence among the individual 
domains, with RMSD values ranging from 1.5 to 4 Å (Figure 1.7 C). However, three trends 
emerge when comparing both structural alignments as well as their sequence conservation 
(Figure 1.7 C,D): 1) PB structures share greater primary and tertiary structure elements 
within the same spatial orthologs (i.e., PB1s are more similar in both structure and sequence 
to other PB1s, PB2s are more similar to other PB2s, etc.); 2) As predicted, C.e. ZYG-1 is the 
least similar in primary structure for each respective PB than any other species; 3) PB2 
architecture deviates from the prototypical PB structure in that its β6 strand is parallel to its 
neighbor and occurs C-terminal to the single α-1 helix (Figure 1.7 E, blue arrow pointing to 
β6 within C.e. ZYG-1 PB2). Despite these trends, the average RMSD difference between any 
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known single PB structure is 2.55 ± 0.62 Å, indicating that the wide variety of PB functions 
arises not due to large structural differences among individual PB domains, but due to the 
overall differences among varied PB oligomeric arrays and possibly different conserved 
residues across similar folds. 
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Figure 1.7. The structure of each solved PB domain takes on a conserved fold. (A) The 
structure of a single PB domain (D.m. Plk4 PB1, PDB accession code 4G7N, Slevin et al., 
2012) reveals a 6-stranded antiparallel β-sheet packed (cyan, labeled β1-β6) orthogonally 
against a single α-helix (olive, labeled α1). Loops are shown in dark gray and have been 
smoothened for simplicity. (B) A schematic depicting the architecture of a typical PB 
domain, mimicking the geometry of the PB domain shown in A. Note that the N-terminus of 
the protein begins at β1, the middle forms the serpentine β-sheet, and then the C-terminus 
consists of the final α1. The dotted lines indicate that the loop connecting β6 and α1 goes 
back into the plane of the field of view. (C) A series of structural alignments (using the DALI 
pairwise alignment server, Holm and Rosenström, 2010) reveals little differences among the 
solved PB domain structures, regardless of species or Plk origin. The species, Plk, and PB 
number are noted for each PB tested; each was aligned to every other PB within the grid, and 
the RMSD and percent identity is reported within the corresponding box. Each box within 
the grid is colored according to a green/red scale, with green indicating the lowest RMSD 
(best alignment) and red indicating the highest RMSD (poor alignment).  (D) A grid showing 
the sequence conservation between the same individual pairs as in C, with green indicating 
high conservation and red indicating low conservation. (E) Alignment between D.m. Plk4 
PB1 (shown in eggplant) and either H.s. Plk4 PB1 (PDB accession code 4N9J (Park et al., 
2014), shown in bronze) or C.e. ZYG-1 PB2 (PDB accession code 4NKB (Shimanovskaya et 
al., 2014), shown in blush) reveals conservation among Plk4 PB1 homologs and structural 
differences between Plk4 PB1 and PB2 homologs. 
 
  
 Illustrating the differences in PB function in a Plk context-dependent manner is a 
recent study illuminating the mechanism by which Plk1’s PB1-PB2 array regulates FL 
catalytic activity (Xu et al., 2013). This study employed x-ray crystallography to show that 
Plk1’s PB1-PB2 bind each other in cis, forming a structural unit that collectively binds and 
stabilizes the kinase domain within the same molecule (Figure 1.8 A,B). In binding the 
kinase domain, the PB1-PB2 heterodimer collectively prevents the flexibility needed for the 
kinase to accept substrates; thus, in binding the kinase, the PB1-PB2 heterodimer effectively 
autoinhibits the FL molecule. Interestingly, the mechanism of activating the kinase and 
localizing the FL molecule to the right place at the right time is one and the same: the PB1-
PB2 heterodimer binds primed (phosphorylated) targets at subcellular structures including 
the kinetochore, relieving the PB1-PB2-kinase interaction, activating the kinase, and 
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localizing it to its catalytic targets (Elia et al., 2003; Kang et al., 2006; Yun et al., 2009). 
More specifically, the PB heterodimer recognizes the consensus motif Pro/Phe-X-X-
Thr/Gln/His/Met-Ser-pThr/pSer-Pro/Y (Elia et al., 2003) (where X is a hydrophobic residue 
and Y is any residue) within its binding targets, which are known to include at least CENP-
50 (also known as PBIP1/KLIP1/MLF1IP (Lee et al., 2014)) at kinetochores and hCenexin1, 
an ODF2 splice variant that localizes to somatic centrosomes (Soung et al., 2009). Plk1 
targets can either be primed by other cell cycle-related kinases (i.e., Cdk1) or Plk1 itself, 
indicating that Plk1 may have a positive feedback regulation feature: the more active Plk1 is, 
the more it phosphorylates its targets, and thus the more frequent the binding events between 
PB1-PB2 and primed targets. The structure of human Plk1 PB1 bound to a phospho-peptide 
representative of primed CENP-50 reveals that the PB heterodimer collectively binds the 
target, relieving autoinhibition of the kinase activity (Yun et al., 2009; Xu et al., 2013) 
(Figure 1.8 B,C). Both PB1 and PB2 determinants contribute to binding phospho-CENP-50, 
underlining the importance of the PB1-PB2 array.  
  
Figure 1.8. Plks employ PB domains to take on differential dimeric configurations for 
cellular function. (A) A list of the compared Plks and their known PB oligomeric states. 
Those states labeled with asterisks (*
conservation between mouse and human Plk4. (B) Plk1 PB1
architecture to bind the kinase and allosterically inhibit its catalytic activity 
Following phosphorylation events of centrosomal and/or centromeric targets, the PB1
structural unit binds the phospho
domain. (C) The crystal structure of PB1
CENP-50 (PDB accession code 3FVH
shown in two orientations.  
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) indicate predicted oligomeric states based on the 
-PB2 take on a 
(
-primed targets, releasing the interaction with the kinase 
-PB2 bound to a phospho-peptide representative of 
, Yun et al., 2009) with the same color scheme as B, 
 
 
 
multidomain 
Xu et al., 2013). 
-PB2 
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 Importantly, PB domains also act in arrays within Plk4 PB pairs; however, instead of 
interacting as a heterodimer in cis, Plk4 PB1-PB2 function as a homodimer in trans (compare 
Figure 1.8 B to Figure 1.6 B). Additionally, extensive studies in both D.m. and H.s. cultured 
cells have demonstrated the phospho-independence of Plk4-Asl/SPD-2 binding, indicating 
that the mechanism by which Plk4 PB1-PB2 binds targets and attains subcellular localization 
differs from that of Plk1 PB1-PB2 target binding, which is phospho-dependent (Dzhindzhev 
et al., 2010; Hatch et al., 2010; Shimanovskaya et al., 2014). To date, many of the PB 
structures that have been solved have included pairs of PB domains. Consistent with the idea 
that PB pairs are employed differently by each Plk, the structures of PB pairs display much 
more sequence variance than individual PB domains (Figure 1.9 A). Structural alignments of 
all known PB1-PB2 pairs reveals that Plk1’s PB1-PB2 heterodimer also takes a different 
conformation than Plk4 PB1-PB2 pairs (Figure 1.9 B, bottom left). Plk1 PB1-PB2 
collectively create a composite clamshell fold, which acts as a pincer used to bind 
phosphotargets (Xu et al., 2013). In this conformation (Figure 1.9 B, purple), Plk1 PB1-PB2 
each contributes their six-stranded β-sheet to interface in the center of the clamshell, with the 
single α-helix flanking on either side. In contrast, Plk4 PB1-PB2 pairs form a head-to-tail 
conformation in which PB1’s C-terminal α1 helix leads directly into PB2’s β1 strand, 
restricting the distance between the two PB domains and preventing them from creating a β-
clamshell like that of Plk1’s PB1-PB2. The head-to-tail formation of D.m. Plk4’s PB1-PB2 is 
a conserved fold, as it has also been described in both C.e. ZYG-1 and H.s. Plk4 (Figure 1.9 
B, bottom right; Shimanovskaya et al., 2014; Park et al., 2014). The novelty of the Plk4 PB1-
PB2 homodimer formation, as well as its unusual head-to-tail conformation, indicates that 
Plk4 PB1-PB2 performs a distinct function in the context of the FL molecule (see Chapter 2 
 for a thorough discussion).  
 
                                  
Figure 1.9. PB1-PB2 pairs diverge in both sequence and structure. 
alignment (Holm and Rosenström, 2010
reveals large differences between Plk1 PB pairs and Plk4 PB pairs (top row, ranging from 
12-18% sequence identity). All known Plk4 homolog PB1
closely, with sequence identities ranging from 18
color-code sliding scale, with white 
representing complete identity.
accession code 4G7N, in oranges; 
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) of all structurally characterized PB1
-PB2 pairs align much more 
-40%. Sequence similarity is shown on a 
squares representing low similarity and cobalt squar
 The structures of 3 specific PB1-PB2 pairs (
H.s. Plk1, PDB 4J7B, in purples; H.s. Plk4, PDB 4N9J, in 
 
(A) Pairwise 
-PB2 pairs 
es 
D.m. Plk4, PDB 
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greens) are shown in the sidebar. (B) Structural alignments between PB1-PB2 pairs 
demonstrate large differences between Plk1 and Plk4 PB arrays. Plk4 PB1-PB2 from both 
D.m. and H.s. align well with similar folds and primary sequences, while Plk1 PB1-PB2 
collectively form a “pincer,” interacting side-to-side rather than head-to-tail. 
 
PB3: The odd one out 
 Much of the work completed regarding Plk4’s PB domains has focused on the central 
PB1-PB2 array (Slevin et al., 2012; Park et al., 2014; Shimanovskaya et al., 2014), leaving 
the centriole duplication with a fascinating question: what is the purpose of Plk4’s C-terminal 
PB domain (PB3)? As discussion in-depth in Chapter 2, Plk4 PB1-PB2 collectively play an 
integral role in binding centriole targets, localizing the FL molecule to the site of nascent 
centriole formation, and regulating the stability of the FL molecule (Slevin et al., 2012). In 
Plk1, PB1-PB2 fulfills all of these important roles, but with one additional job: it also 
directly regulates kinase activity by allosteric inhibition. At press time, Plk4 is unknown to 
have such autoinhibition mechanism. It is tempting then to speculate that PB3 may play a 
role in regulating Plk4 catalytic activity, though this is yet to be shown. Interestingly, despite 
Plk4’s PB1-PB2 forming a structurally and sequence-conserved domain throughout all 
studied animals, PB3 appears to be more divergent; in humans and mice, PB3 forms a stable 
dimer in solution (author’s work, unpublished; Leung et al., 2002, respectively), while in 
fruit flies, it remains a monomer in solution (author’s work, unpublished). Whether PB3 
plays different roles in different Plk4 homologs remains an interesting question, and is the 
focus of the work described in Chapter 3. The future promises to hold exciting discoveries 
concerning polo box domains, which will shed light not only on their direct functions in a 
cellular context, but also on the evolutionary development of mechanisms to limit centriole 
duplication to a single, cell cycle-dependent event. 
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CHAPTER 2: THE STRUCTURE OF THE PLK4 CRYPTIC POLO BOX REVEALS 
TWO TANDEM POLO BOXES REQUIRED FOR CENTRIOLE DUPLICATION 1 
 
 
Summary 
 Centrioles are key microtubule polarity determinants. Centriole duplication is tightly 
controlled to prevent cells from developing multipolar spindles, a situation that promotes 
chromosomal instability. A conserved component in the duplication pathway is Plk4, a polo 
kinase family member that localizes to centrioles in M/G1. To limit centriole duplication, 
Plk4 levels are controlled through trans-autophosphorylation that primes ubiquitination. In 
contrast to Plks 1-3, Plk4 possesses a unique central region called the “Cryptic Polo Box”. 
Here, we present the crystal structure of this region at 2.3-Å resolution. Surprisingly, the 
structure reveals two tandem, homodimerized polo boxes, PB1-PB2, that form a unique, 
winged architecture. The full PB1-PB2 cassette is required for binding the centriolar protein 
Asterless as well as robust centriole targeting. Thus, with its C-terminal polo box (PB3), Plk4 
has a novel, triple polo box architecture that facilitates oligomerization, targeting, and 
promotes trans-autophosphorylation, limiting centriole duplication to once per cell cycle. 
 
 
Introduction 
 
 Centrioles are cylindrical, microtubule-based structures that form the core 
 
 
_____________________________ 
1
 Slevin, L.K., Nye, J., Pinkerton, D.C., Buster, D.W., Rogers, G.C., and Slep, K.C. (2012). The structure of the 
Plk4 Cryptic Polo Box reveals two tandem Polo Boxes required for centriole duplication. Structure. 20(11), 
1905-1917.  
components of centrosomes and basal bodies, organelles that nucleate and spatially organize 
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microtubules to form the mitotic spindle and cilia (Bornens 2012). Centriole number is 
precisely controlled with centriole duplication restricted to a single cell cycle event (Tsou 
and Stearns, 2006; Tsou et al., 2009; Nigg and Stearns, 2011). Centrioles exist as pairs 
composed of an older (mother) centriole and a daughter centriole, assembled on the mother 
centriole in the preceding cell cycle. G1-phase cells contain a single mother-daughter 
centriole pair. During S-phase, centrioles separate and duplicate, generating two mother-
daughter pairs that facilitate bipolar spindle assembly. The mechanisms underlying centriole 
duplication define a critical step in cellular biology, as misregulation of centriole number is 
linked to chromosome instability and diseases including ciliopathies, male sterility, primary 
microcephaly, and tumorigenesis (Bettencourt-Dias et al., 2011; Rosario et al., 2010; Nigg 
and Raff, 2009).  
 Several proteins are required for centriole biogenesis. Among these are the conserved 
proteins Polo-like kinase 4 (Plk4/Sak), Asterless/Cep152, SAS-6, SAS-5/Ana2/STIL, 
Cep135, and SAS-4/CPAP (Song et al., 2008; Azimzadeh and Marshall, 2010). The order of 
subunit addition suggests a hierarchical centriole assembly pathway conserved across phyla. 
Asterless (Asl), a scaffolding protein, initially recruits Plk4 to the site of daughter centriole 
assembly (Hatch et al., 2010; Dzhindzhev et al., 2010; Cizmecioglu et al., 2010). Plk4 
activity is upstream of the SAS proteins and primes the mother centriole for S-phase 
duplication (Pelletier et al., 2006; Kleylein-Sohn et al., 2007; Kitagawa et al., 2009). 
Daughter centriole (procentriole) assembly begins at the proximal end of the mother centriole 
with the formation of a nine-fold symmetric cartwheel structure composed of SAS-6 
homodimers (Kitagawa et al., 2011; van Breugel et al., 2011). How Plk4 initiates centriole 
assembly is not well defined. In Caenorhabditis elegans, ZYG-1 (the Plk4 homolog) 
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phosphorylates SAS-6, triggering centriole formation (Kitagawa et al., 2009), although this 
has not been shown in other systems. In humans, Plk4 inactivates FBXW5, a SCF (Skp, 
Cullin, F-box) component used to degrade SAS-6, suggesting that Plk4 initiates centriole 
duplication by stabilizing SAS-6 (Puklowski et al., 2011). However, Drosophila FBXW5 has 
no role in controlling centrosome number (Rogers et al., 2009). Thus, while species show 
some divergence in the duplication pathway, Plk4 has emerged as a master-regulator of 
centriole assembly. 
Plk4 and its binding partner Asl are required for centriole duplication (Bettencourt-
Dias et al., 2005; Habedanck et al., 2005; Varmark et al., 2007) and studies in human, 
Drosophila and Xenopus systems show that Plk4 or Asl overexpression promotes centriole 
amplification as well as de novo centriole assembly (Rodrigues-Martins et al., 2007; Peel et 
al., 2007; Dzhindzhev et al., 2011; Eckerdt et al., 2011). Plk4 is regulated by the SCFSlimb/β-
TrCP ubiquitin ligase which recognizes Plk4 after homodimer-dependent trans-
autophosphorylation of the phosphodegron known as the Downstream Regulatory Element 
(DRE) (Guderian et al., 2010, Cunha-Ferreira et al., 2009; Rogers et al., 2009; Brownlee et 
al., 2011; Holland et al., 2010). In cultured Drosophila cells, Plk4 is degraded throughout 
most of the cell cycle to prevent centriole amplification (Peel et al., 2007; Kleylein-Sohn et 
al., 2007). During M-phase however, Plk4 is dephosphorylated by Protein Phosphatase 2A, 
thereby stabilizing Plk4, allowing a brief mitotic debut that restricts centriole duplication to a 
single event per cell cycle (Brownlee et al., 2011). 
 Plk4 is a member of the Polo-like kinase family. Plk members 1-4 share sequence 
similarity to the founding member, Drosophila Polo (Plk1) (Sillibourne and Bornens, 2010). 
Like Polo, Plk members regulate cell-cycle events that collectively include spindle 
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formation, the metaphase-to-anaphase transition, mitotic exit, cytokinesis, and DNA damage 
checkpoints. To perform these critical functions, Plk gene expression, protein expression, 
localization, kinase activity, and destruction are tightly regulated throughout the cell cycle 
(Archambault and Glover, 2009) as aberrant Plk activities contribute to chromosome 
instability and oncogenesis.  
 Plks share an amino-terminal serine/threonine kinase domain, as well as one or more 
~100-residue polo box (PB) domains. Plk members 1-3 contain two carboxy-terminal PBs 
(Figure 2.1 A) that interact in cis to bind phosphorylated targets, mediate localization, and 
activate the kinase (Lowery et al., 2005). The architecture of a PB domain consists of an anti-
parallel 6-stranded β-sheet that lies across a C-terminal α-helix (Leung et al., 2002). Plk1’s 
tandem PBs  (PB1-PB2) clamp around a phosphopeptide target with each PB contributing 
binding determinants (Elia et al., 2003; Cheng et al., 2003). Intriguingly, Plk4 is structurally 
divergent. It was annotated as containing only a single, carboxy-terminal PB, which confers 
homodimerization and moderate centriole localization by binding an unidentified target 
(Leung et al., 2002). The structure of the Plk4 PB is homodimeric and adheres to a general 
PB architecture, though it is formed through swapped chains of the homodimer. The 
homodimeric arrangement of this Plk4 PB is distinct from the tandem arrangement of the 
Plk1 PB1-PB2 pair, indicative that PBs adopt differential spatial arrangements. 
 Plk4 also contains a conserved central domain, hitherto called the “Cryptic Polo Box” 
(CPB), which bridges the kinase domain and the carboxy-terminal PB. This region was 
initially identified as a centriole-targeting component, capable of binding the kinase domain 
in trans (Leung et al., 2002). Based on these properties, the region was named the “Cryptic 
Polo Box” though it showed no apparent sequence homology to canonical PBs (Swallow et 
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al., 2005). Recent work has identified a CPB binding partner, Asterless (Asl)/Cep152, which 
targets Plk4 to centrioles (Dzhindzhev et al., 2010; Hatch et al., 2010, Cizmecioglu et al., 
2010). To date, the CPB has largely remained an enigma, with questions concerning its 
structure, function in centriole localization, and role in Plk4 activity outstanding. 
 Here, we present the crystal structure of the CPB, determined to a resolution of 2.3 
Å. Surprisingly, this structure reveals that the CPB comprises two structurally unique PB 
domains, PB1 and PB2. Cellular localization and biochemical studies indicate that the entire 
tandem PB1-PB2 cassette is required for robust centriole localization and Asl binding. The 
PB1-PB2 cassette also mediates Plk4 oligomerization, and when expressed as a trans 
cassette, protects endogenous Plk4 from trans auto-phosphorylation and subsequent 
degradation. Thus, the Plk4 PB1-PB2 cassette is a unique architectural component required 
for Plk4 function. 
 
Experimental Procedures 
Cloning and Protein Purification 
 Drosophila melanogaster Plk4 (DG7186) PB1-PB2, residues 382-602, was subcloned 
into pET28b (Novagen), engineering a thrombin-cleavable N-terminal His6 tag. Protein was 
expressed in BL21 DE3 E. coli cells under kanamycin selection and induced with 100 µM 
IPTG for 16 hr at 20°C. Cells were harvested, resuspended in lysis buffer (25 mM Tris pH 
8.0, 300 mM NaCl, 10 mM Imidazole, 0.1 % β-ME) supplemented with 1 mM PMSF, and 
sonicated to lyse. Lysate was clarified at 23,000 x g for 45 min and supernatant applied to a 
Ni2+-NTA resin (Qiagen). Plk4 was eluted using a 250 ml, 10-300 mM Imidazole gradient in 
lysis buffer. Fractions containing Plk4 were pooled, supplemented with 1 mM CaCl2 and 
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digested for 12 hr at 4°C with 1 µg/ml bovine α-thrombin. Digested Plk4 was filtered through 
1 ml benzamidine sepharose (GE Healthcare) and exchanged into 100 ml of 25 mM HEPES, 
pH 7.0, 0.1 % β-ME, loaded onto a SP-sepharose column (GE Healthcare), and eluted over a 
250 ml, 0-1 M NaCl gradient in 25 mM HEPES, pH 7.0, 0.1 % β-ME. Fractions containing 
Plk4 were pooled, exchanged into protein storage solution (50 mM Tris pH 9.5, 300 mM 
NaCl, 0.1% β-ME, 10% glycerol), concentrated to 7.2 mg/ml, and frozen in liquid nitrogen. 
Selenomethionine (SeMet)-substituted Plk4 (aa 382-602) proved insoluble. We hypothesized 
that one of the four methionine residues in the PB1-PB2 cassette was affecting solubility 
when substituted by SeMet, so we systematically mutated each of the four methionines to 
leucine or alanine and screened for solubility when only three selenomethionines were 
incorporated into the region spanning aa 382-602. Point mutants were generated using the 
Quikchange method (Stratagene). SeMet-substituted Plk4 M517A was expressed in B834 
DE3 E. coli cells using SeMet minimal media (Leahy et al., 1994). SeMet-substituted Plk4 
(aa 382-602) M517A proved marginally soluble and could be concentrated to 3.2 mg/ml 
before precipitating out of solution, in contrast to wild-type Plk4 (aa 382-602) that could be 
concentrated to 7.2 mg/ml before starting to precipitate out of solution. Expression and 
purification protocols for SeMet-substituted Plk4 (aa 382-602) M517A were identical to 
wild-type Plk4 (aa 382-602) except for the difference in final concentrations. The PB2 
residues M514 and M517 reside on the two β-strands that are bridged by the C511-C566 
disulfide bond. The cystine likely limits the degree of change in packing caused by SeMet-
substitution. In addition, both M514 and M517 form interactions with neighboring β-strands 
that contribute to domain stability. We hypothesize that SeMet-substitution at these residues 
disrupted these interactions, and in turn the stability of the PB2 domain fold, leading to 
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insolubility for the SeMet wild-type construct as well as decreased solubility for the SeMet 
M517A construct. 
Crystallization, Data Collection, and Structure Determination 
 Native Plk4 was crystallized by the hanging drop method using a mother liquor (1ml) 
containing 1.2 M Li2SO4, 100 mM HEPES, pH 7.5 and a drop containing 2 µl 7.2 mg/ml 
protein stock and 2 µl mother liquor. Native crystals were transferred to Fomblin oil (Sigma) 
and flash frozen in liquid nitrogen. SeMet-substituted M517A Plk4 was crystallized using a 
mother liquor (1 ml) containing 1.4 M Li2SO4, 100 mM HEPES pH 7.5 and a drop 
containing 2 µl of 3.2 mg/ml protein stock and 1 µl mother liquor. SeMet-substituted crystals 
grew on the same time scale and to the same dimensions as native crystals. SeMet M517A 
Plk4 crystals were transferred to fomblin oil and flash frozen in liquid nitrogen. Diffraction 
data were collected at the Advanced Photon Source SER-CAT beamlines 22-ID (native data, 
1.00890 Å) and 22-BM (M517A Se peak SAD data, 0.97980 Å). Crystals belong to the space 
group P21212 with two molecules in the asymmetric unit. Data were processed and scaled 
using the HKL2000 suite (Otwinowski and Minor, 1997). The Phenix program suite (Adams 
et al., 2010) was used to find selenium sites, phase, build, and refine the structure with 
reiterative building in Coot (Emsley et al., 2010). Refinement was monitored using 10% of 
the data randomly excluded from the refinement and used to calculate an R free (Brünger, 
1992). Initial refinement employed a MLHL target function and SeMet phases followed by a 
ML target function against native data to 2.3 Å. The SeMet-substituted M517A crystals and 
the native crystals were isomorphous, indicative that the M517A mutation, and the 
incorporation of SeMet at the remaining methionine positions did not affect the overall 
structure of the PB1-PB2 cassette. The model includes two Plk4 protomers: chain A (residues 
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382-596) and chain B (residues 382-548, 553-597) each preceded by a four residue (Gly-Ser-
His-Met) N-terminal cloning artifact, 186 water molecules, and six sulfate ions. Electrostatics 
were calculated using APBS (Baker et al., 2001). Structural alignments and rmsd values were 
calculated using the Dali server (Hasegawa and Holm, 2009). Because the Plk4 PB3 domain 
uses two molecules to form a canonical PB domain, residues from PB3 chains A and B were 
selected to form a single chain PB3 domain for comparative purposes.  
Size Exclusion Chromatography and Multi-angle Light Scattering (SEC-MALS) 
 D.m. Plk4 PB1-PB2 was purified without cleaving the N-terminal His6 tag (MW = 
27,558 Da) and exchanged into running buffer (300 mm NaCl, 25 mm HEPES, pH 7.0, 0.1% 
β-mercaptoethanol, and 0.2 g/liter sodium azide). A Superdex 200 10/300 GL gel filtration 
column (GE Healthcare) was equilibrated in the running buffer and runs containing 100 µl of 
protein were injected onto the column. Eluate was passed in tandem through a Wyatt DAWN 
HELEOS II light scattering instrument and a Wyatt Optilab rEX refractometer. The light 
scattering and refractive index data were used to calculate the weight-averaged molar mass of 
each peak using the Wyatt Astra V software program (Wyatt Technology Corp.)(Wyatt, 
1993). Two Plk4 PB1-PB2 runs were performed, the first with 100 µl of 19 µM protein, the 
second with 100 µl of 28 µM protein. A control run was also performed using 100 µl of 90 
µM bovine serum albumin (MW = 66463 Da) which gave monomer, dimer and trimer peaks 
with experimentally determined molecular weights of 63 ± 1 kDa, 134 ± 9 kDa and 207 ± 43 
kDa respectively (Figure 2.S1 D).  
Dynamic Light Scattering 
 Purified Plk4 PB1-PB2 protein with the N-terminal His6 tag removed (MW 25,675 
Da, concentrated to 3.6 mg/ml in 50 mM Tris pH 9.5, 300 mM NaCl, 0.1% β-ME, 10% 
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glycerol) was analyzed in a Wyatt DynaPro dynamic light scattering plate reader. 
Measurements are reported in Table 2.2. 
Centriole Localization Assay 
 S2 cell culture was performed and maintained as described in Rogers and Rogers 
(2008). In brief, S2 cells were cultured in SF900II serum-free media (Invitrogen) 
supplemented with 1% Antibiotic-Antimycotic (Invitrogen). Plk4 constructs were subcloned 
into D-TOPO/pENTR (Invitrogen), and shuttled via Gateway technology (Invitrogen) into a 
modified pMT destination vector that engineers a C-terminal EGFP tag (D. Roberts). 
Constructs included PB1-PB3 (aa 382-741), PB1-PB2 (aa 382-602), PB1 (aa 382-500), PB2 
(aa 500-602), PB1+ (382-525), and Linker-PB3 (L-PB3, aa 603-741). S2 cells were 
transfected (Amaxa Cell Line Nucleofector Kit V, Lonza), induced with ~100 µM CuSO4, 
plated on Concanavalin A (ConA)-coated coverslips, and washed with HL3 media (70 mM 
NaCl; 5 mM trehalose; 115 mM sucrose; 5 mM HEPES; pH 7.2). Cells were then fixed in 
HL3 with 10% formaldehyde for 15 minutes, washed in phosphate buffered saline containing 
0.1% Triton X100 and TWEEN (PBST), and blocked with 5% normal goat serum (NGS, 
Invitrogen) in PBST. Primary rabbit anti-D-PLP antibody was diluted 1:3000 and applied to 
cells for 30 minutes. Following PBST rinses, cells were treated with a Cy3 labeled secondary 
antibody (Jackson ImmunoResearch Laboratories) diluted 1:500 for 30 minutes and rinsed 
with PBST. Samples were mounted in a glycerol-based medium (90% glycerol, 10% PBS, 
3% w/v n-propyl gallate) and imaged using a 100x objective (NA 1.49) Apochromatic TIRF 
objective (Nikon) mounted on an inverted microscope (Nikon Eclipse Ti) equipped with a 
cooled charge-coupled device camera (CoolSNAP HQ, Roeper Scientific), an excitation and 
emission wheel (LUDL), and emission filters (Chroma). All microscope hardware was 
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controlled by Nikon NIS-Elements. All images were processed and prepared for publication 
using Photoshop (CS5 version 12.0). Cells were processed and binned into one of three 
categories: strongly co-localized, weakly co-localized, or not co-localized. Co-localized cells 
displayed GFP signal at every centriole labeled using anti-D-PLP antibody; weakly co-
localized cells displayed weak GFP signal at some, but not all centrioles; and not co-
localized cells displayed no GFP punctae that overlapped with centrioles. All cells were 
blindly scored in at least two independent trials. Only cells with sufficient GFP expression 
levels were scored. 
Centriole Count Assay 
 Plk4 constructs not cloned through Gateway technology (Invitrogen), were subcloned 
into the inducible metallothionein-promoter pMT vector (Life Technologies) and tagged with 
either a C-terminal EGFP or a V5 epitope tag. S2 cell transient transfections were performed 
using the Nucleofector II (Amaxa) according to manufacturer’s instructions, using 1 µg of 
the specified Plk4 construct. Constructs include full-length Plk4, Plk4-SBM (Rogers et al., 
2009), Plk4 ∆PB1-PB2] (amino acids 382-602 deleted), Plk4 ∆PB1 (amino acids 382-500 
deleted), Plk4 PB1-PB2 (amino acids 382-602), Plk4 PB1+ (amino acids 382-500), and 
Asterless N-terminus (1-374). To count centriole numbers in transfected cells, we co-
transfected Plk4 constructs with 0.2 µg of Nlp-EGFP (a constitutively expressed nuclear 
protein) (Rogers et al., 2009). Centrioles were then counted in cells with GFP-positive nuclei. 
Expression of all constructs was induced by addition of 0.5-2 mM copper sulfate to the 
media. The PB1-PB2-GFP construct was also systematically analyzed using 0.25, 0.50 and 
1.00 mM copper sulfate to differentially drive expression of the construct. Cells were fixed 
and processed exactly as described (Rogers and Rogers, 2008) by spreading on concanavalin 
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A coated, glass-bottom dishes and fixing with 10% formaldehyde. Affinity-purified rabbit 
anti-D-PLP antibody was used to stain centrioles, diluted to a concentration of 1 µg/ml. 
Secondary antibodies (conjugated with Cy2, Rhodamine Red-X, or Cy5 (Jackson 
ImmunoResearch Laboratories)) were used at manufacturer recommended dilutions. 
Hoeschst 33342 (Life Technologies) was used at a final dilution of 3.2 µM. Cells were 
mounted in 0.1M n-propyl galate, 90% (by volume) glycerol, 10% PBS solution. Specimens 
were imaged at room temperature using a DeltaVision Core system equipped with an 
Olympus IX71 microscope, a 100x objective (NA 1.4), and a CoolSnap HQ2 cooled-CCD 
camera (Photometrics). Images were acquired with SoftWorxTM v1.2 software (DeltaVision). 
At least 200 cells were counted per construct. Statistical analyses of centriole counts were 
performed using two-tailed two-sample t-tests, assuming equal variances. 
Immunoblotting 
 S2 cell extracts were produced by lysing cells in PBS, 0.1% TritonX-100. The 
Bradford protein assay (BioRad; manufacturer’s instructions) was used to measure lysate 
protein concentrations. Laemmli sample buffer was then added and samples boiled for 5 
minutes. For comparative Western blots, equal amounts of total protein from each sample 
was loaded and the integrated densities of chemiluminescent bands (measured with ImageJ 
(NIH)) were normalized relative to the integrated densities of endogenous α-tubulin (loading 
control). Antibodies used for Western blots include monoclonal anti-GFP JL8 Living Colors 
(Clontech), anti-Slimb (Brownlee et al., 2011), anti-V5 (Life Technologies), anti-α tubulin 
DM1A (Sigma-Aldrich), diluted 1:1000. HRP-conjugated secondary antibodies (Sigma-
Aldrich) were prepared according to the manufacturer’s instructions, diluted 1:1500. Slimb 
RNAi and control RNAi was performed as described (Brownlee et al., 2011). 
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Immunoprecipitation   
 For GFP immunoprecipitations, GFP-binding protein (GBP) (Rothbauer et al., 2008) 
was fused to the Fc domain of human IgG (pIg-Tail) (R&D Systems), tagged with His6 in 
pET28a (EMD Biosciences), expressed in E. coli and purified on Talon resin (Clontech) 
according to manufacturer’s instructions. GBP was bound to Protein A-coupled Sepharose, 
cross-linked to the resin using dimethylpimelimidate by rocking for 1 hour at 22°C, and 
quenched in 0.2 M ethanolamine (pH8.0) by rocking for 2 hours at 22°C. Antibody or GBP-
coated beads were washed 3x with 1.5 ml of cell lysis buffer (CLB; 100 mM Tris pH 7.2, 
125 mM NaCl, 1 mM DTT, 0.1% TritonX-100, 0.1 mM PMSF). Transient-transfected S2 
cells were induced to express recombinant Asl or Plk4 constructs with 1-2 mM CuSO4, lysed 
in CLB, pre-cleared and diluted to 2-5 mg/ml in CLB. Antibody-coated beads were mixed 
with lysate for 40 minutes at 4°C, washed 3x with 1 ml of CLB, and boiled in SDS-PAGE 
sample buffer.   
In vitro Kinase Assay 
 For in vitro kinase assays, His6-tagged Plk4 kinase domain plus the downstream 
regulatory element (Kin-DRE) (Drosophila Plk4 residues 1-317) was cloned into the pET28a 
vector, expressed in BL21(DE3) E. coli, and purified on Talon resin (Clontech) according to 
manufacturer’s instructions. Kinase assays were conducted in reaction buffer (40 mM Na 
HEPES, pH 7.3, 150 mM NaCl, 5 mM MgCl2, 0.5 mM MnCl2, 0.1 mM dithiothreitol, 0.1 
mM PMSF) supplemented with 10% (v/v) glycerol. Varying amounts of His6 and GST-
tagged Plk4 domains (bacterially-expressed and purified on glutathione sepharose 4 fast flow 
resin, GE Healthcare, or Talon resin, Clontech) were also added. The tagged Plk4 domain 
constructs were either His6-Plk4-PB1-PB2 (Plk4 residues 382-602) or GST-Plk4-PB3 
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(residues 660-769). Finally, 85 µM γ32P-ATP was added and the reactions were incubated at 
25°C for 1-2 hours. Reactions were terminated by the addition of Laemmli sample buffer and 
boiling. Samples were resolved on SDS-PAGE, Coomassie stained, dried, and the gels 
exposed to X-ray film, or a phosphorimaging screen (Molecular Dynamics) to detect radio-
labeled bands. Band intensity was quantitated using the Image J program (NIH). 
 
 
Results 
Crystallization and Structure Determination of the Plk4 Cryptic Polo Box 
 Plk4’s central region, termed the “cryptic polo box,” was analyzed using secondary 
structure prediction algorithms in parallel with conservation to delineate the boundary 
residues for structural, biochemical and cellular analysis. D. melanogaster Plk4382-602 was 
bacterially expressed, purified and crystallized as described in Experimental Procedures. 
Crystals belonged to the space group P21212. A native dataset was collected on a single 
crystal to a resolution of 2.3 Å. To obtain phasing information, selenomethionine (SeMet)-
derivatized protein was produced but proved insoluble. We found that a SeMet- M517A 
mutant was marginally soluble and produced isomorphous crystals. Single wavelength peak 
anomalous dispersion data to 2.9 Å resolution was collected. Phases were calculated and 
extended to 2.3 Å. The structure was built and refined to R and Rfree factors of 18.5 and 
25.5%, respectively. The final model contains two molecules of Plk4 in the asymmetric unit, 
comprising residues 382-596 (chain A) and 382-548, 553-597 (chain B). Crystallographic 
information is presented in Table 2.1. 
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The Cryptic Polo Box Comprises Two Structurally Unique Polo Box Domains 
 Plk4382-602 forms a multi-domain structure, surprisingly composed of two tandem, 
structurally unique PBs (Figure 2.1 B,C,D). This contrasts with the prediction that Plk4 is 
composed of a single C-terminal PB. In contrast to Plk1-3 that each contain two PBs, Plk4 
was designated the “odd one out” (Sillibourne and Bornens, 2010), which holds true, though 
not because it contains one PB, but three PBs. We henceforth demarcate the Plk4382-602 PBs 
and assign them the sequential numbering PB1 (aa 382-499) and PB2 (aa 500-602), and 
propagate this scheme to the ultimate C-terminal PB, not included in our structure, assigning 
it PB3 (aa 660-741). We refer to the structure reported here as PB1-PB2. Both PB1 and PB2 
adopt a canonical PB fold, delineated by an N-terminal anti-parallel β-sheet that packs 
against a C-terminal helix that runs diagonal to the β-strands. PB1 has a sequential anti-
parallel β-sheet composed of the six strands 1β1-1β2-1β3-1β4-1β5-1β6 that pack against the 
1α1 helix. PB1 contains two unique structural attributes. First, the 1β3-1β4 strands form an 
extended hairpin off the β-sheet giving PB1 a winged structure (Figure 2.1 C,D, tan 
arrowheads). Second, a sixteen-residue segment that we term the “stirrup” bridges 1β5 and 
1β6 and blankets one face of the β-sheet, effectively sandwiching the PB1 β-sheet between 
1α1 and the stirrup (Figure 2.1 C,D, purple arrowheads). The 1β4 portion of the winged β-
hairpin buttresses the N-terminal flank of the stirrup, implicating a structural co-dependence 
between these unique PB elements. The 1α1 helix completes PB1, followed by a two amino 
acid linker that bridges PB1 and PB2: threonine 499 and proline 500. T499 is conserved 
across species and caps the 1α1 helix by forming a hydrogen bond between the T499 γ-
hydroxyl and the K496 backbone carbonyl (Figure 2.1 E). The invariant proline P500 makes 
a jog in the backbone, offsetting the first strand of the PB2 sheet, 2β1, from the 1α1 axis.  
  45
Plk4 PB2 also contains unique features that deviate from the canonical PB fold, 
including secondary structure elements that flank the β-sheet as well as an extended 2α1 
helix. The PB2 β-sheet proceeds in an anti-parallel fashion, consecutively snaking through 
strands 2β1-2β2-2β3-2β4-2β5. Instead of forming a sixth consecutive β-strand, as is the case 
with PB1, PB2 2β5 is followed by an ordered loop that connects 2β5 with the 2α1 helix 
(Figure 2.1 C,D, green arrowheads). The 2β5-2α1 loop is stabilized by a hydrogen bond 
between the conserved D542 δO and the M546 backbone amine as well as Van der Waals 
interactions between hydrophobic residues in the loop, the 2β5 strand, and the 2α1 helix. The 
C-terminal region of this loop is variable across species and contains a seven-residue insert in 
higher eukaryotes. The 2α1 helix runs diagonal to the β-sheet, spanning 40 Å and extending 
13 Å past the 2β1 strand (Figure 2.1 C, grey arrowhead). The helix-sheet interaction is 
stabilized both by a hydrophobic core as well as a disulfide bond between C511 in 2β2 and 
C566 in 2α1 (Figure 2.1 F). The 2α1 helix leads into a loop that curls back towards 2β1, 
effectively stabilizing the extended 2α1 helix by packing F588 against the β-sheet-2α1 
hydrophobic core. The loop terminates at an invariant proline, P589, that facilitates a bend in 
the backbone, leading into PB2’s final β-strand, 2β6, which runs parallel to 2β1 and 
completes the PB2 β-sheet and the PB1-PB2 cassette (Figure 2.1 C, blue arrowhead). The 
location and polarity of the Plk4 2β6 strand is unique, normally running anti-parallel to β5 in 
other PB structures.
  
 
Figure 2.1. The Plk4 Cryptic Polo Box is Composed of Tandem PB domains, 
PB2. (A) Polo-like kinase family 
contains three PB domains. Plk4 levels are regulated by 
structure topology diagram of Plk4’s conserved central
helix in pink, stirrup in lavender, loops in black
yellow, loops in black). (C) Tertiary structure of the Plk4 PB1
(D) Quaternary structure of homodimeric Plk4 PB1
representation of the junction between PB1 1
1α1 helix. (F) Stick representation of the PB2 intra
C566 and 2β2 C511. 
 
46
domain architecture. Plk1-3 contain two PB domains, Plk4 
the DRE (green). (B)
 domain: PB1 (β-strands in red, 
) and PB2 (β-strands in orange
-PB2 monomer colored as in B. 
-PB2, rotated 90° relative to C. 
α1 and PB2 where the T449 hydroxyl caps the 
-domain disulfide formed between 2
 
 
PB1 and 
 Secondary 
α-
, α-helix in 
(E) Stick 
α1 
  47
Collectively, PB1 and PB2 form a composite structure, with a conserved core 
interface that buries 329 Å2 and limits molecular flexibility to peripheral loop regions. 
Relative to PB1, PB2 is rotated approximately 120°. The protomers align well with 1.2 Å 
rmsd across 214 Cα atoms. PB1 and PB2 individually align to their dimeric mate with a Cα 
rmsd equal to 1.1 and 1.2 Å respectively. Structural differences between the protomers, 
indicative of molecular flexibility, localize to loop regions, specifically the stirrup’s C-
terminal region, the 2β4-2β5 loop, and the 2β5-2α1 loop (Figure 2.2 A, black arrows). As a 
second metric for structural flexibility, we mapped B factors on the PB1-PB2 structure. The 
structure’s Cα B-factors range from 14-105 Å2, with increased levels in the stirrup, the 2β4-
2β5 loop, the 2β5-2α1 loop, and the 2α1-2β6 loop, correlating with structural differences 
noted in the alignment of the protomers (Figure 2.2 B, arrowheads). The core regions of PB1 
and PB2 as well as the T499-P500 bridge exhibit low temperature factors and little structural 
divergence when protomers are compared, indicative that the relative arrangement of PB1 
and PB2 is static. 
 
 
Plk4 PB1-PB2 Forms a Pseudo-symmetric Homodimer 
 The two Plk4 PB1-PB2 molecules in the asymmetric unit form a homodimer. The two 
PB1-PB2 molecules are related by a pseudo-symmetric two-fold axis that runs parallel to the 
1α1 helices (Figure 2.1 D). A translational component along the pseudo two-fold axis shifts 
protomer A approximately 5 Å relative to protomer B. The homodimerization interface is 
mediated by PB1-PB1 contacts as well as PB2-PB2 contacts (Figure 2.2 C,D). Due to the 
translational component, non-equivalent sets of residues are involved in the asymmetric 
  48
dimerization. The PB1-PB1 interface primarily involves residues from 1α1 with additional 
contributions from neighboring residues in the β-sheet. The PB2-PB2 interface involves 
residues from 2β4, the 2β4-2β5 loop, 2β5, and 2α1. The PB1-PB1 and PB2-PB2 dimerization 
interfaces bury 1511 Å2 and 1065 Å2 of solvent accessible surface area respectively, 
collectively totaling 2576 Å2. While crystallographic interfaces between protomers exist 
(Figure 2.S1 A,B,C), the homodimer in the asymmetric unit buries the largest surface area 
and is the only interaction that involves both PB1 and PB2; thus it likely represents the 
biological dimer. 
 To verify that Plk4 PB1-PB2 forms an oligomeric species in solution, we analyzed 
the oligomeric state using light scattering. Size exclusion chromatography coupled to multi-
angle static light scattering was conducted at pH 7.0. His6-Plk4 PB1-PB2 protein (MW 27.6 
kDa) was injected at initial concentrations of 19 and 28 M. Single elution peaks had 
experimentally determined molecular weights equal to 56.3 ± 4 kDa and 54.3 ± 2 kDa 
respectively (Figures 2.2 E, 2.S1 D). We also investigated the oligomeric state using batch 
dynamic light scattering at pH 9.5 using 140 M Plk4 PB1-PB2 (MW 25.7 kDa) which 
yielded an experimental mass of 66 ± 16 kDa (Table 2.2). Collectivley, the static and 
dynamic light scattering values indicate that Plk4 PB1-PB2 exists as a homodimer with 
potential higher order oligomers forming at elevated concentration and pH. This is supported 
by prior work showing that the mouse Plk4 PB1-PB2 region self-associates (Leung et al., 
2002). 
                                          
                      
  
Figure 2.2. Plk4 PB1-PB2 is an Asymmetric Homodimer with Plastic Stirrups and 
Loops. (A) Superposition of Plk4 PB1
stirrup as well as the 2β4-2β5 and 2
cartoon format. (B) Plk4 PB1
B-factor values ranging from 14 (dark blue) to 105
the structurally plastic loop segments between
arrows). The region bridging PB1 and PB2 shows little structural divergence and is
dominated by low B-factor values. Plk4 PB1
in sphere format; oriented as shown in the inset. Residues involved in homodimerization 
from both protomers, unique to protomer A, and unique to protomer B, are colored
purple, and raspberry, respectively.
scattering analysis of H6-Plk4 PB1
trace)(100 µl). Y-axis at left displays molecular weight (kDa), Y
normalized differential refractive index, X
Figure 2.S1). 
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Unique Features of Plk4 PB1 and PB2 and Implications for Target Binding 
 While Plk4 PB1 and PB2 contain characteristic features of a PB domain, each 
diverges from PB structures determined to date, yielding implications for target binding. To 
highlight these differences, we compare Plk4’s PB1 and PB2 domains with Plk1’s PB1 
domain bound to a phosphopeptide target (Figure 2.3 A). The Plk1 PB1 1β1 strand forms key 
contacts with the phosphopeptide target. The Plk4 PB1 domain aligns to Plk1 PB1 with an 
rmsd of 2.0 Å across 76 aligned Cα atoms (Figure 2.3 B). Structural divergence occurs at the 
Plk4 PB1 1β3-1β4 hairpin extension, the stirrup, the positioning of 1β6 and the elongated 
1α1 N-terminal region. While there is structural divergence, the 1β1 strand, used in Plk1 PB1 
to bind phosphopeptide targets, is accessible and may facilitate target binding as observed in 
Plk1 PB1 (Figure 2.3 C). 
Plk4 PB2 diverges from the Plk1 PB1 structure, with differences in loops, a helix 
extension, and the positioning of 2β6. Plk4 PB2 aligns to Plk1 PB1 with a 2.3 Å rmsd over 
72 structurally aligned Cα atoms (Figure 2.3 B). Plk4 PB2 differs from Plk1 PB1 in the 
positioning of the 2β2-2β3 and 2β4-2β5 loops. Plk4 PB2 contains an ordered loop between 
2β5 and 2α1 that substitutes for the Plk1 PB1 1β6 strand. Plk4 PB2 forms a C-terminal 
extension on the 2α1 helix. The Plk4 PB2 2β6 strand does not occur between 2β5 and 2α1, 
but resides C-terminal to 2α1 and runs parallel to 2β1, a site occupied by the phosphopeptide 
target in Plk1 PB1. Thus, 2β6 occludes the Plk4 PB2 domain from interacting with a 
phosphopeptide in a manner equivalent to Plk1 PB1. 
   
Figure 2.3. Plk4 PB1 and PB2 Diverge from Plk1 PB Domain Structures and Form a 
Unique Inter-domain Interaction.
(colored red and orange, respectively
target (3FVH, PB1 in green, peptide in 
structures of human Plk1 PB1 and PB2, fly Plk4 PB1 and PB2, and mouse Plk4 PB3. 
Superposition of Plk4 PB1-PB2 homodimer and the Plk1 PB1
structure, aligned over Plk4 PB1 and Plk1 PB1, highlighting the differential 
Plk1 PB1-PB2 as compared to
corresponding binding site of Plk1 PB2. The 
phosphopeptide target is accessib
Plk4 PB3 homodimer, aligned over single PB1 and PB3 domains. 
of each independent structure (C,D)
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 (A) Structural alignment of Plk4 PB1 and Plk4 PB2 
) with human Plk1 PB1 bound to a phosphopeptide 
slate). (B) Matrix showing the rmsd (Å) between 
-PB2-phosphopeptide
organization of 
 Plk4 PB1-PB2. The Plk4 PB1 stirrup overlaps with the 
location where Plk1 PB1 binds its 
le on Plk4 PB1. (D) Superposition of Plk4 PB1
Insets show the orientation 
. 
 
 
(C) 
 
-PB2 and the 
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Plk4 PB1-PB2 has a Novel Inter-domain and Homodimeric Arrangement 
 PB structures determined to date show diverse intra- and inter-molecular PB-PB 
interactions. Here we compare Plk4 PB1-PB2 with Plk1 PB1-PB2 and Plk4 PB3. Plk1 PB1-
PB2 is monomeric, with PB1 and PB2 positioned to form a collective β-sandwich. In 
contrast, Plk4 PB3 is homodimeric and dimerizes across a symmetric β-sandwich (Leung et 
al., 2002). Like Plk1 PB1-PB2, the Plk4 PB3 β-sheets are sandwiched orthogonal to one 
another; however, PB3 dimerizes across the opposite face of its PB β-sheets. Plk4 PB1-PB2 
adopts a third, unique PB domain arrangement (Figure 2.3 C,D). To highlight the differential 
inter-domain arrangements across these paired PB domain structures, we superimposed the 
Plk4 PB1-PB2 structure and the Plk1 PB1-PB2 structure after a least squares fit of their 
respective PB1 domains (Figure 2.3 C). Relative to PB1, the Plk4 PB2 domain is positioned 
dramatically different than Plk1 PB2, each engaging a distinct, non-overlapping face on their 
respective PB1 partner. In Figure 2.3D, the Plk4 PB1-PB2 structure is superimposed on the 
Plk4 PB3-PB3 structure after a least squares fit of individual Plk4 PB1 and PB3 domains. 
The position of the PB3 dimeric mate does not correlate with the relative positioning of PB2, 
or the PB1 dimeric mate. Overall, all PB-PB structures exhibit non-homologous domain 
arrangements. One consistent feature across Plk4 PB structures is homodimerization of the 
individual PB domains. However, while the PB3-PB3 interface is symmetric, the PB1-PB1 
and PB2-PB2 interfaces are asymmetric. 
 
 
The Conserved Plk4 PB1-PB2 Inter-domain Groove Corresponds to the Plk1 PB1 Target 
Binding Site  
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 To highlight conserved determinants across the Plk4 PB1-PB2 structure, we 
generated an alignment of PB1-PB2 across ten diverse species and contoured identity at 
100% and 80% (Figure 2.4 A, green and yellow, respectively). When mapped onto the Plk4 
PB1-PB2 homodimer structure, the prime cluster of invariant residues occurs at a composite 
site formed at the PB1-PB2 junction, with contributions by PB1 1β1-1β2 and PB2 2β1-2β4 
(Figure 2.4 B,C, green arrows). The majority of conserved sequences in PB1 1β2-1β5 are 
occluded by the stirrup and accessibility would thus require a dramatic rearrangement of the 
stirrup which we do not rule out. The PB1-PB2 junction is formed on a single protomer, 
thereby constituting two independent sites on the homodimer. The PB1-PB2 junction is 
concave with both hydrophobic and basic determinants (Figure 2.4 B,C, green arrows). When 
Plk1 PB1 with bound phosphopeptide is aligned with Plk4 PB1, the phosphopeptide is 
positioned at the Plk4 PB1-PB2 conserved junction (Figures 2.3 C; 2.4 B,C). Whether this 
site on Plk4 binds targets remains to be determined. 
 
 
The Full Plk4 PB1-PB2 Cassette is Required for Asterless Binding 
 A fragment of Plk4’s PB1-PB2 region has been shown to bind the centriole 
component Asl in vitro (Dzhindzhev et al., 2010). The Asl-binding region spans Plk4 
residues 376-525, while a shorter fragment spanning residues 376-500 (encompassing only 
PB1), lacks Asl-binding activity. The Plk4 PB1-PB2 structure spans residues 382-602, with 
proline P500 defining the PB1-PB2 bridge and residues 501-525 encoding the first three 
contiguous anti-parallel β-strands in PB2 (2β1-2β3). While 2β1-2β3 is conserved and 
contributes to the composite PB1-PB2 conserved patch, it is unlikely that 2β1-2β3 would 
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fold into an ordered β-sheet in the absence of 2α1, though it may fold upon Asl binding. To 
test the ability of Plk4 PB1-PB2 to bind Asl, taking structural insight into construct design, 
we immunoprecipitated various Plk4-GFP constructs from S2 cell lysates transiently co-
expressing the Asl Plk4-binding domain, V5-Asl (residues 1-300), and immunoblotted for 
these proteins. As expected, full-length Plk4 did not express at high levels, due to its 
ubiquitin-mediated degradation, and thus did not co-immunoprecipitate detectable levels of 
Asl (Figure 2.4 D). To ensure that Plk4 was capable of immunoprecipitating Asl, we 
examined a full-length Plk4 Slimb Binding Mutant (SBM), S293A/T297A, that prevents 
phospho-dependent Slimb binding and concomitant Plk4 ubiquitination, yielding stable Plk4 
(Rogers et al., 2009). Plk4-SBM-GFP was stably expressed and co-immunoprecipitate Asl 
(Figure 2.4 E). Intriguingly, Plk4 lacking PB1 (Plk4 ∆PB1) expressed to a high level, 
implicating a possible role for PB1 in Plk4 degradation (Figure 2.4 D). However, Plk4 ∆PB1 
failed to co-immunoprecipitate Asl. Strikingly, expression of only PB1-PB2 (residues 382-
602) robustly co-immunoprecipitated Asl. In contrast, a construct containing the previously 
described Plk4 Asl-binding domain, Plk4 PB1+ (residues 382-525), exhibited low expression 
and failed to co-immunoprecipitate detectable levels of Asl, suggesting that the full PB1-PB2 
structural cassette is required for robust Asl binding in vivo.  
 
 
 
 
 
 
       
 
Figure 2.4. Plk4 PB1 and PB2 Form a Composite Inter
Conserved and Basic Residues.
A solvent accessible surface area (ASA) (Å
green, 80% identity in yellow (homologous residues also highlighted in yellow where the 
80% identity criteria is met). Human Plk1 PB1 sequence is aligned against Plk4 PB1 and 
PB2, based on structural alignment. Residues involved in homodimerization are 
below the alignment, colored as in Fig 
shown in sphere format with conserved residues colored as in A (left) and in surface 
representation (right) showing electrostatics contoured from 
A rotated 45° relative to the orientation shown in B showing conservation and electrostatics 
as in B. The phosphopeptide from the Plk1 PB1
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and colored blue, is docked onto the Plk4 structure in both B and C, based on the structural 
alignment of Plk1 PB1 and Plk4 PB1 shown in Fig 2.3 C. (D-E) Anti-GFP 
immunoprecipitates from S2 cell lysates transiently-expressing N-terminal Asl-V5 and the 
indicated Plk4-GFP construct or control GFP, probed for GFP and V5. 
 
 
 
The PB1-PB2 Cassette is Necessary and Sufficient for Robust Centriole Targeting 
 In light of our finding that the “cryptic polo box” is composed of two bona fide PB 
domains, we set out to determine whether individual PBs could mediate centriole localization 
or if the full PB1-PB2 structure was required for centriole targeting. Localization 
experiments were conducted in interphase S2 cells containing endogenous Plk4, as Plk4 
depletion causes dramatic centriole loss. We transiently expressed a series of inducible Plk4 
PB-GFP constructs (Figure 2.5 A). After transgene induction, cells were immunostained for 
pericentrin-like protein (D-PLP) to mark centrioles, and co-localization was scored as strong, 
weak, or no centriole localization (Figure 2.5 B-H). Only two constructs, PB1-PB3 (aa 382-
741) and PB1-PB2 (aa 382-602), containing the entire PB1-PB2 cassette defined in our 
crystal structure, displayed robust centriole localization. PB1-PB3 and PB1-PB2 strongly co-
localized with centrioles in 88% and 96% of cells assayed respectively (Figure 2.5 B-D). 
Examination of constructs lacking the full PB1-PB2 cassette showed significantly reduced 
centriole co-localization. Expression of the single PB domains that compose the PB1-PB2 
cassette, individually displayed no centriole localization in the majority of cells scored 
(Figure 2.5 B,E,F). We also scored the centriole targeting activity of the previously described 
Plk4 Asl-binding region (PB1+) (Dzhindzhev et al., 2010). PB1+ displayed a dramatic 
reduction in centriole co-localization as compared to PB1-PB2 (Figure 2.5 B,G), suggesting 
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that the full PB1-PB2 cassette is necessary to bind Asl and target Plk4 to centrioles. To 
determine if the PB1-PB2 cassette is necessary for centriole targeting, we designed a full 
length, SBM construct with the PB1-PB2 cassette deleted (SBM ∆[PB1-PB2]). SBM ∆[PB1-
PB2] showed strong centriole co-localization in only 6% of cells and weak co-localization in 
49% of cells (Figure 2.5 B,H). [PB1-PB2]-independent centriole association is likely 
conferred by PB3 as mouse PB3 has weak centriole targeting activity (Leung at al., 2002). In 
agreement, we found that a Linker-PB3 construct (L-PB3; aa 602-741) showed some level of 
centriole co-localization in 49% of cells (Figure 2.5 B,I).  
 
 
PB1-PB2 Scaffolds Plk4 Trans-autophosphorylation to Limit Centriole Duplication 
 Previous work has revealed an auto-regulatory mechanism in Plk1 whereby its PB1-
PB2 cassette binds the kinase domain in trans and inhibits kinase activity in vitro. It has also 
been shown that the mouse Plk4 central region (encompassing PB1-PB2) can bind the Plk4 
kinase domain in trans (Leung et al., 2002; Leung et al., 2007). To determine whether 
inhibition of kinase activity is a conserved PB feature, we incubated a fly Plk4 construct 
containing the kinase domain + DRE (Kin-DRE) with increasing molar ratios of the PB1-
PB2 cassette or the PB3 domain and assayed Plk4 autophosphorylation. No change in 
autophosphorylation was detected upon titration with PB1-PB2 or PB3 in trans (Figure 
2.S2).  
 
      
Figure 2.5. The Plk4 PB1-PB2 Cassette is Required for Robust Centriole Localization.
(A) Schematic of PB-GFP containing constructs assayed for centriole localization. 
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(B) S2 
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cells were transiently-transfected with the constructs shown in A (GFP), induced to express 
for 24 hours, and immunostained with anti D-PLP antibody to mark centrioles (Cy3). 
Centriole co-localization was classified as strong (green), weak (chartreuse), or no co-
localization (purple). Total number of cells analyzed and independent experiments performed 
noted at right. (C, D) Expression of PB1-PB3 (B) or the PB1-PB2 cassette (D) results in 
strong centriole co-localization. Cell margins are indicated (white dashed lines). (E-I) Single 
or incomplete PBs primarily display weak or no centriole co-localization. Representative 
images of differential localization are shown. Boxed regions are magnified in the lower 
panels. Scale bar, 5µm. 
 
 
 Endogenous Plk4 levels are tightly regulated through trans-autophosphorylation of the 
DRE. Trans-autophosphorylation should be promoted by Plk4 oligomerization. Given that 
our PB1-PB2 structure is homodimeric, we tested whether expression of the PB1-PB2 
cassette could inhibit Plk4 degradation by heterodimerizing with full-length Plk4 and 
preventing trans-autophosphorylation. We first analyzed Plk4 stabilization by assessing 
centriole number, as increased Plk4 stabilization promotes centriole amplification. Cells 
transfected with full-length Plk4 or non-degradable Plk4-SBM resulted in centriole 
amplification, with Plk4-SBM generating a stronger effect (Rogers et al., 2009). Strikingly, 
cells transfected with PB1-PB2 displayed centriole amplification on par with Plk4-SBM 
(Figures 2.6 A,B, 2.S3). Other Plk4 constructs including Plk4-∆PB1, Plk4-∆[PB1-PB2], and 
PB1+ did not alter the centriole count from the GFP control, indicating that the entire PB1-
PB2 cassette is required to stimulate centriole amplification, presumably by hyper-stabilizing 
endogenous Plk4. While low PB1-PB2 induction levels caused centriole amplification, this 
effect varied slightly at higher induction levels, potentially due to PB1-PB2 homodimers 
saturating centriole binding sites (Figure 2.S4). 
 To directly test if PB1-PB2 promotes centriole amplification through stabilization of 
Plk4, we co-transfected full-length Plk4-GFP with either PB1-PB2-GFP, Plk4-∆[PB1-PB2]-
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GFP or GFP and analyzed Plk4-GFP levels. We found that full length Plk4-GFP levels 
increased dramatically when co-transfected with PB1-PB2-GFP but not with Plk4-∆[PB1-
PB2]-GFP or GFP alone, demonstrating that PB1-PB2 promotes Plk4 stability in trans 
(Figure 2.6 C). To test if PB1-PB2-GFP could bind Plk4-FL-myc in trans, we co-transfected 
these constructs, immunoprecipitated PB1-PB2-GFP and probed for Plk4-FL-myc. We found 
that PB1-PB2-GFP was able to immunoprecipitate Plk4-FL-myc, indicative of an interaction 
mediated by PB1-PB2 (Figure 2.6 D). Both PB1-PB2 and PB3 independently confer 
dimerization. We asked whether Plk4 homodimerization, as mediated by PB1-PB2, is 
required for efficient trans-autophosphorylation and degradation or whether PB3-mediated 
dimerization suffices. To test this, we expressed a construct containing PB3 but lacking PB1-
PB2 (Plk4-∆[PB1-PB2]-GFP) and compared its levels to wild-type Plk4-GFP and a stable, 
full-length Plk4 kinase-dead mutant (Figure 2.6 E) (Brownlee et al., 2011). Wild-type Plk4-
GFP protein levels were extremely low. In contrast, Plk4-∆[PB1-PB2] protein levels were 
dramatically stabilized and on par with kinase-dead Plk4. To ensure that Plk4-GFP was 
expressed in these cells and could be compared to Plk4-∆[PB1-PB2], we depleted Slimb via 
RNAi and immunoblotted for GFP. Slimb depletion yielded detectable Plk4-GFP, confirming 
Plk4 expression and its Slimb-mediated degradation (Figure 2.6 F). These findings indicate 
that PB1-PB2 plays a key role in Plk4 degradation beyond homodimerization and may 
extend to scaffolding the kinase for trans-autophosphorylation (Guderian et al., 2010). To 
test if PB1-PB2 plays a role in auto-phosphorylation of the DRE, we examined Slimb-
binding as a read-out for DRE phosphorylation. Plk4-FL-GFP ran as a broad band on SDS 
PAGE and was able to co-immunoprecipitate Slimb, however Plk4-∆[PB1-PB2]-GFP ran as 
a tight doublet and co-immunoprecipitated comparatively reduced levels of Slimb, indicative 
 that the PB1-PB2 cassette enhances auto
binding (Figure 2.6 G). 
       
 
Figure 2.6. Plk4 PB1-PB2 Promotes Centriole Amplification and Protects Full
Plk4 in trans. (A) S2 cells were transiently
PB2-GFP, or non-degradable Plk4
for centrioles (PLP, Cy3, red) and DNA (
regions are magnified in the insets and highlight centriole clusters not observed in controls.
(B) Histograms of centriole counts were measured from S2 cells tra
indicated constructs after 3 days of induction
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with a centriole count per cell <2, 2, and >2 is indicated. (C) Ectopic Plk4 PB1-PB2-GFP 
expression is sufficient to stabilize full-length Plk4-GFP. Immunoblots of S2 cell lysates 
showing that overexpression of PB1-PB2-GFP (but not Plk4-∆[PB1-PB2]-GFP or GFP) 
stabilizes wild-type full-length Plk4-GFP. Tubulin, loading control. (D) PB1-PB2-GFP co-
immunoprecipitates Plk4-FL-myc. Immunoblots of anti-GFP immunoprecipitates from S2 
cells co-transfeted with Plk4-FL-myc and PB1-PB2-GFP or GFP (control). (E) Anti-GFP 
immunoblot of Plk4-GFP constructs transiently expressed in S2 cells showing differential 
stability. Tubulin, loading control. (F) Plk4-FL-GFP is expressed but rapidly degraded by 
Slimb-mediated ubiquitination. Cell lysates from S2 cells transfected with Plk4-FL-GFP and 
treated with control or Slimb dsRNA. Tubulin, loading control. (G) Plk4 lacking the PB1-
PB2 cassette shows reduced auto-phosphorylation of the DRE as assayed by Slimb binding. 
Immunoblots of anti-GFP immunoprecipitates from S2 cells transfected with Plk4-FL-GFP 
or Plk4-∆[PB1-PB2]-GFP and blotted for GFP and Slimb. (H) Model of the Plk4 
homodimer. PB1 and PB2 mediate homodimerization. PB1 and PB2 form a composite 
Asl/Cep152 binding site, recruiting Plk4 to the centriole. PB1-PB2 homodimerization 
scaffolds Plk4 trans-autophosphorylation, priming the DRE for SCFSlimb binding and 
ubiquitination. 
 
 
Discussion 
 Plk4’s essential role in centriole duplication is well established, but a fundamental 
understanding of its mechanism has been lacking. Here, we have determined the structure of 
the Plk4 CPB and found that it is actually composed of two PB domains, PB1-PB2. This 
finding recalibrates the number of PB domains in Plk4 from one to three. Both the Plk4 PB1 
and PB2 domains have unique structural features that distinguish them from Plk1 PB1, PB2 
and Plk4 PB3. 
 The spatial arrangement of Plk4 PB1 and PB2 differs from the arrangement observed 
in Plk1 PB1-PB2 structures. Plk4 PB1 and PB2 pack end-to-end, linked by a short, ordered 
threonine-proline segment, flanked by hydrophobic residues that anchor PB1 on PB2. The 
PBs are rotated relative to their β-sheet planes and translated, placing the 1α1 helix axis in 
line with the PB2 2β2 strand. In contrast, Plk1’s tandem PBs are packed around a pseudo 2-
fold axis, forming a β-sandwich. Thus, Plk4 and Plk1 each have distinct, non-homologous 
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arrangements of their PB1-PB2 domains. The Plk1 PB1-PB2 structure is monomeric in 
contrast to the homodimeric Plk4 PB1-PB2 structure. Plk4 PB1-PB2 has extensive pseudo-
symmetric dimerization interfaces across PB1-PB1 and PB2-PB2. Our light scattering data 
confirm a Plk4 PB1-PB2 homodimeric state, in agreement with previous work showing that 
the CPB confers self-association (Leung et al., 2002). The Plk4 PB3 structure is also 
homodimeric (Leung et al., 2002), indicating that full-length Plk4 has at least three 
dimerization interfaces mediated by its three PB domains. Overall, the three Plk4 PBs are 
unique among themselves and distinct from Plk1 PB1 and PB2 in their structure, multi-
domain arrangement, and oligomeric state.  
 Plk4 PB1-PB2 localizes robustly to centrioles in S2 cells while the individual PB1 
and PB2 domains display only weak centriole co-localization, indicating that the full PB1-
PB2 cassette collectively confers strong centriole targeting. Previous work examining Plk4’s 
interaction with Asl in vitro mapped the Plk4 determinants to a segment embodying PB1 and 
the first three β-strands of PB2 (PB1+) (Dzhindzhev et al., 2010). In the same study, the Plk4 
PB1 region failed to bind Asl in vitro. This maps key Plk4 Asl-binding determinants to the 
conserved inter-domain, concave junction defined by PB1 1β1 and PB2 2β1-2β3 (Figure 2.4 
B,C). We found that while PB1+ enhances centriole localization over PB1 alone, it is not as 
effective as the full PB1-PB2 cassette. In support we found that PB1-PB2 co-
immunoprecipitates Asl while PB1+ does not. Collectively, our work and previous work can 
be interpreted in light of our PB1-PB2 structure. While PB1+ contains prime Asl-binding 
determinants, the remaining PB2 elements are likely required to complete the domain fold 
and stabilize the determinants that bind Asl and afford robust centriole targeting.  
 The conserved PB1-PB2 inter-domain groove contains the PB1 1β1 strand, which in 
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Plk1 PB1 is primarily responsible for phosphopeptide binding. It is possible that the Plk4 
PB1 1β1 strand is used to bind Asl, but Plk1 and Plk4 target binding will have significant 
differences. First, bacterially expressed Asl binds Plk4 in vitro, indicative that the interaction, 
in contrast to Plk1, is not phospho-dependent. Second, Plk4 binds to a minimal, 300 residue 
N-terminal segment of Asl (Dzhindzhev et al., 2010). This is in contrast to the short, 
phosphorylated motifs Plk1 recognizes and suggests that Plk4 binds a domain in Asl rather 
than a short motif. In support, Plk4 PB1-PB2 forms a large, concave surface that could 
accommodate domain binding. This contrasts with Plk1, where PB1 and PB2 clamp around a 
phosphopeptide target.  
 Expression of the PB1-PB2 cassette caused interesting dominant effects. First, PB1-
PB2 amplified centriole levels on par with the non-degradable Plk4-SBM construct. Second, 
we found that full-length Plk4 was stabilized in trans by the PB1-PB2 construct. Plk4 down-
regulates its own protein level by trans-autophosphorylating its DRE to promote Slimb 
binding (Holland et al., 2010; Guderian et al., 2010). We found that the PB1-PB2 construct 
heterodimerizes with endogenous Plk4 and protects it from trans-autophosphorylation. 
Trans-autophosphorylation is not simply mediated by oligomerization because a Plk4 
construct lacking the PB1-PB2 cassette but retaining the PB3 homodimerization domain was 
itself dramatically stabilized. This indicates that PB1-PB2 dimerization positions the kinase 
domains and DREs optimally for trans-autophosphorylation in order to restrict centriole 
duplication to once and only once per cell cycle (Figure 2.6 H). 
 Our results reveal unique structural and functional determinants in Plk4 (Figure 2.6 H). 
In contrast to Plk1-3, Plk4 is a unique polo kinase member, containing three PBs that mediate 
centriole localization as well as homodimerization. The PB1-PB2 cassette collectively binds 
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Asl and affords robust centriole localization, optimally positioning the kinase domain for 
trans-autophosphorylation. While PB1-PB2 affords centriole localization via Asl, we do not 
rule out the possibility that PB1-PB2 interacts with additional centriole factors. While PB3 
does not bind Asl in vitro (Dzhindzhev et al., 2010), it does mediate centriole localization, 
albeit weakly, implicating a non-Asl PB3-binding factor at the centriole. Further structural 
studies are needed to illuminate the Plk4/Asl interaction, understand how the PB1-PB2 
cassette regulates trans-autophosphorylation, and identify additional Plk4 centriole targets. 
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TABLES 
 
 
            
 
Table 2.1. Plk4 PB1-PB2 crystallographic data, phasing, and refinement. Values in 
parentheses are for the highest resolution shells unless otherwise denoted.  
*Rsym = ΣhΣi|Ii(h) − <I(h)>|/ΣhΣiIi(h), where Ii(h) is the ith measurement and <I(h)> is the 
mean of all measurements of I(h) for Miller indices h.  
*Log-likelihood gain value as determined by Phenix.  
†Figure of merit is the weighted mean of the cosine of the deviation from αbest.  
R value = Σ(|Fobs|-k|Fcalc|) / Σ|Fobs|. 
‡Rfree is calculated using a 10% subset of the data that is removed randomly from the original 
data and excluded from refinement (Brünger 1992). 
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Run Number % Polydispersity MW (kDa) % Intensity % Mass 
1 52.9 80 71.5 99.9 
2 59.5 88 68.4 99.9 
3 35.2 43 56.4 99.9 
4 45.2 63 67.4 99.9 
5 31.4 59 81.8 99.9 
6 29.7 65 50.9 94.0 
Mean ± S.D.  66 ± 16   
 
Table 2.2. Plk4 PB1-PB2 dynamic light scattering. Plk4 PB1-PB2 at 3.6 mg/mL in 50 mM 
Tris pH 9.5, 300 mM NaCl, 0.1% β-ME, 10% glycerol, measured on a Wyatt DynaPro 
dynamic light scattering plate reader (Wyatt 1993). The Plk4 PB1-PB2 monomeric molecular 
weight is 25,675 Da.  
                
 
Figure 2.S1. Plk4 PB1-PB2 forms numerous crystallographic interfaces but is a 
homodimer in solution. (A-C)
involved in crystal packing. The total buried surface area for each interaction is indicated. 
This data supplements the homodimeric interface observed in the asymmetric unit, presented 
in Figure 2.2 C,D. (D) Size exclusion chromatography 
MALS) analysis of H6-Plk4 PB1
trace)(100 µl). Bovine serum albumin control, 100 
at left displays molecular weight (kDa), Y
refractive index, X-axis displays time component of the run. Plk4 constructs showed a single 
peak with molecular weight of that peak concordant with homodimer
serum albumin control produced three peaks with the respective molecular weights of those 
peaks concordant with monomer, homodimer and homotrimer formation (bovine serum 
albumin molecular weight = 66,463 Da). This data supplements the S
presented in Figure 2.2 E. 
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SUPPLEMENTAL FIGURES 
 
 
 
 Cartoon diagram of Plk4-PB1-PB2 molecular interfaces 
– multi-angle light scattering (SEC
-PB2 injected at 19 µM (red trace) and 28 µ
µl injected at 90 µM (blue trace).
-axis at right displays normalized differential 
ization. The bovine 
EC-MALS data 
 
 
-
M (green 
 Y-axis 
                     
 
Figure 2.S2. The presence of either the PB1
the in vitro kinase activity of Plk4
His6-tagged Plk4 PB1-PB2 were incubated with constant amounts of purified His
Plk4-Kin-DRE and γ32P-ATP. The Coomassie
vitro reactions is shown above its corresponding autoradiograph. The calculated molar ratios 
of Plk4 PB1-PB2 to Plk4-Kin
DRE is not affected by Plk4 PB1
to Plk4-Kin-DRE in the autoradiograph and gel shown in A were measured by densitometric 
scanning. Each 32P measurement was then normalized to the measure of its corresponding 
Coomassie-stained band. (C)
increasing amounts of purified Plk4 PB3 were incubated with constant amounts of His
tagged Plk4-Kin-DRE and γ32
could not be measured by densitometry bec
and Plk4 PB3. However, the presence of Plk4 PB3 does not 
incorporation relative to the control. 
and Discussion section: “PB1
Centriole Duplication.” 
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-PB2 or PB3 domain of Plk4 does not inhibit 
-Kin-DRE in trans. (A) Increasing amounts of purified 
-stained SDS-PAGE gel of the resolved 
-DRE are shown at top. (B) Incorporation of 32P into Plk4
-PB2. To calculate 32P incorporation, bands corresponding 
 A similar in vitro assay was performed with GST
P-ATP. In this case, the autophosphorylation of Plk4
ause of the similar mobilities of Plk4
change the level of
This data supports the findings reported in the Results 
-PB2 Scaffolds Plk4 Trans-autophosphorylation to Limit 
 
6-tagged 
in 
-Kin-
-Plk4 PB3: 
6-
-Kin-DRE 
-Kin-DRE 
 
32P 
  
Figure 2.S3. Expression of Plk4 PB1
amplification. Graphs and histograms of centriole counts measured from S2 cells transiently 
expressing the indicated constructs after 3 days of induction. 
distribution shown for cells transfected with a GFP control construct or the Plk4
construct indicated. Mean and median values are shown
This data supplements the binned histograms and values reported in Figure 2.6 B.
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-PB2 is sufficient to promote centriole 
(A-G) Centriole count 
 including standard error of the mean
 
 
-GFP 
. 
 
    
 
 
 
Figure 2.S4. Titrated expression of Plk4 PB1
amplification. Histograms of centriole counts measured from S2 cells transiently expressing 
PB1-PB2-GFP after 3 days of induction
(250, 500 and 1000 µM) to differentially induce PB1
metallothionein promoter. Centriole counts per cell are binned under <2, 2, and >2
and median values are indicated. At least 179 cells were examined in each of the copper 
sulfate treatments. This data supplements the observations reported in Figure 2.6 B
showing that a PB1-PB2 construct can bind full length Plk4 and protect it 
autophosphorylation and subsequent Slimb binding, which would promote its ubiquitin
mediated degradation. 
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-PB2 causes differential centriole 
 using three different concentrations of copper sulfate 
-PB2-GFP expression under the 
from 
 
 
 
. Mean 
-G, 
trans-
-
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CHAPTER 3: PLK4 PB3 IS A DIVERGENT PB DOMAIN WITH  
SPECIES-DEPENDENT ROLES AND A VARIABLE STRUCTURE 
 
 
Summary 
 Prior work from our lab demonstrated that Plk4 contains three PB domains as 
defined by the canonical PB structural fold. This finding highlights Plk4 divergence from the 
Plk family of kinases, which usually contain exactly two PB domains to attain subcellular 
localization and regulate catalytic activity. Plk4 PB1-PB2 homodimerizes, allowing for 
centriole localization via interactions with centriole scaffold components and dimerization-
dependent trans autophosphorylation that primes subsequent downregulation, begging the 
question: what is the purpose of PB3? In this study, we employ x-ray crystallography to 
determine the structure of D.m. Plk4 PB3 and find that it surprisingly forms a different 
structure than that of the previously reported M.m. Plk4 PB3. Specifically, D.m. PB3 does not 
undergo chain-swapping to complete two PB folds, as does M.m. PB3; instead, each of the 
two D.m. PB3 chains in the ASU produces an independent PB domain. Consistent with this 
finding, D.m. PB3 exists solely as a monomer in solution, while M.m. (Leung et al., 2002) 
and H.s. PB3 (this study) exist primarily as a dimer in a concentration-independent manner. 
Expression of an mCherry-tagged H.s. PB3 in human RPE1 cells confirms the inability of 
PB3 to localize to centrioles. Ongoing work in our lab is discussed here, in which we 
examine the complementation of D.m. and H.s. PB3 in a centriole amplification assay in 
human cell lines. Our work has important implications for the divergent role of PB3 in a 
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species-dependent Plk4 context and conjures questions regarding the evolutionary history of 
the third Plk4 PB domain.  
 
Chapter 1 serves as an introduction to this chapter− 
 
Experimental Procedures 
Cloning and Protein Purification 
 Drosophila melanogaster Plk4 (DG7186) PB3, residues 657-745, was subcloned into 
pET28b (Novagen), engineering a thrombin-cleavable N-terminal His6 tag. Protein was 
expressed in BL21 DE3 E. coli methionine auxotrophic cells under kanamycin selection with 
SeMet media (Leahy et al., 1994) and induced with 100 µM IPTG for 16 hr at 20°C. Cells 
were harvested, resuspended in lysis buffer (25 mM Tris pH 8.0, 300 mM NaCl, 10 mM 
Imidazole, 0.1 % β-ME) supplemented with 1 mM PMSF, and sonicated to lyse. Lysate was 
clarified at 23,000 x g for 45 min and supernatant applied to a Ni2+-NTA resin (Qiagen). Plk4 
PB3 was eluted using a 250 ml, 10-300 mM Imidazole gradient in lysis buffer. Fractions 
containing Plk4 were pooled, supplemented with 1 mM CaCl2 and digested for 12 hr at 4°C 
with 1 µg/ml bovine α-thrombin. Digested Plk4 was filtered through 1 ml benzamidine 
sepharose (GE Healthcare) and exchanged into 100 ml of 25 mM HEPES, pH 7.0, 0.1 % β-
ME, loaded onto an SP-sepharose column (GE Healthcare), and eluted over a 250 ml, 0-1 M 
NaCl gradient in 25 mM HEPES, pH 7.0, 0.1 % β-ME. Fractions containing Plk4 SeMet PB3 
were pooled, exchanged into protein storage solution (25 mM HEPES at pH 7.0, 100 nM 
NaCl, and 0.1% β-ME), concentrated to 15 mg/ml, and frozen in liquid nitrogen. 
Selenomethionine (SeMet)-substituted Plk4 (aa 657-745) proved soluble and yielded 
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diffractable crystals; however, these crystals provided a very weak anomalous signal, 
preventing phase information. We hypothesized that the single methionine residue in PB3 
(M696) may reside in a disordered loop, consistent with both secondary structure prediction 
algorithms and lack of phase information from SeMet-substituted protein-derived crystals. 
Therefore, we systematically mutated several hydrophobic residues at the end of predicted 
secondary structure features to methionine (L675M, V692M, and V723M) in order to 
provide structured sites of SeMet incorporation. Point mutants were generated using the 
Quikchange method (Stratagene). Following solubility tests and crystallization trials, only 
V692M yielded protein crystals.  
Crystallization, Data Collection, and Structure Determination 
 SeMet-substituted V692M Plk4 PB3 was crystallized using a mother liquor (1 ml) 
containing 32% PEG 4000, 200 mM Li2SO4, and 200 nM Tris at pH 8.5. Crystals formed in a 
drop containing 2 µl of 15 mg/ml protein stock and 2 µl mother liquor. SeMet V692M Plk4 
crystals were transferred to MiTeGen LV CryoOil (Mitegen) and flash-frozen in liquid 
nitrogen. Diffraction data were collected at the Advanced Photon Source SER-CAT beamline 
22-ID (V692M Se peak SAD data, 0.97926 Å). Crystals belonged to the space group P21 
with two molecules in the asymmetric unit. Data were processed and scaled using the 
HKL2000 suite (Otwinowski and Minor, 1997). The Phenix program suite (Adams et al., 
2010) was used to find selenium sites, phase, build, and refine the structure with reiterative 
building in Coot (Emsley et al., 2010). Refinement was monitored using 10% of the data 
randomly excluded from the refinement and used to calculate an R free (Brünger, 1992). The 
model includes two Plk4 PB3 protomers: chain A (residues 660-714, 716-743) and chain B 
(residues 659-693, 700-714, 722-743) and 52 water molecules. Electrostatics were calculated 
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using APBS (Baker et al., 2001). Structural alignments and rmsd values were calculated 
using the Dali server (Hasegawa and Holm, 2009).  
Size Exclusion Chromatography and Multi-angle Light Scattering (SEC-MALS) 
 D.m. Plk4 PB3 was purified without cleaving the N-terminal His6 tag (MW = 11,942 
Da), concentrated to either 10 or 27 mg/mL, and exchanged into running buffer (25 mM 
HEPES, pH 7.5, 300 mM sodium chloride, 0.1% β-mercaptoethanol, and 0.2 g/L sodium 
azide). H.s. Plk4 PB3 (resi 884-970, based on alignments with the published M.m. PB3 
(Leung et al., 2002); MW = 11,860 Da) was purified using the same protein expression and 
purification protocols, and concentrated to either 4.6 or 8 mg/mL in running buffer. A 
Superdex 200 10/300 GL gel filtration column (GE Healthcare) was equilibrated in the 
running buffer and runs containing 100 µl of protein were injected onto the column. Eluate 
was passed in tandem through a Wyatt DAWN HELEOS II light scattering instrument and a 
Wyatt Optilab rEX refractometer. The light scattering and refractive index data were used to 
calculate the weight-averaged molar mass of each peak using the Wyatt Astra V software 
program (Wyatt Technology Corp.) (Wyatt, 1993). Two D.m. Plk4 PB3 and H.s. Plk4 PB3 
runs were performed for each purification scheme, with two purifications for each construct, 
for a total of eight experiments.  
Centriole Localization Assay 
 Human hTERT-immortalized retinal pigment epithelial cells (RPE1) with a stable 
CSAP-GFP expression background (Backer et al., 2012) were transiently transfected with 
mCherry-tagged H.s. Plk4 constructs with the intent of assaying for co-localization. 
However, CSAP-GFP signal was greatly reduced following fixing and staining procedures; 
therefore, Pericentrin (Pctn) staining was used in the Cy2 channel to enhance centrosome 
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marker signal. In brief, RPE cells were cultured at 37°C with 5% CO2 in DMEM media 
(Gibco) supplemented with 1% Antibiotic-Antimycotic (Gibco) and 10% FBS (Gibco). H.s. 
Plk4 PB3 (resi 884-970) was subcloned into pmCherry-N1 using HindIII and BamHI 
restriction sites (yielding a C-terminal mCherry tag under the constitutively active CMV 
promoter; Clontech). Stable RPE1 cells were transfected (Lipofectamine LTX with Plus 
reagent, Invitrogen; following the manufacturer’s protocol) with 2 µg DNA directly on glass 
coverslips and allowed to express PB3:mCherry for 12 hours at 37°C with 5% CO2. Cells 
were briefly rinsed with PBS and fixed with 4% p-formaldehyde in PBST (PBS with 1% 
TWEEN) for 15 min. Cells were then blocked for 30 min at ambient temperature in 1X 
PBST supplemented with 10 mg/mL BSA (herein “blocking solution”). Primary rabbit anti-
Pericentrin antibody (Cat. # ab4448, Abcam) was diluted 1:1000 and applied to cells for 1 
hour in blocking solution. Following PBST rinses, cells were treated with a Cy2 labeled anti-
rabbit secondary antibody (Jackson ImmunoResearch Laboratories) diluted 1:500 and DAPI 
diluted to 1:2000 (Molecular Probes, Invitrogen) for 30 min and rinsed with PBST followed 
by PBS. Samples were mounted in a glycerol-based medium (90% glycerol, 10% PBS, 3% 
w/v n-propyl gallate) and imaged using a 100x objective (NA 1.49) Apochromatic TIRF 
objective (Nikon) mounted on an inverted microscope (Nikon Eclipse Ti) equipped with a 
cooled charge-coupled device camera (CoolSNAP HQ, Roeper Scientific), an excitation and 
emission wheel (LUDL), and emission filters (Chroma). All microscope hardware was 
controlled by Nikon NIS-Elements. All images were processed and prepared for publication 
using Photoshop (CS5 version 12.0). Cells were processed and binned into one of three 
categories: strongly co-localized (interphase cells), weakly co-localized (interphase), not co-
localized (interphase), or spindle-enhanced (mitotic cells). Co-localized cells displayed 
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strong mCherry signal at every centriole labeled using anti-Pctn antibody; weakly co-
localized cells displayed weak mCherry signal at marked centrioles; and not co-localized 
cells displayed no mCherry punctae that overlapped with centrioles.  
 
Results 
Crystallization and Structure Determination of Plk4 PB3 
 Plk4’s C-terminal PB region, called PB3 (Slevin et al., 2012), was delineated in D.m. 
and H.s. based on both secondary structure prediction algorithms and protein conservation 
(Figure 3.1 D). D.m. Plk4 PB3 (resi 657-745) and H.s. Plk4 PB3 (resi S884-H970) were 
expressed and purified as described in Experimental Procedures. Only D.m. PB3 yielded 
protein crystals; thus, we pursued SeMet-substituted PB3 crystals to gain experimental 
phasing. D.m. Plk4 PB3 SeMet crystals diffracted, but produced a weak anomalous signal 
that failed to provide phasing information. To increase anomalous signal, we designed a 
point mutant (V692M) predicted to increase SeMet signal in an ordered portion of the protein 
(see Experimental Procedures). D.m. Plk4 PB3 V692M crystals diffracted to 1.90 Å and 
belonged to the space group P21 (see Table 3.1 for crystallographic data, phasing, and 
refinement statistics and geometries). The current model of D.m. PB3 V692M contains two 
molecules in the ASU (Chain A: resis 660-714, 716-743; Chain B: resis 659-693, 700-714, 
722-743; Figure 3.1 A,B) and is built and refined to R and Rfree values of 22.8 and 28.9, 
respectively. Refinement of the model is ongoing to reduce both parameters and converge 
their values.  
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The Structure of D.m. PB3 Contains Two Chains in the ASU but Lacks a Dimerization 
Interface 
 The D.m. PB3 structure forms a canonical Polo Box (PB) domain, with six 
consecutive β-strands folding to form a 6-stranded anti-parallel β-sheet (β1-β6; shown in 
indigo in Figure 3.1 A,D). The C-terminal single α-helix (α1) (shown in lavender, Figure 3.1 
A,D) packs nearly perpendicularly to the β-sheet, stabilizing its formation via a shared buried 
hydrophobic interface. The structure of the single PB3 aligns well to published single PB 
domains (Slevin et al., 2012; Leung et al., 2012; Shimanovskaya et al., 2014; Park et al., 
2014), despite sharing highest sequence homology only with PB3 domains from other 
species (Figure 1.7; Figure 3.1D). While our structure of the D.m. PB3 contains two PB 
domains in the ASU (much like the H.s. PB3 structure (Leung et al., 2002)), the two chains 
do not undergo swapping, with each chain forming a complete PB domain (Figure 3.1 B). 
Close examination of the contacts made by each chain demonstrates a weak interface 
between consecutive PBs. The interface between chains varies with the symmetry mate being 
compared, indicative that there is no conserved interface to suggest biological dimerization in 
our crystal. Indeed, inspection of the ASU shown in Figure 3.1 demonstrates that there are 
only two points of potential contact within the ASU between chains: two van der Waals-
based interactions between L735 and I693 and S691 (Figure 3.1 C). These interactions are 
weak, as they nearly exceed the limit of distance between atoms to create a van der Waals 
interaction; thus, they likely represent a crystallographic interface rather than a biological 
dimerization interface within our presented ASU. 
 
 Figure 3.1. The structure of 
the asymmetric unit. (A) The structure of 
6-stranded anti-parallel β-sheet (
helix (α1, lavender). The domain packs in order of primary structure, with 
terminus and the α1 at the C-
comprises two complete PB3 chains, Protomers A 
693, 700-714, 722-743). The two protomers are shown in two orientations for clarity.
Protomer A is shown in the remaining figures. 
encompassing two PB3 protomers for orientation. Right, f
demonstrating a high correlation between observed density and the final model. Highlighted 
in orange are the only three residues between Protomer A (S691 and I693) and Protomer B 
(L735) that form contacts to suggest a possible 
the interactions are separated by 3.5 Å
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D.m. PB3 reveals a single PB domain with two protomers in 
D.m. PB3 depicts a canonical PB domain, with a 
β1-β6, indigo) packed perpendicularly against a single 
β1 at 
terminus. (B) The crystallographic asymmetric unit (ASU) 
(resis 660-714, 716-743) and B
(C) Left, the structure of the ASU 
inal 2Fo-Fc density shown in green, 
dimerization interface; however, note that 
, indicating a weak interaction, if any. (D) 
 
 
α 
the N-
 (resis 659-
 
Plk4 
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sequence alignment across ten species. Protomer A solvent accessible surface area (ASA) 
(Å2) is indicated. 100% identity is highlighted in green, 80% identity in yellow (homologous 
residues also highlighted in yellow where the 80% identity criteria is met). D. mel., 
Drosophila melanogaster, fruit fly; N. vec., Nematostella vectensis, sea anemone; N. vit., 
Nasonia vitripennis, wasp; D. rer., Danio rerio, zebrafish; T. nig., Tetraodon nigroviridis, 
puffer fish; M. mus., Mus musculus, mouse; R. nor., Rattus norvegicus, rat; B. tau., Bos 
taurus, cow; P. abe., Pongo abelii, orangutan; H. sap., Homo sapiens, human. 
 
 
 
Comparison of D.m. and M.m. Structures Reveals both Conserved PB3 Features and Unique 
PB3 Oligomer Configurations 
 To date, the only other published PB3 structure belongs to mouse Plk4 (M.m. Plk4 
PB3, Leung et al., 2002). Our D.m. PB3 aligns well to a single M.m. PB3 domain, with an 
RMSD value of 2.25 Å (Figure 3.2 A). Interestingly, though the structural elements align 
well, the identity of each element differs between the two structures: D.m. β1 aligns with 
M.m. β6, D.m. β2 with M.m. β1, etc. such that the M.m. PB3 β-sheet is offset as compared 
with D.m. (Figure 3.2 A, bottom, and C, which shows schematics of secondary structural 
features mapped to primary sequences). Additionally, the single α1 helix aligns well between 
D.m. and M.m. structures; however, the helix is markedly truncated in M.m. as compared to 
D.m. (10 resi and 19 resi, respectively, leading to a 16.3-Å difference in helix lengths; Figure 
3.2 B,C). As a result, there are considerably more contacts between the D.m. α1 helix and β-
sheet, wherein D.m. β1 forms several contacts with the C-terminus of α1 (Figure 3.2 B). 
M.m. PB3 does not form these contacts due to a shortened α1 helix, and as a result, its 
equivalent β-strand (M.m. β6) splays away from the α1 interface (Figure 3.2 B). 
 M.m. PB3 forms a unique PB homodimer among known PB homodimers (Leung et 
al., 2002). In contrast to Plk4 PB1-PB2, which forms a homodimer via PB2-PB2 contacts to 
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form an extended, central, 12-stranded β-sheet to bind acidic partners Asl and SPD-2 (Slevin 
et al., 2012; Shimanovskaya et al., 2014; Park et al., 2014), the M.m. PB3 homodimer forms 
via chain-swapping from the two protomers in the ASU (Leung et al., 2002). As a result, the 
composite M.m. PB3 homodimer contains two PB domains, each of which has contributions 
from each chain (Figure 3.2 C and D, top right inset. One protomer is shown in dark teal, 
while the other is in light cyan, with the composite PB domains each delineated). This has 
proven to remain a unique PB dimerization formation, as no other known PB homodimer 
forms via chain-swapping. Alignment of our D.m. PB3 ASU with the published M.m. PB3 
homodimer reveals poor agreement between the two structures, with the second PB domains 
(PB) in different positions relative to the aligned PBs (Figure 3.2 D). No crystallographic 
symmetry mate recapitulates the interactions seen in PB1-PB2, highlighting that PB3 likely 
takes a different oligomerization state in a species-dependent manner. D.m. PB3 represents 
an architectural departure from both M.m. PB3 and D.m. PB1-PB2, as PB3 does not display 
an apparent conserved basic patch as seen in PB1-PB2 to bind centriole targets (Figure 3.2 
E). Therefore, D.m. PB3 is a unique PB3 structure that does not form dimerization interfaces 
in crystal form. 
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Figure 3.2. D.m. and M.m. Plk4 PB3 form similar folds but maintain different spatial 
crystallographic arrangements. (A) D.m. PB3 (indigo) and M.m. PB3 (teal) (PDB 
accession code 1MBY; Leung et al., 2002) overlay with an RMSD of 2.25 Å; however, their 
individual architectures differ. Note that the M.m. β-sheet comprises 6 β-strands out of 
chronological order. (B) An alternative view of the D.m./M.m. PB3 alignment reveals that the 
M.m. α1 helix is significantly shorter (16.3 Å) than the D.m. equivalent. The D.m. β-sheet 
forms van der Waals contacts between β1 (K662, I664, and V666) and the extended C-
terminus of α1 (K736, L737, A738, and A740), effectively pulling D.m. β1 closer to α1 as 
compared to the equivalent position of M.m. β6. (C) A primary sequence alignment among 
D.m., H.s., and M.m. reveals conservation among mammalian PB3 sequences, with D.m. PB3 
sharing 30% conservation with H.s. and M.m. PB3. Secondary structural alignments between 
D.m. PB3 (indigo, top) and M.m. PB3 (teal, bottom) reveal offset secondary structure 
elements between D.m. and M.m. PB3s despite high residue conservation. Yellow residues 
notate identity or similarity between two species; green residues notate identity among all 
three species. Note that the composite M.m. PB3 is formed by the two PB3 chains in the 
published structure (PDB 1MBY), which undergo swapping to form two inter-dependent PB 
domains. (D) Structural alignment of the D.m. PB3 asymmetric unit and the published M.m. 
PB3 dimer reveals a lack of the M.m. dimerization interface in the D.m. PB3. (E) Mapping 
both conservation (spherical model, top) and electrostatics (surface representation, bottom) 
indicates the absence of a conserved basic patch as observed in D.m. PB1-PB2 (Figure 6.1). 
Conservation is contoured to 80% similarity (yellow) or 100% identity (green).  
 
 
D.m. PB3 is a Monomer in Solution, while Mammalian PB3s Exist as Dimers 
 To determine the oligomerization state of D.m. PB3 as compared with mammalian 
PB3, we purified both D.m. PB3 (resi 657-745) and H.s. PB3 (resi S884-H970) as described 
in Experimental Procedures and used SEC-MALS to obtain accurate MW measurements. 
Both proteins remained soluble throughout purification and concentration, and exceeded 50 
mg/mL without precipitating out of solution. To avoid detection of oligomerization states 
forced by exceedingly high concentrations, we performed all SEC-MALS experiments with 
ranges of concentrations of purified proteins, from 2-27 mg/mL. Both D.m. and H.s. PB3 
were purified in two independent rounds, and yielded the same results. Representative traces 
are shown in Figure 3.3, with the MW reported as the average and standard deviation of all 
experiments. 
 Figure 3.3. PB3 takes on a species
shown here are representative profiles of 
for each construct is displayed as the average
the entire timecourse for each run shown 
size, with an additional peak at ~15 min corresponding to 
The expected monomeric size of either construct is 11.9 kDa. (B) Gel filtration of either 
PB3 (orange) or D.m. PB3 (two independent purification schemes shown in green and blue) 
yields a single major peak, indicating stability at specific oligomeric states. 
as a dimer (22.9 ± 0.2 kDa), while 
 
 Consistent with our findings that 
in the crystal, D.m. PB3 eluted as a single peak (Figure 3.3, mint green and 
with a measured MW of 11.6 ± 0.2 kDa (dark green and blue traces; expected monomeric 
MW=11.9 kDa). The MW of 
protein exceeded 27 mg/mL, confirming that 
work from other labs indicated that 
suggesting that PB3 oligomerization state might be species
tested H.s. PB3, which shares nearl
the PB3 regions, as shown in Figure 3.2 C). 
peak (Figure 3.3, peach trace)
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-dependent oligomerization state in solution. 
all completed SEC-MALS experiments. The
 value ± standard deviation. (A) An overview of 
showcases that each protein runs at a characteristic 
elution of a non-specific aggregate. 
H.s. 
D.m. PB3 elutes as a monomer (11.6 ± 0.2 
D.m. PB3 lacks a convincing dimerization interface 
light 
D.m. PB3 was consistent, even when concentrations of purified 
D.m. PB3 forms a monomeric species. Previous 
M.m. PB3 primarily forms a dimer (Leung et al., 2002)
-dependent. To confirm this, we 
y complete identity with M.m. PB3 (>98% identity over 
Similar to D.m. PB3, H.s. PB3 eluted as a single 
; however, the peak corresponded to a MW value of 22.9 ± 0.2 
 
 
All data 
 MW 
H.s. 
PB3 elutes 
kDa). 
blue traces) 
, 
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kDa (orange trace; expected monomeric MW=11.9 kDa), corresponding to formation of a 
dimer. H.s. PB3 consistently eluted as a dimer, regardless of concentration. The H.s. PB3 
dimer formation at dilute concentrations (2 mg/mL) indicates that the dimerization interface 
between the two protomers is strong, and that PB3 dimerization is a conserved feature of 
mammalian PB3s. 
 
 
H.s. PB3 is Not Sufficient for Centriole Subcellular Localization 
 Previous work from our lab determined that in D.m. S2 cultured cells, D.m. PB3 
robustly localizes to centrioles in only 23% of cells (Slevin et al., 2012; see L-PB3, Figure 
2.5 B,I). Conversely, PB1-PB2 localizes to centriole markers in ~96% of cells (Figure 2.5 
B,D), indicating that Plk4 uses PB1-PB2 to bind targets and attain proper localization. To 
determine whether insufficiency of PB3 for centriole localization is conserved among 
species, we expressed m-Cherry-tagged H.s. PB3 (resi 884-970) under the constitutive CMV 
promotor in human RPE1 cells expressing a stable centriole marker, CSAP:GFP (Backer et 
al., 2012). We then assayed for PB3:mCherry co-localization with Pctn, a centrosomal 
marker, following fixing and staining protocols (see Experimental Procedures). Consistent 
with our previous results in D.m. cultured cells, we found that H.s. PB3 lacks robust centriole 
localization in human RPE cells and is largely cytoplasmic (Figure 3.4 A). A small 
percentage (~25%) of cells examined showed a slight mCherry enhanced signal in centriole 
regions (called “weak centriole localization,” Figure 3.4 B), though no cells displayed strong 
centriole localization. A small number of transfected cells (~3/slide) were mitotic, and we 
noticed that in transfected mitotics, PB3:mCherry signal was enhanced along the spindle 
 MTs (Figure 3.4 C). There is no p
indirect; whether this observation is indicative of a MT or kinetochore fibre interaction with 
PB3 is yet to be determined. 
 
Figure 3.4. H.s. PB3 is not a robus
Scale bar, 10 µm. (A, B) Constitutive expression of 
in a stable RPE1 cell line in interphase cells reveals a lack of centriole localization, as 
assayed via staining for Pctn (green). 
Pctn (cytoplasmic) (A), while 15
(C) Mitotic cells displayed a weak enhancement of PB3:mCherry on the spindle. 
 
 
Discussion 
 Our work with Drosophila 
and cell biology to determine the structure and function of PB3 in the context of FL Plk4. 
The crystal structure of D.m. 
important differences as compared to the published 
1MBY; Leung et al., 2002). First, 
however, the D.m. structure’s two chains each form an independent PB domain, whereas the 
M.m. structure features two chains that collectively form two inter
91
recedence for a PB3-MT interaction, whether direct or 
t centriole localization domain in cultu
H.s. PB3 with a C-terminal mCherry tag 
85% of cells assayed displayed no co-localization with 
% of cells displayed weak enhancement at centrioles (B). 
PB3 combines x-ray crystallography with biochemistry 
PB3 surprisingly reveals a monomeric PB domain with several 
M.m. PB3 structure (PDB accession code 
D.m. PB3 contains two chains in the ASU, like 
-dependent PB domains
 
 
red RPE1 cells. 
 
M.m. PB3; 
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that undergo chain-swapping (Figure 3.2 D). Second, D.m. PB3 secondary structural 
elements fold in chronological order, more closely mimicking the known Plk4 PB1 as well as 
Plk1 PB structures, whereas M.m. PB3 folds out of order with regards to primary sequence 
(Figure 3.2 A). Third, the single α1 helix in D.m. is approximately twice as long as the M.m. 
α1, allowing for more stabilizing contacts between the D.m. α1 and the β-sheet (Figure 3.2 
B). These differences are perplexing, as they result in poor alignment between secondary and 
tertiary structure of the two species (Figure 3.2 C,D), and yet the primary amino acid 
sequences align very well between M.m. and D.m. (Figure 3.2 C). How similar sequences 
could yield such different structures, even out of the context of the rest of the protein and in 
the absence of any binding partners, remains an important question.   
 Careful examination of the M.m. PB3 crystallization methodology reveals that 
crystals were obtained with 50 mg/mL PB3 (Leung et al., 2002). While crystallization 
requires concentrating protein far beyond biological concentrations, 50 mg/mL is even higher 
than typical crystallization conditions, raising questions of whether the published structure 
involving a unique chain-swapping mechanism represents a true biological protein 
configuration. Future work with the PB3 domains should include small-angle x-ray scattering 
to determine a low-resolution envelope of D.m., H.s., and M.m. PB3 domains in order to 
confirm the differences seen in crystallographic form.  
 Interestingly, our SEC-MALS data seem to confirm what is known thus far about 
each crystal structure: that D.m. PB3 forms a monomer in solution (even at higher 
concentrations), while M.m. PB3 forms a dimer (even at lower concentrations; Figure 3.3 B). 
Whether the individual PBs take on different oligomerization states depending on the context 
of the FL protein, stage of the catalytic and regulation cycle, or presence of PB3 binding 
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partners (as well as determining if there are any), remains a priority to determine in future 
experiments. 
 Finally, our lab is currently interested in learning more about the role of PB3 
function within Plk, as well as determining whether PB3 function is species-dependent. 
Others’ previous work in cultured cells demonstrated that Plk4 homologs across species 
cannot complement each other following depletion of endogenous proteins (Carvalho-Santos 
et al., 2010). However, extensive work has shown that PB1-PB2 maintains similar function 
and structures across species (Slevin et al., 2012; Shimanovskaya et al., 2014; Park et al., 
2014), suggesting that the variation and lack of complementation among species arises 
specifically from PB3. We are currently undertaking experiments in human HeLa cells to 
determine whether PB3 has a species-dependent role in Plk4 centriole licensing activity, in 
which we overexpress mCherry-tagged Plk4 constructs (FL, ∆PB3, and a chimeric construct 
in which D.m. PB3 replaces H.s. PB3) and determine the effects on centriole numbers. Our 
assay design allows for detecting whether PB3 has a directed role in Plk4-dependent 
centriole duplication. PB domains in other Plks serve to localize the FL molecule, bind 
targets, and regulate kinase activity; while PB1-PB2 bind the only known Plk4 PB targets 
and acts as the centriole localization domain, it remains unknown if any or which PB 
domain(s) regulates catalytic activity. While more work will need to be done to demonstrate 
a PB3-kinase interaction, our current experiments will aid in laying the foundation to better 
understand the role of PB3 in Plk4 centriole duplication licensing.  
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TABLES 
 
 
            
Crystal SeMet V692M PB3 
Beamline APS 22-ID 
Space Group P21 
Cell: a,b,c (Å) ; α,β,γ (°) 35.3, 52.1, 41.1 ; 90.0, 106.2, 90.0 
Wavelength (Å) 0.97926 
Resolution (Å) 50.0-1.90 
Completeness (%) 95.5 (73.2) 
I/σ 26.0 (5.4) 
Redundancy 6.6 (4.2) 
No. of observations 71,961  
Rsym (%)* 7.6 (30.6) 
Overall log-likelihood gain** / 
figure of merit† 
93,634 / 0.361 
Refinement (Å) 50.0-1.90 (1.98-1.90) 
R value 22.8 (23.2) 
Rfree‡ 28.9 (31.1) 
Rmsd bond lengths (Å) 0.008 
Rmsd bond angles (°) 1.3 
Mean B-value (min / max) (Å2) 21.6  (8.3 / 74.3) 
No. atoms: protein / water   1151 / 52 
B-factor rmsds (MC / SC) 2.2 / 3.0 
 
 
Table 3.1. Plk4 PB3 crystallographic data, phasing, and refinement. Values in 
parentheses are for the highest resolution shells unless otherwise denoted.  
*Rsym = ΣhΣi|Ii(h) − <I(h)>|/ΣhΣiIi(h), where Ii(h) is the ith measurement and <I(h)> is the 
mean of all measurements of I(h) for Miller indices h.  
**Log-likelihood gain value as determined by Phenix.  
†Figure of merit is the weighted mean of the cosine of the deviation from αbest.  
R value = Σ(|Fobs|-k|Fcalc|) / Σ|Fobs|. 
‡Rfree is calculated using a 10% subset of the data that is removed randomly from the original 
data and excluded from refinement (Brünger 1992). 
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CHAPTER 4: A MOTOR-INDEPENDENT FUNCTION OF DYNEIN LIGHT CHAIN 
IN MITOTIC SPINDLE ORIENTATION 
An Introduction to Chapter 5 
 
 
Asymmetric divisions play a critical role in tissue specification in the developing 
embryo 
 
 All multicellular eukaryotes undertake the gargantuan task of developing from a 
single-celled zygote to an elaborate organism with compartmentalized tissue structures and 
functions. To do so, cells must continually divide; however, simple division is not sufficient 
to explain the complexity of such organisms. In order to form different organs, cells must be 
programmed to take on specific traits, including shape, orientation and localization within the 
context of the whole organism, to perform tissue-specific functions. For instance, the 
neuronal cells that comprise the vertebrate central nervous system are elongated (with lengths 
in humans measuring up to 1 m) and have an inherent polarity in which one end contains the 
soma, or cell body, while the other, the dendrite (Lodish et al., 2000). The structure of the 
neuron is designed for its function, which is to communicate information via chemoelectrical 
signals quickly and unidirectionally over long distances in the body. Throughout 
development, genetic and biochemical pathways must converge to produce progenitors of 
differentiating tissues, an undertaking that requires asymmetric cell divisions (ACDs). Each 
ACD event is critical to create two daughter cells with different fates. 
 Despite the apparent importance of ACD in generating new cell fates during 
development, it has historically been difficult to study ACD events due to the symmetry 
inherent in most cultured cell types. However, one model of ACD that has recently become 
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routinely studied is the Drosophila melanogaster neuroblast, a stem cell that divides 
asymmetrically to produce both a stem population and a neuron progenitor within the D.m. 
larval brain (Jiang and Reichert, 2014). In this ACD event, the neuroblast is initially formed 
by delaminating from the neuroectoderm epithelial layer within the central region of the 
developing brain (Figure 4.1). In subsequent steps, the neuroblast maintains apicobasal 
polarity by maintaining different protein complex populations in the apical and basal ends of 
the cell, which collectively act as internal cues to determine the differential fates of the two 
daughter cells resulting from ACD. One daughter inherits the apical complex and retains its 
“stemness,” while the other inherits the basal complex and is terminally fated to give rise to 
exactly two neuron cells (Vorhagen and Niessen, 2014) (Figure 4.1). The inherent 
asymmetry in this division event is clearly visible in the daughter cell sizes alone; the 
neuroblast (NB) daughter remains a large cell, while the fated cell (a Ganglion Mother Cell, 
or GMC) is much smaller and remains basally located. The ability to clearly observe 
daughter cell fates, as well as newer technologies that allow for genetic manipulation to study 
specific proteins in fruit flies, has made the Drosophila developing brain a favorite model to 
learn more about the mechanisms underlying ACDs (Lerit et al., 2014). 
  
Figure 4.1. The Drosophila 
and the mitotic spindle structure to achieve asymmetric cell division along an 
apicobasal polarity axis. The 
neuroectoderm, a tissue fated to become the nervous system. Specific cells delaminate from 
the layer (top, beige), and take on a rounded shape and are neuroblasts. The mitotic spindle 
within the neuroblast aligns with apical (purple) and basal (neon blue) protein networks, with 
a different centrosome, mother or daughter, aligned with the apical and basal sides, 
respectively. The neuroblast divides asymmetrically to produce two daughters: a larger, 
apical neuroblast (NB) cell that remains stem cell
cell (GMC) fated to become exactly two neuron cells
Reina and Gonzalez, 2014; Vorhagen 
2014). Inset, top right: several molecular complexes have been determined to orient th
spindle and direct cell fates: the Par complex, G
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larval neuroblast marshals cell fate determinant complexes 
D.m. third instar larval brain (bottom, dark blue) contains the 
-like, and a smaller, basal ganglion mother 
 (Bowman et al., 2006; Li et al
and Neissen, 2014; Wang et al., 2011; 
αi/Pins/Mud/Dynein, and Mud/LC8/Ana2. 
 
 
., 2014; 
Slevin et al., 
e 
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ACDs require cooperation between the cortex, molecular motors, dynamic cytoskeletal 
polymers, and the centrosome 
 
 Much of the research regarding D.m. NB asymmetry has focused on the mutual 
regulation of the apical and basal complexes to maintain polarity. Briefly, the apical cortex 
contains two complexes with both distinct and overlapping functions. One is collectively 
referred to as the “Par complex”, which anchors to the apical cortex through both direct and 
indirect mechanisms (Figure 4.1). The Par complex negatively regulates proteins associated 
with neural fate via phosphorylation events, relegating their cortical location to the basal side 
(reviewed in Vorhagen and Niessen, 2014). Par proteins can also indirectly localize to the 
apical cortex via Pins and Gαi, scaffolding and signaling components, respectively, that act to 
orient the spindle within the cell. Importantly, Pins and Gαi assert their control over spindle 
orientation by binding Mud (Mushroom body-defect, D.m.; NuMA, H.s.), which in turn can 
interact with the molecular motor dynein via dynactin (Figure 4.1) to anchor it to the cortex 
(Merdes et al., 1996). As a minus-end-directed motor, dynein plays a critical role in exerting 
pulling forces on the astral microtubules to anchor one spindle pole at the apical end, 
resulting in a division event in line with polarity cues and segregated fate determinants (Li et 
al., 2014). 
 Interestingly, Mud/NuMA plays an essential, complicated role in orienting NB 
ACDs. In Drosophila null Mud alleles, NB mitotic spindles fail to align properly with 
polarity cues; additionally, Mud is a conserved component that can bind to dynactin, Pins, 
and even directly to MTs (Bowman et al., 2006; Merdes et al., 1996). Whether the interaction 
between Mud and MTs is high-affinity to afford a direct role in Mud/astral MT-based spindle 
alignment remains to be determined. In addition, it is not known if and how Mud can interact 
with all of its binding partners. Nevertheless, the requirement of Mud to ensure faithful 
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asymmetric cell segregation indicates that Mud is a critical hub in directing the axis of 
division (Figure 4.1).  
   
An interaction among Ana2, LC8, and Mud regulates divisions within the developing 
Drosophila brain 
 
 While centrioles are essential in building the bipolar mitotic spindle in mammalian 
cells, recent evidence has suggested that centriolar components play a more direct role in 
orienting the mitotic spindle during ACDs. Using fluorescent microscopy, in vitro binding 
assays and yeast two-hybrid tests, Mud was shown to form a complex with a dynein light 
chain, LC8, and the essential centriole component Ana2 at the daughter centrosome (Wang et 
al., 2011). This tripartite complex was further shown to be required for faithful spindle 
alignment in D.m. NBs, as null mutants in either LC8 or Ana2 randomized spindle 
orientation (Wang et al., 2011) (Figure 4.1). Ana2 remains the only centriolar component 
known to be directly involved in spindle orientation, indicating a possible role of the 
centrosome in orienting spindle alignment during ACD. This study did not resolve whether 
this interaction directs orientation through the known Mud/Pins/Gαi, Mud/Dynactin/Dynein, 
or Mud/MT pathways (inset in Figure 4.1; dotted lines showing the potential modes of 
action).  
 Critical to the function of the Mud/Ana2/LC8 complex is its asymmetrical 
formation, as LC8 and Ana2 are both enhanced in the apical (daughter) centrosome (Wang et 
al., 2011) according to the apical localization of Mud. The two centrosomes at the mitotic 
spindle poles are known to be asymmetric, as the mother centrosome recruits high levels of 
pericentrin-like protein (PLP) to block D.m. Plk1-mediated centrosome maturation; thus, the 
daughter centrosome is able to mature and recruit higher levels of PCM and centriole 
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components while the mother remains inactivated (Lerit and Rusan, 2013). The inherent 
asymmetry of the centrosomes mirrors the asymmetry of the cell, and ensures that older 
centrioles are inherited by the resulting GMC daughter cells while younger centrioles 
segregate to the NB (Figure 4.1). The mechanism through which the Mud/Ana2/LC8 
complex exerts spindle orientation regulation at the daughter centrosome remains unknown. 
 
 
LC8 is a motor-independent dimerization module 
  LC8 is a dynein light chain conserved among almost all known eukaryotic branches. 
As its name suggests, LC8 is a regulatory dynein chain that complexes with intermediate 
chains to enhance their dimerization, effectively acting as a processivity factor (Rao et al., 
2013). However, LC8 also acts as a dimerization “hub” in various contexts throughout the 
cell, binding many targets in a motor-independent fashion (reviewed in Barbar, 2008). 
Several examples of LC8-mediated dimerization include Nup159 (a nucleoporin component, 
Romes et al., 2012), Swallow (an mRNA localization factor in the developing D.m. embryo, 
Kidane et al., 2013), and Pak1 (a kinase that regulates cell motility, Lightcap et al., 2008), 
highlighting the many subcellular uses of LC8. There are two common motifs that bind LC8: 
G
-2I-1Q0V1D2 and K-3X-2T-1Q0T1, where the glutamine (Q) is held in a constant position 
relative to the LC8 binding groove and X corresponds to any residue (Rapali et al., 2011). 
LC8 itself exists as a homodimer in solution (Romes et al., 2012; Slevin et al., 2014), and 
therefore contains two identical target-binding sites (Figure 4.2 A,B). Binding targets, though 
diverse in cellular localization and function, generally conform to the LC8 binding motifs 
and also contain an adjacent low-affinity dimerization domain (Figure 4.2 C; Barbar, 2008). 
LC8 binds two identical targets, effectively bringing them closer together and lowering 
 energy barriers for their own dimerization domains (
coiled-coil. These collective binding events 
independent manner, allowing for increased function of the targets. While work in 2011 
initially identified the LC8/Ana2/
the LC8/Ana2 interaction at the molecular level. 
 
 
Figure 4.2. LC8 acts to homodimerize its targets in parallel. 
the crystal structure of the D.m. 
LC8 forms a homodimer via formation of a central 
pair of α-helices that support folding. (B) A schematic and the crystal structure of one side of 
the β-sandwich, as seen in the middl
from one LC8 protomer (green), one strand from the other protomer (purple), and the final 
strand is contributed by a binding target, which forms the last anti
(C) Cartoon of LC8-induced dimerization. Two identical targets (left), contain
binding motif and a low-affinity dimerization domain, bind an LC8 homodimer, creating a 
stabilized target homodimer in parallel
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Figure 4.2 C), often ultimately forming a 
increase dimerization of LC8 targets in a motor
Mud complex (Wang et al., 2011), little was known about 
 
(A) A cartoon schematic 
LC8 homodimer (shown in green and purple for clarity)
β-sandwich, flanked on either side by a 
e of the sandwich. Each β-sheet comprises 4 strands 
-parallel strand (orange). 
.   
 
-
 
and 
. 
ing an LC8-
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CHAPTER 5: THE MECHANISM OF DYNEIN LIGHT CHAIN LC8-MEDIATED 
OLIGOMERIZATION OF THE ANA2 CENTRIOLE DUPLICATION FACTOR 1 
 
 
Summary 
 Centrioles play a key role in nucleating polarized microtubule networks. In actively 
dividing cells, centrioles establish the bipolar mitotic spindle and are essential for genomic 
stability. Drosophila Anastral spindle-2 (Ana2) is a conserved centriole duplication factor. 
While recent work demonstrated that an Ana2-dynein light chain (LC8) centriolar complex is 
critical for proper spindle positioning in neuroblasts, how Ana2 and LC8 interact is yet to be 
established. Here we examine the Ana2-LC8 interaction and map two LC8-binding sites 
within Ana2’s central region, Ana2M (residues 156-251). Ana2 LC8-binding site 1 contains 
a signature TQT motif and robustly binds LC8 (KD of 1.1 µM) while site 2 contains a TQC 
motif and binds LC8 with lower affinity (KD of 13 µM). Both LC8-binding sites flank a 
predicted ~34-residue α-helix. We present two independent atomic structures of LC8 dimers 
in complex with Ana2 LC8-binding site 1 and site 2 peptides. The Ana2 peptides form β-
strands that extend a central composite LC8 β-sandwich. LC8 recognizes the signature TQT 
motif in Ana2’s first LC8 binding site, forming extensive van der Waals contacts and 
hydrogen bonding with the peptide, while the Ana2 site 2 TQC motif forms a uniquely  
extended β-strand, not observed in other dynein light chain-target complexes. Size-exclusion  
 
_____________________________ 
1
 Slevin, L.K.,* Romes, E.M.,* Dandulakis, M.G., and Slep, K.C. (2014). The mechanism of dynein light chain 
LC8-mediated oligomerization of the Ana2 centriole duplication factor. Journal of Biological Chemistry. 289, 
20727-20739. *indicates equal contributions 
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chromatography coupled with multi-angle static light scattering demonstrates that LC8 
dimers bind Ana2M sites and induce Ana2 tetramerization, yielding an Ana2M4-LC88 
complex. LC8-mediated Ana2 oligomerization likely enhances Ana2’s avidity for centriole 
binding factors and may bridge multiple factors as required during spindle positioning and 
centriole biogenesis. 
 
 
Introduction 
 Centrioles are cylindrical cellular structures that form the core of centrosomes and 
basal bodies, organelles responsible for nucleating polarized microtubule networks in the 
cytoplasm and cilia, respectively. A cell’s centriole count largely determines its capabilities, 
as single centrioles form the base of sensory cilia while multiple centrioles are needed to 
nucleate motile cilia (Bornens 2012). A centriole pair constitutes the core of the centrosome, 
needed for bipolar mitotic spindle formation. Centriole structure is largely conserved across 
metazoans, protists, and some plants, with a characteristic 9-fold radial symmetry established 
by an inner, 9-spoked cartwheel structure (Gönczy 2012). While different species have 
different microtubule arrangements in the surrounding blades (singlets, doublets, or triplets, 
as shown in Figure 5.1 A) as well as different cartwheel architectures (Guichard et al., 2013), 
the critical centriole duplication components are conserved. The inner cartwheel recruits 
centriolar proteins and pericentriolar matrix components to build and elongate the outer 
centriole wall. During elongation, nine sets of microtubule blades (each a microtubule triplet 
in the case of Drosophila) form around the centriole perimeter parallel to the longitudinal 
axis, propagating the organelle’s 9-fold radial symmetry.  
  108
 Canonical centriole duplication is coupled to the cell cycle to limit centriole number 
(Tsou and Stearns, 2006). A subset of conserved centriole proteins are involved in centriole 
duplication (Pelletier et al., 2006), as their misregulation leads to increased or decreased 
centriole counts (Figure 5.1 B). Three key initiation factors include Polo-Like Kinase 4 
(Plk4), Spindle assembly abnormal protein 6 (Sas-6), and Anastral spindle 2 
(Ana2/STIL/Sas-5, found in D. melanogaster, humans, and C. elegans, respectively). Plk4 is 
a serine/threonine kinase whose catalytic activity is required for centriole duplication. Plk4 
phosphorylates a set of both known and unknown components to transmit the centriole 
duplication signal (Habedanck et al., 2005; Lettman et al., 2013). Plk4 is recruited to the 
centriole through an interaction with Asterless (Asterless/Cep-152 found in D. melanogaster 
and humans, respectively), but the conserved definitive target of Plk4’s kinase activity 
remains unknown (Lettman et al., 2013). Downstream of Plk4, nascent centriole construction 
involves Sas-6 oligomerization to form the inner, 9-fold symmetric cartwheel (van Breugel et 
al., 2011; Kitagawa et al., 2011; Hilbert et al., 2013). A third and less-studied centriole-
initiating factor is the Sas-6-binding protein, Ana2, whose role in centriole duplication is 
unclear. 
 Ana2 was identified in a genome-wide screen in which Ana2 depletion caused a 
decrease in centriole count (Goshima et al., 2007). Ana2 is functionally conserved across 
metazoan species, with orthologs in humans (STIL), D. rerio (STIL), and C. elegans (SAS-5) 
(Stevens et al., 2010a). However, the Ana2 sequence has diverged among species, with 
similarity restricted to an N-terminal Sas-4 binding site (Cottee et al., 2013; Hatzopoulos et 
al., 2013), a central predicted coiled coil, and a C-terminal STAN (STil/ANa2) domain that 
binds Sas-6 in vitro (Stevens et al., 2010a; Leidel et al., 2005; Qiao et al., 2012) (Figure 5.1 
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C; see domain conservation presented in the inset, scored using % identity and % similarity 
between species). In Drosophila oocytes, Sas-6 overexpression results in centriole 
amplification only when Ana2 is dually overexpressed (Stevens et al., 2010b). In human 
systems, expression of Ana2 is essential in maintaining centriole count (Arquint et al., 2012). 
Furthermore, mutations in Ana2 have been linked to primary microcephaly, leukemia, and 
cancer (Aplan et al., 1991; Izraeli et al., 1997; Erez et al., 2004; Basto et al., 2008; Kumar et 
al., 2009). How Ana2 and Sas-6 synergistically function remains to be determined. While 
Ana2’s function is poorly understood, recent work demonstrated that Drosophila Ana2 
interacts with the dynein light chain, LC8 (Cut up (Ctp)) (Wang et al., 2011), a ubiquitous 
protein that binds diverse targets throughout the cell to confer or potentiate target 
dimerization (reviewed in Barbar 2008). The Ana2-LC8 interaction is important for directing 
spindle orientation during Drosophila larval brain development (Figure 5.1 D). Loss of either 
Ana2 or LC8 results in aberrant spindle positioning and defective separation of apico-basal 
polarity determinants during neuroblast asymmetric cell division. 
 While LC8 acts as a processivity factor for the dynein motor by enhancing motor 
dimerization, it largely plays a dynein motor-independent role throughout the cell to 
potentiate dimerization of its binding partners (Lei and Davis, 2003; Liang et al., 1999; 
Chaudhury et al., 2008; Romes et al., 2012; Nyarko et al., 2013; Purohit et al., 1999; Navarro 
et al., 2004; Asthana et al., 2012; Nyarko and Barbar, 2011; Benison et al., 2007; Williams et 
al., 2007; Stuchell-Brereton et al., 2011). It was shown in a yeast two-hybrid screen that LC8 
binds two Ana2 fragments: the first fragment spanning residues 1-200, and the second 
spanning residues 201-274, which includes a predicted α-helix highly conserved across fly 
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species (Figure 5.1 E, F) (Wang et al., 2011; Stevens et al., 2010a). To date, there is no 
structural insight into the LC8-Ana2 complex. 
 Here, we use x-ray crystallography, isothermal microtitration calorimetry (ITC), and 
size-exclusion chromatography with multi-angle static light scattering (SEC-MALS) to 
characterize the interactions between LC8 and Ana2. Our results demonstrate that LC8 
dimers bind Ana2 at two distinct sites, the first of which contains a high-affinity, canonical 
LC8-binding TQT motif (residues 159-168), while the second contains a non-canonical TQC 
motif (residues 237-246). We present the structures of LC8 bound to peptides encompassing 
both of Ana2’s LC8 binding sites as well as the apo LC8 dimer, and highlight the conserved 
Ana2 features that underlie these different interactions with the peptides. SEC-MALS 
analysis of WT and mutant Ana2M (residues 156-251) in complex with LC8 reveals LC8-
dependent Ana2M tetramerization in an Ana2M4-LC88 complex. The Ana2 LC8 binding 
sites flank a predicted α-helix likely involved in Ana2 oligomerization. Our findings suggest 
that LC8 is responsible for enhancing Ana2’s oligomerization and structural stability. LC8-
potentiated Ana2 oligomerization has spatial and avidity implications for Ana2’s N-terminal 
Sas-4 binding motif and its C-terminal Sas-6-binding STAN domain. 
 FIGURE 5.1. Ana2 contains two conserved LC8 binding sites.
cartwheel with mapped components. The precise
unknown, but it is known to bind the Sas
Sas-4 C-terminal region (Cottee et al., 2013). (B) A conserved set of proteins drive centriole 
duplication. Conserved centriole duplication pathway components from 
111
 (A) The nascent centriole 
 location of Ana2 on the cartwheel remains 
-6 N-terminal region (Stevens et al., 2010a) and the 
Drosophila 
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melanogaster (D.m.), Homo sapiens (H.s.), and Caenorhabditis elegans (C.e.) are presented 
with orthologous proteins listed on the same row. Drosophila Asterless (Asl) recruits 
SAK/Polo-Like Kinase-4 (Plk4) to the site of nascent centriole formation via a direct 
interaction (Dzhindzhev et al., 2010; Slevin et al., 2012), where it phosphorylates both a 
known and unknown set of substrates in the centriole duplication pathway (Lettman et al., 
2013; Puklowski et al., 2011). Spindle-assembly Abnormal-6 (Sas-6) oligomerizes to form 
the first structure observed using electron microscopy; this 9-spoked cartwheel depicted at 
left. In cells, Sas-6 oligomerization is Anastral Spindle-2 (Ana2)-dependent (Kitagawa et al., 
2011; Stevens et al., 2010a; Stevens et al., 2010b). Spindle-assembly Abnormal-4 (Sas-4) is 
thought to recruit triplet microtubule blades and stabilize centriole elongation and maturation 
(mature centriole shown at left) (Pelletier et al., 2006; Cottee et al., 2013; Hatzopoulos et al., 
2013). (C) Comparison of H.s., Danio rerio (D.r.), D.m., and C.e. Ana2 orthologs reveals 
diversity in protein structure. While the length of Ana2 orthologs differ, the presence of a 
Sas-4 binding domain (red), a Sas-6 binding domain (STAN domain, gray), and a predicted 
central coiled-coil region remain constant (domains shown as determined in Hatzopoulos et 
al., 2013; Stevens et al., 2010a). Inset, alignments of individual Sas-4 binding domains and 
STAN domains between D.m. and H.s, D.r., or C.e. reveal high percentages of invariant (first 
value) and similar (second value) residues. (D) Ana2 and LC8 form a complex with Mud to 
orient the mitotic spindle during asymmetric divisions in the developing Drosophila 
neuroblast (Wang et al., 2011). Asymmetry is achieved, in part, via differential maturation of 
the centrosomes. The daughter centrosome forms the LC8/Ana2/Mud complex that 
coordinates spindle alignment with cortical polarity cues to maintain a stem population 
(GMC: ganglion mother cell) (Lerit and Rusan, 2013; Wang et al., 2011). (E) Full-length 
Drosophila Ana2 has an N-terminal Sas-4 binding region (Cottee et al., 2013; Hatzopoulos et 
al., 2013) and a C-terminal STAN motif (Stevens et al., 2010a) conserved across functional 
Ana2 orthologs. The central predicted helical domain is flanked by two LC8 binding sites 
(Site 1, residues 159-168; Site 2, residues 237-246). Residue identity across Drosophila 
species is noted below in green. (F) Conservation within the Ana2 central helical domain and 
LC8 binding sites. Residues with 100% identity are highlighted in green, while those with 
80% similarity are highlighted in yellow. Note that both the TQT (165-166) and TQC (243-
244) sites are conserved within the genus. 
 
 
Experimental Procedures 
Cloning and Expression of full-length LC8 
 Full-length Drosophila melanogaster LC8 was subcloned into the pGEX-6P-2 
expression vector (GE Healthcare). pGEX-6P-2-LC8 was transformed into E. coli BL21 DE3 
(pLysS) and grown under ampicillin selection in 6 L of LB media at 37°C. At an optical 
density of 0.6 (600 nm), GST-LC8 expression was induced using 0.1 mM isopropyl-1-thio-β-
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D-galactopyranoside for 16 hours at 18°C. Cells were harvested by centrifugation at 2100 x g 
for 10 minutes at 4°C and the pellets resuspended in buffer A: 25 mM Tris, pH 8.0, 300 mM 
sodium chloride, and 0.1% β-mercaptoethanol, and stored at -20°C. 
Protein Purification for Crystallization 
 LC8 was purified as previously described for the yeast homologue Dyn2 (Romes et 
al., 2012). Briefly, cells expressing GST-LC8 were lysed by sonication, clarified by 
centrifugation at 23,000 x g for 45 minutes, and the supernatant loaded onto a Glutathione-S-
sepharose column (GE Healthcare). The column was washed with buffer A and the GST-LC8 
fusion step eluted in buffer A supplemented with 25 mM glutathione. The GST tag was 
cleaved with PreScission protease (GE Healthcare). LC8 was subsequently purified on an SP 
Sepharose Fast Flow column (GE Healthcare) and exchanged into MES storage buffer (25 
mM MES, pH 6.0, 50 mM NaCl, and 0.1% β-mercaptoethanol). LC8 was concentrated to 0.5 
mM, snap frozen in liquid nitrogen and stored at -80°C. The final LC8 contains an N-
terminal five-residue (GPLGS) cloning artifact. 
Synthesis of Ana2 Peptides  
 Ana2 peptides were synthesized at the UNC Microprotein Sequencing and Peptide 
Synthesis Facility and lyophilized peptides were reconstituted in final MES storage buffer. 
An N-terminal, non-native Asn and Tyr were added to each peptide to facilitate peptide 
concentration determination (underlined in the sequences presented below). The Ana2 
peptide sequences are peptide 1 (pep1): NYTICAGTQTDP (Ana2 residues 159-168) and 
peptide 2 (pep2): NYSSTTGTQCDI (Ana2 residues 237-246). 
Crystallization of the LC8/Ana2 peptide complexes  
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 Final concentrations of 0.5 mM LC8 and 0.6 mM Ana2 pep1 (or 0.75 mM LC8 and 
0.9 mM Ana2 pep2) in MES storage buffer were incubated for 30 minutes on ice. For the 
LC8/pep1 complex, crystallization followed the hanging drop protocol using 2 µL of the 
LC8-Ana2 pep1 mixture and 2 µL of a 1 mL well solution that contained 0.3 M magnesium 
acetate, 0.1 M sodium cacodylate, pH 6.5, and 26% (w/v) polyethylene glycol 8000. The 
same method was used for LC8/pep2 in a well solution containing 0.19 M ammonium 
acetate, 27% (w/v) polyethylene glycol 4000, 0.1% β-mercaptoethanol, and 0.1 M sodium 
acetate, pH 4.6. For both structures, crystals grew at 20°C into rods (pep1) or rounded cubes 
(pep2) within three days and remained at full size for up to three weeks. Crystals were 
transferred into fomblin oil (Sigma) cryoprotectant and flash frozen in liquid nitrogen. 
Data Collection, Structure Determination, and Refinement  
 Diffraction data were collected on LC8-Ana2 crystals (both peptides) at the 
Advanced Photon Source SER-CAT beamline 22-ID with 1° oscillations over 180° from 
single crystals. Data were indexed, integrated, and scaled using HKL2000 (Otwinowski and 
Minor, 1997). The LC8-Ana2 peptide structures were determined using the AutoMR 
molecular replacement program (PHENIX crystallographic suite (Adams et al., 2010)) and a 
modified 2PG1 (Williams et al., 2007) coordinate file in which a monomeric (for LC8/Ana2 
pep1) or dimeric (for LC8/Ana2 pep2) apo Drosophila LC8 search model was used. The 
models were built using AutoBuild (PHENIX) and refined iteratively through manual builds 
in Coot (Emsley et al., 2010) followed by refinement runs using phenix.refine against a 
maximum likelihood target (PHENIX) (Adams et al., 2010). Refinement statistics were 
monitored using a Free R, calculated using 5.4% or 5.6% of the data for pep1 and pep2, 
respectively, randomly excluded from refinement (Brünger 1992). 
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Isothermal Microtitration Calorimetry  
 ITC experiments were carried out at 26°C in MES storage buffer on a MicroCal 
AutoITC200 (GE Healthcare). Lyophilized peptides were solubilized in MES storage buffer. 
19 x 2 µL injections of 1.0 mM Ana2 pep1 were automatically injected into 200 µL of 50 µM 
LC8 and 2.0 mM pep2 was automatically injected into 200 µL of 100 µM LC8. The resulting 
binding isotherms were analyzed using the Origin 7.0 software package (OriginLab) and 
were fit to a single-site, independent-binding model. Ana2 peptide control experiments were 
performed to determine the contribution from each peptide’s heat of dilution. These controls 
involved 19 x 2 µL injections of 1.0 mM Ana2 pep1 or 2.0 mM Ana2 pep2 into a chamber 
containing 200 µL of MES storage buffer. The Ana2 pep1 control isotherm did not reveal 
significant heat of dilution; therefore, the final five injection values (where binding was 
saturated in the pep1-LC8 isotherm) were averaged and this value was subtracted from each 
injection in the pep1-LC8 experiment. The Ana2 pep2 control isotherm revealed a significant 
endothermic heat of dilution (data not shown); therefore, these control values were 
individually subtracted from the corresponding raw experimental values from the pep2-LC8 
binding isotherm. Experiments were conducted in triplicate, the internal or external controls 
were subtracted, and the resulting heats of dilution were averaged to determine respective 
mean KD values and standard deviations. 
Cloning and Expression of LC8 and Ana2M Constructs for SEC-MALS  
 Full-length Drosophila melanogaster LC8 was subcloned into a pET28b expression 
vector (EMD Millipore) with an engineered PreScission protease (GE Healthcare) cleavage 
site following the N-terminal His6 tag. The subcloning of SNAP-tag-LC8 (New England 
Biolabs) into pET28b followed a similar protocol. Drosophila melanogaster Ana2 residues 
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D156-Q251 (Ana2M) was subcloned into a pGEX-6P-2 expression vector (GE Healthcare). 
pET28b-LC8 and pGEX-6P-2-Ana2M were separately transformed into E. coli BL21 DE3 
(pLysS) and grown individually under kanamycin (LC8) or ampicillin (Ana2M) selection, 
each in 5 L of LB media at 37°C. At an optical density of 0.6 (600 nm), His6-LC8 or GST-
Ana2M expression was induced using 0.2 mM isopropyl-1-thio-β-D-galactopyranoside for 
16 hours at 18°C. Cells were harvested by centrifugation at 2100 x g for 10 min at 4°C and 
the pellets of both His6-LC8 and GST-Ana2M were combined and resuspended in buffer A: 
25 mM Tris, pH 8.0, 10 mM imidazole, 300 mM sodium chloride, and 0.1% β-
mercaptoethanol, and stored at -20°C.  
Ana2M-LC8 Complex Purification for SEC-MALS  
 The composite pellet of His6-LC8 and GST-Ana2M was thawed and lysed by 
sonication with addition of phenylmethanesulfonylfluoride to a final concentration of 200 
µM. The supernatant was purified over Ni2+-NTA resin (QIAGEN) followed by PreScission 
protease (GE Healthcare) treatment to cleave off the His6 and GST tags. The LC8:Ana2M 
complex was subsequently purified over a Superdex 200 size exclusion column (GE 
Healthcare) and concentrated in SEC-MALS buffer: 25 mM HEPES, pH 7.5, 300 mM 
sodium chloride, 0.1% β-mercaptoethanol. The presence of both components was confirmed 
by SDS-PAGE. Expression and purification of the Ana2M-SNAP-LC8 complex followed a 
similar protocol. 
Mutagenesis of Ana2M  
 An Ana2M site 1 LC8-binding mutant (Q165A/T166A) was created using the 
QuikChange (Agilent Technologies) method on the wild-type GST-Ana2M construct 
  117
according to the manufacturer’s instructions. The mutant GST fusion protein was expressed 
and co-purified with wild-type LC8 as described above. 
SEC-MALS  
 LC8/Ana2M
 
complexes (100 µL) were injected onto a Wyatt WTC-030S5 silicone 
size exclusion column (for elution of 5 –1,250 kDa proteins) in SEC-MALS buffer 
supplemented with 0.2 g/L sodium azide and passed in tandem through a Wyatt DAWN 
HELEOS II light scattering instrument and a Wyatt Optilab rEX refractometer. The light 
scattering and refractive index data were used to calculate the weight-averaged molar mass 
and the mass fraction in each peak using the Wyatt Astra V software program (Wyatt 
Technology Corp.) (Wyatt 1993). 
 
Results 
Ana2 Contains Two High-Affinity LC8 Binding Sites 
 Drosophila Ana2 is a 420-residue centriole duplication component that lacks apparent 
conservation across species barring an N-terminal Sas-4 binding region (Cottee et al., 2013; 
Hatzopoulos et al., 2013), a central predicted coiled-coil domain, and the highly conserved 
C-terminal STAN (STil/ANa2) motif (Figure 5.1 C, E, F) (Stevens et al., 2010a). Previous 
studies demonstrated a physical interaction between the N-terminal 274 residues of Ana2 and 
LC8, a dynein light chain, via yeast two-hybrid (Wang et al., 2011). Structure function 
analysis indicated that Ana2 contained at least two LC8 binding sites, one within the region 
spanning residues 1-200, and the second within the region spanning residues 201-274. LC8 
binds many subcellular targets across species in a cytoplasmic dynein motor-independent 
mechanism to promote target dimerization (Rao et al., 2013), suggesting that LC8 may 
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potentiate Ana2 oligomerization. To map the interactions between Ana2 and LC8, we 
scanned Ana21-274 for potential LC8 binding sites. LC8 target motifs comprise up to 11 
contiguous residues, which, though diverse in sequence composition, often contain a K
-3X-2T-
1Q0T1 or G-2I-1Q0V1D2 motif with the conserved glutamine, Q0, set as the zero reference point 
(Rapali et al., 2011a). Target peptides with these LC8-binding motifs bind LC8 with KD 
values in the 0.1-100 µM range (Rapali et al., 2011a; Benison et al., 2008). We identified two 
potential binding sites within Ana2, corresponding to residues 159-168 (containing a T
-1Q0T1 
sequence) and 237-246 (containing a T
-1Q0C1 sequence). These two sites flank either end of 
the conserved predicted coiled-coil (Figure 5.1 E, F) and correlate with the two fragments 
identified via yeast two-hybrid as LC8-binding segments.  
 To determine whether these sites were conserved, we aligned several Ana2 sequences 
from ten different Drosophila species. Much of the protein is conserved within the genus, 
with the largest concentration of identity mapping to the STAN motif and an N-terminal 
region with no predicted secondary structure, but involved in Sas-4 binding (Figure 5.1 E) 
(Cottee et al., 2013; Hatzopoulos et al., 2013). Additional identity maps to the central 
predicted coiled-coil and the flanking regions that contain the tentative LC8-binding sites we 
identified (Figure 5.1 F). The linkers that bridge the predicted LC8 binding sites with the 
central, predicted coiled coil show diversity in both sequence length and composition. When 
we analyzed the central, predicted coiled-coil domains in Ana2 orthologs: human STIL, 
zebrafish STIL, and C. elegans Sas-5, only Sas-5 contained a potential QT-motif N-terminal 
to the predicted coiled coil with the sequence KTVNVSQTVE, suggesting that the LC8-
Ana2 interaction may be specific to a subset of Ana2 orthologs. 
  To confirm the ability of Ana2’s putative LC8
synthesized peptides corresponding to the two predicted Ana2
E,F) and performed ITC, monitoring the heat released as each peptide was titrated into the 
calorimeter cell containing purified LC8. Experiments were performed in triplicate, with 
reported values reflecting the average of all trials. The Ana2 peptide 1 
isotherm was exothermic and yielded a K
Compared to reported LC8-target affinities (100 
al., 2008), Ana2 pep1 binds LC8 in the higher
isotherm was also exothermic, and yielded an experimentally determined LC8 K
12.8 ± 1.5 µM (Figure 5.2 B), a weaker binding affinity than pep1, but within the commonly 
reported range of LC8-target affinities. 
 
            
 
FIGURE 5.2. LC8 binds two Ana2 sites with different affinities. 
peptide-LC8 interactions. (A) 19 × 2 
of 50 µM LC8. (B) 18 × 2 µL of 2 mM Ana2 peptide 2 was injected into 200 
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LC8. Both Ana2 peptides display exothermic binding to LC8. The thermal profiles were 
integrated (top panels in A, B) and fit to a one-site binding model during iterative fitting until 
the model best fit the data. Each experiment was run in triplicate, with the KD reported as the 
average (lower corner of bottom panels) with standard deviation indicated. 
 
 
Crystallization of the LC8 Ana2 Pep1 and Pep2 Complexes 
  To determine the molecular determinants underlying the LC8-Ana2 interaction, we 
attempted to crystallize LC8 in complex with each synthesized Ana2 peptide. Both LC8-
peptide complexes were amenable to crystallization, though diffraction-quality crystals 
formed in different conditions (see Experimental Procedures). Ana2 pep1-LC8 crystals 
diffracted to 1.83 Å resolution and belonged to the space group P212121 (Table 1). Ana2 
pep2-LC8 crystals diffracted to 1.9 Å resolution and belonged to the space group P1 (Table 
1). To solve both structures, we performed molecular replacement using a search model 
containing a single Drosophila LC8 chain (for Ana2 pep1) or an LC8 dimer (for Ana2 pep2) 
without bound peptide, derived from PDB 2PG1 (Williams et al., 2007).  
  
 
The Structure of LC8 Bound to Ana2 Pep1 
 Four LC8 chains were found in the asymmetric unit. The LC8 chains are paired to 
form two independent homodimers, each arranged around non-crystallographic 2-fold axes. 
Clear electron density was evident in the initial Fo-Fc map to build four Ana2 pep1 chains 
(Figure 5.3 A), two bound to each LC8 homodimer. The structure was built and refined to R 
and Rfree values of 17.6 and 20.7%, respectively (see Table 1 for refinement statistics). 
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 The LC8 homodimer forms a composite platform for Ana2 pep1 binding (Figure 5.3 
B). The homodimeric core is characterized by a central 12-stranded β-sandwich, each half of 
which is formed by four β-strands from one LC8 chain (β1 from V7-D12, β4 from H72-L78, 
β5 from V81-K87, β2 from W54-G59), one β-strand from the LC8 homodimeric mate (β3′ 
from G63′-E69′), and the Ana2 peptide, which contributes the sixth and final β-strand (Figure 
5.3 B). Each β-sheet is entirely anti-parallel. The β-sandwich is flanked on either side by two 
α-helices. Ana2 pep1 binding engages determinants in both LC8 chains, with β3 forming a 
key extended interface with the peptide (Figure 5.3 B). Peptide binding is stabilized by 
backbone/backbone anti-parallel β-sheet hydrogen bonding (Figure 5.4 A) as well as several 
side chain interactions. Ana2’s conserved glutamine Q165 (notated as Q0 in reference to its 
position in the canonical K
-3X-2T-1Q0T1 binding motif) forms key contacts including van der 
Waals interactions with both LC8 chains and hydrogen bonds with the E35′ side chain 
carboxylate group and the K36′ backbone amide, serving to cap the α2′ helix’s N-terminal 
region (Figure 5.4 B).  
 
 
The Structure of LC8 Bound to Ana2 Pep2 
 The Ana2 pep2-LC8 crystal contains three LC8 dimers in the P1 unit cell. One LC8 
dimer is bound to two Ana2 pep2 chains (Figure 5.3 A,C), while the other two LC8 dimers 
are in the apo form with crystal packing sterically occluding the peptide binding sites. The 
structure was built and refined to R and Rfree values of 18.5 and 23.7 %, respectively (see 
Table 1 for refinement statistics). 
 
       
FIGURE 5.3. Structures of LC8
parallel Ana2 peptides. (A) LC8
free LC8 search models. Initial F
green and contoured at 2.0σ (Pep1) and 1.65
below in gray with the final Ana2 pep1 and pep2 model included; electron density is 
contoured at 2.0 σ (pep1) and 1.0 
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complexes are presented in the upper left (LC8-Ana2 pep1) and upper right (LC8-Ana2 
pep2) with peptides in the same orientation for reference. (B and C) The final structures of 
LC8 bound to Ana2 pep1 (orange, B) and Ana2 pep2 (cyan, C) are shown looking down the 
complex’s two-fold axis (left) and after a 90° rotation about the y-axis (right). Center 
schematic in B and C summarizes the secondary structure elements that comprise a single β-
sheet in the LC8-peptide complexes. Each β-sheet is extended by the third β-strand 
contributed by the LC8 homodimeric mate (purple) as well as the bound Ana2 peptide (pep1 
shown in orange, B; pep2 shown in cyan, C). The final β-sheet comprises a total of six 
strands is flanked by two α-helices (shown in mint, behind the sheet). 
 
  
 Ana2 pep2 binds in a manner similar to Ana2 pep1, extending either side of LC8’s 
core β-sandwich and making several backbone interactions with LC8 β3 (Figure 5.3 C, 
Figure 5.4 A). Ana2 pep2’s Q0 participates in similar interactions as observed in the LC8-
Ana2 pep1 structure; however, pep2 contains a non-canonical cysteine residue at the +1 
position, C244. To our knowledge, this is the first example of an LC8 target with a cysteine 
in the +1 position. In contrast to the canonical threonine at the +1 position, Ana2 pep2 C244 
is angled into the LC8 peptide binding groove, with its side chain engaging LC8 E35′, R60, 
N61, F62, Y77, and A82. Specifically, the cysteine’s terminal sulfhydryl group forms a 3.6-
Å electrostatic interaction with the backbone carbonyl of LC8 R60 (Figure 5.4 C). This shift 
allows for extended backbone-backbone contacts including interactions between Ana2 C244 
and LC8 F62, as well as between Ana2 I246 and LC8 R60 (Figure 5.4 D). As a result, the 
Ana2 pep2 C-terminal region differentially engages the LC8 dimer as compared to Ana2 
pep1, whose respective determinants are positioned upwards of 5 Å away (Figure 5.4 D).  
       
 
FIGURE 5.4. Ana2’s LC8-
binding determinants. (A)
homodimer (y-axis) and Ana2 pep1 (orange, top x
Interactions are presented where atoms are less than or equal to 3.5 Å apart (hydrogen bonds 
and electrostatic interactions; shown in red for pep1 and pink for pep2) and 4.5 Å apart (van 
der Waals contacts; shown in dark gray for pep1 and light gray for pep2). B
filled in reflect similar LC8 interaction modes with each peptide while those boxes that are 
half-filled indicate unique, peptide
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binding sites 1 and 2 employ both shared and unique LC8
 Interaction matrix displaying contacts between the LC8 
-axis) or Ana2 pep2 (cyan, bottom x
-specific interactions. (B) Ana2 pep1’s conserved Q165 
 
 
-
-axis). 
oxes completely 
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forms hydrogen bonds to LC8′ residues E35′ and K36′. (C) Ana2 pep2’s C244 forms an 
electrostatic interaction with LC8 residue R60. (D) The Ana2 pep2 (cyan) C-terminal region 
forms extensive backbone hydrogen bonds with LC8 and is positioned different that Ana2 
pep1 (orange) which has been overlayed on the LC8-Ana2 pep2 structure for comparative 
purposes. In contrast to the Ana2 pep2 C244 backbone carbonyl and the I246 backbone 
amide that interact with LC8 F62 and R60 respectively, the comparable Ana2 pep1 
determinants (indicated with magenta arrows) are splayed and rotated away from LC8. 
  
 
The LC8 Binding Pocket Undergoes Structural Shifts to Accommodate Ana2 Peptides 
 In addition to observing an LC8-Ana2 pep2 complex in the P1 unit cell, two sets of 
apo LC8 homodimers were also present. As previously observed (Benison et al., 2008), the 
apo LC8 binding pocket is narrower than the peptide-bound cleft observed in both Ana2-
bound LC8 structures (Figure 5.5 A). Several LC8 residues that directly engage the Ana2 
peptides are swung towards the peptide binding pocket in the apo state, including N10, K36′, 
Y65, T67, F73, Y75, and Y77, highlighting the mobility of LC8 side chains upon target 
binding. 
 
  
Ana2 Employs a Unique Tandem Set of LC8 Binding Motifs 
 LC8 targets vary widely in their binding affinity and motif composition, both within 
and beyond the canonical K
-3X-2T-1Q0T1 or G-2I-1Q0V1D2 sequence motifs. Interestingly, both 
Ana2 LC8 binding motifs combine features from each canonical motif (pep1: A
-3G-2T-
1Q0T1D2; pep2: T-3G-2T-1Q0C1D2). Both Ana2 LC8 sites have threonine residues at the -1 
position as found in the K
-3X-2T-1Q0T1 motif, and both have glycine and aspartate residues at 
the -2 and +2 positions as found in the G
-2I-1Q0V1D2 motif. Neither Ana2 site employs a 
basic residue at the -3 position, which is often seen in high-affinity LC8 interactors (Rapali et 
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al., 2011b) including Nek9 (a kinase that regulates mitotic spindle formation and 
chromosome separation) (Gallego et al., 2013) and the dynein intermediate chain (DIC, a 
dynein motor complex component used in cargo recognition) (Williams et al., 2007) (Figure 
5.5 A,B,C). Both Nek9 and DIC LC8 target sites contain a lysine at the -3 position (K
-3) that 
interacts with the LC8 D12′ side chain carboxyl group, and promotes relatively strong LC8-
binding interactions (KDs on the order of 0.1-0.2 µM) (Williams et al., 2007; Gallego et al., 
2013) (Figure 5.5 B,C). Ana2 sites 1 and 2 contain an alanine and threonine, respectively, at 
position -3 that do not engage the D12′ side chain carboxyl (Figure 5.5 A). At the -3 position, 
Pak1 (a kinase that regulates cell motility and, together with LC8, plays a role in cancer 
transformation (Lightcap et al., 2008)) is an interesting point of comparison. Pak1 contains 
the non-canonical LC8 binding sequence V
-3A-2T-1S0P1I2 and has the weakest affinity for 
LC8 (KD of 42 µM) of the peptides we use for comparison. Like both Ana2 peptides, Pak1 
employs a non-charged residue at the -3 position, but similar to the -3 lysine in Nek9 and 
DIC, positionally equivalent aliphatic side chain determinants are used to engage LC8, 
highlighting LC8’s ability to accept side chain variability at the -3 position.  
 We next examined how the conformations of Ana2 pep1 and pep2 compared to other 
LC8 binding peptides by aligning LC8-peptide complex structures (Figure 5.5 D,E,F). Ana2 
pep1 aligns well with other LC8 binding peptides including Nek9, DIC, and Pak1 (Figure 5.5 
E). However, the C-terminal region of Ana2 pep2 departs from this common LC8-bound 
architecture. The aforementioned Ana2 pep2 cysteine, C244, at position +1 is angled into the 
LC8 peptide-binding groove, effectively positioning the peptide’s C-terminal region closer to 
the LC8 homodimer. In contrast, Ana2 pep1, Nek9, DIC, and Pak1, each of which has a 
threonine at position +1, splay away from the LC8 dimer, with their C-terminal regions 
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positioned ~3-5 Å from the comparative location of Ana2 pep2 (Figure 5.5 E). Underlying 
the differential position of Ana2 pep2 is comparative placement of the cysteine C244 
backbone carbonyl in the same location of the threonine (T1) side chain hydroxyl as found in 
Ana2 pep1, Nek9, and DIC (Figure 5.5 F).  
 
 
LC8 Mediates Ana2M’s Solubility and Oligomerization State 
 Multiple attempts to express various Ana2 constructs containing either or both of the 
LC8 binding sites yielded insoluble protein, making it difficult to study Ana2’s oligomeric 
state in the absence of LC8. However, co-purification of Ana2M (residues 156-251, 
encompassing both LC8 binding sites and a central predicted helical domain, Figure 5.1 B) 
and LC8 yielded a stable, soluble complex that could be purified via LC8’s His6 affinity tag 
followed by size exclusion chromatography. LC8’s canonical role as a dimerization “hub” 
led us to predict that the purified LC8-Ana2M complex would form a heterohexamer, with 
two Ana2M chains forming a central coiled-coil flanked at either end by LC8 homodimers. 
To experimentally determine the Ana2M-LC8 complex’s mass and stoichiometry, we 
analyzed the complex using SEC-MALS.  
 
    
FIGURE 5.5. Ana2’s two LC8 bi
the LC8 target-binding site among the apo, Ana2 pep1
structures. Several LC8 residues within the binding pocket show conformational change upon 
binding peptides and are colored red: N10, Y65, T67, F73, Y75, Y7
Comparative panel showing the positioning of other peptides bound to 
128
nding sites differentially bind LC8. (A) 
-bound, and Ana2 pep2
7, and K36
Drosophila
 
 
A comparison of 
-bound LC8 
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Nek9 (3ZKE), DIC (2PG1), and Pak1 (3DVP) (Gallego et al., 2013; Williams et al., 2007; 
and Lightcap et al., 2008, respectively). (C) Alignment of Ana2 peptides with Nek9, DIC, 
and Pak1, as well as the canonical binding motifs G
-2I-1Q0V1D2 and K-3X-2T-1Q0T1. 
Conservation is shown in yellow, contoured to ≥70% similarity. (D) Ana2 peptides 1 and 2 
superimposed after aligning their respective, bound LC8 homodimers (not shown), viewed in 
two orientations. (E) Comparisons of the Ana2 peptides with Nek9 (periwinkle), DIC (lime), 
and Pak1 (salmon) peptides show that while relative positions of the sidechains are 
conserved, the Ana2 pep2 C-terminus uniquely bends toward the LC8 homodimer. Above: 
stick diagram; below, Cα trace. Measurements of the pep2 backbone show a 3.5 Å and 5.6-Å 
positional shift at the +1 and +2 Cα positions respectively for Ana2 pep2 versus Ana2 pep1. 
(F) Zoom view of the peptides at position +1 reveals the mechanism of Ana2 pep2’s C244 
shift: the same position usually occupied by a +1 position threonine side chain hydroxyl is 
instead occupied by Ana2’s C244 backbone carbonyl group. This effectively positions the 
peptide deeper into the LC8 binding pocket. 
 
 
 As previously reported (Romes et al., 2012), purified LC8 eluted primarily as a dimer 
(Figure 5.6 A, light green trace indicating the Rayleigh ratio) with a mass of 21.6 kDa 
(Figure 5.6 A, dark green trace indicating the molecular weight). Surprisingly, Ana2M-LC8 
formed a stable complex with a mass of 117.1 ± 5.9 kDa (average of four experiments from 
two independent protein purifications, Figure 5.6 A, red traces). This is approximately twice 
the mass an Ana2M2-LC84 heterohexamer would form (68 kDa). Adding excess purified 
LC8 to the Ana2M-LC8 complex did not shift or increase the mass of the eluted complex, 
but yielded a second peak that eluted later with an experimentally determined mass of 21 
kDa, correlating with excess LC8 homodimers (data not shown). These results led us to 
postulate the existence of an LC8-mediated Ana2M tetramer comprising four Ana2M 
molecules and four LC8 homodimers (Ana2M4-LC88, Figure 5.7).  
To test our predicted stoichiometry, we reasoned that mutating Ana2’s first LC8 
binding site to compromise LC8 binding would result in an Ana2M4-LC84 complex with a 
corresponding mass of 90.8 kDa. We mutated Ana2M’s first LC8 binding site (Q165A and 
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T166A or “QT/AA”) and co-purified the Ana2MQT/AA-LC8 complex, noting that the second 
LC8-binding site was sufficient for LC8-mediated Ana2M solubilization. The Ana2MQT/AA-
LC8 mutant retained its solubility and showed an excess of unbound LC8 during size-
exclusion chromatography. In accordance with forming an Ana2M4-LC84 heterooctomer 
(predicted mass of 90.8 kDa), the complex had an apparent mass of 84.8 ± 2.5 kDa (Figure 
5.6 A, blue traces). 
 In our experiments, Ana2M and LC8 were approximately the same mass (11.4 and 
11.3 kDa, respectively), making it difficult to determine the relative contribution of LC8 and 
Ana2M to the complex. To independently confirm the composition of the proposed Ana2M4-
LC88 complex, we purified an N-terminally SNAP-tagged LC8 (monomer mass: 30 kDa) 
alone and in complex with Ana2M. The SNAP tag served the sole purpose of increasing the 
mass of the LC8 construct to see how this change in turn altered the mass of the Ana2M-LC8 
complex. An Ana2M4-SNAP-LC88 complex would have a mass of 286 kDa. SNAP-LC8 was 
expressed with an N-terminal His tag, and behaved similar to wild-type LC8 throughout 
purification. Purified SNAP-LC8 eluted from the SEC-MALS column as a homodimer with 
an apparent mass of 59.3 kDa, indicative that the SNAP tag does not interfere with LC8 
dimerization (Figure 5.6 B, dark green trace). Ana2M co-purified with SNAP-LC8, 
suggesting that SNAP-LC8 retained target-binding capabilities.  The Ana2M-SNAP-LC8 
complex eluted broadly from the SEC-MALS column with experimentally determined 
masses ranging from 290 kDa (early portion of the elution peak) to 150 kDa (later portion of 
the elution peak) (Figure 5.6 B, purple trace). The early portion of the elution peak mass 
correlates with an Ana2M4-SNAP-LC88 complex while the 150 kDa shoulder suggested that 
 the SNAP tag may sterically hinder Ana2 tetramerization, yield
subspecies. 
 
FIGURE 5.6. SEC-MALS of Ana2M co
corresponding to LC88-Ana2M
soluble only when co-purified with excess LC8, and behaved as a single species throughout 
the purification which included affinity tag chromatography followed by two sizing columns. 
(A) Detection of the LC8/Ana2M complex on a sizing column coupled with multi
static light scattering shows a single peak (pink trace, Rayleigh ratio) at 117± 5.9 kDa (red, 
molecular weight measurement). The same experiments with a Q
a single peak (light blue trace, Rayleigh ratio) at 84.8 ± 2.5 kDa (dark blue trace, molecular 
weight measurement). LC8 alone elutes as a dimer with a mass of 21.6 kDa (dark green 
trace; molecular weight measurement). (B)
trace, Rayleigh ratio) at 59.3 kDa (dark green traces), corresponding to a dimer. Co
purification of SNAP-LC8 with Ana2M yielded a complex that eluted from the size 
exclusion column in a broad peak, with a shoulder characteristic of complex dissociation 
(light purple trace, Rayleigh ration). Experimentally determined molecular weight across the 
broad peak indicated complexes of varying size, ranging from 290 to 150 kDa (dark purple 
traces; different parts of the peak were integrated to determine the contri
experiments are consistent with the formation of a stable LC8
 
 
Discussion 
 Ana2 is an integral component of the centriole duplication pathway, but how it works 
with Sas-6 and Sas-4, and whether LC8 plays a role in this 
determined. The Sas-6 dimer interactions that facilitate cartwheel formation are very weak 
(KD of >100 µM), making it unlikely that Sas
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cellular context at endogenous levels. Additionally, Sas-6 overexpression promotes centriole 
amplification only when Ana2 is co-overexpressed, suggesting that Ana2 plays a supporting 
role in enhancing Sas-6 oligomerization and cartwheel formation (Stevens et al., 2010b). One 
mechanism by which Ana2 could promote Sas-6 oligomerization is if Ana2 itself were 
oligomeric. This idea is supported by recent evidence that Ana2 binds LC8, a dynein light 
chain that plays a ubiquitous role as a dimerization machine (Wang et al., 2011). Our work 
provides insight into the Ana2-LC8 quaternary structure, and establishes a foundation upon 
which the Ana2 tetramer’s avidity effects on Sas-6 oligomerization can be investigated. 
 We have identified two LC8 binding sites in Ana2, conserved within the Drosophila 
genus, that flank a central domain with predicted helical structure (Figure 5.1 A). While the 
exact binding sites are not apparent in other metazoan species, the presence of a central 
predicted coiled-coil is conserved across Ana2 orthologs from C. elegans Sas-5 to human 
STIL, and suggests a role in oligomerization. This is supported by a report that the C. elegans 
Sas-5 N-terminal region (containing the central predicted coiled coil) forms a tetramer in 
solution (Shimanovskaya et al., 2013). While Sas-5 tetramerization in vitro is not LC8-
dependent, its oligomeric state parallels the LC8-dependent tetramerization we observe with 
Ana2.  
Dynein light chains often bind targets proximal to an endogenous oligomerization 
domain, potentiating target dimerization. Both of Ana2’s LC8-binding sites are an amalgam 
of the canonical K
-3X-2T-1Q0T1 and G-2I-1Q0V1D2 LC8-binding motifs. Using ITC, we have 
shown that Ana2 pep1 binds LC8 with micromolar affinity (KD = 1.1 µM). Our crystal 
structure of LC8 bound to Ana2 pep1 shows an LC82-Ana2 pep12 binding mode, with Ana2 
pep1’s canonical TQT sequence contributing key binding determinants.  
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 Our second identified LC8-binding site (Ana2 site 2, pep2) flanks the central helical 
domain’s C-terminal region and is composed of the sequence T
-3G-2T-1Q0C1D2. Ana2 pep2 
binds LC8 with lower affinity (KD = 13 µM) than Ana2 pep1. Our crystal structure of LC8 
bound to Ana2 pep2 also has an LC82-Ana2 pep22 binding mode. Interestingly, Ana2 pep2 
adopts a unique architecture when bound to LC8 that contrasts with other LC8-peptide 
structures. The Ana2 pep2 cysteine C244 at position +1 is positioned deeper into the LC8 
binding groove. The affinities we report for the LC8-Ana2 peptide interactions likely 
underestimate the stability of the biological complex involving full length Ana2 and LC8. As 
our solution studies support interactions between LC8 homodimers and a tetrameric Ana2M 
region, we anticipate that avidity effects will increase the complex’s stability beyond the 
affinities we report for LC8 and Ana2 pep1 and pep2. This is consistent with the finding that 
a stable Ana2-LC8 complex can be extracted from Drosophila cell lysate (Wang et al., 
2011). We note that within the genus Drosophila, the two segments that bridge the predicted 
central coiled-coil with the two flanking LC8 binding sites are not conserved in sequence or 
length. We predict that these segments serve as general spacers that link the LC8 binding 
sites to the Ana2 coiled-coil oligomerization domain and maintain a general length that 
enables LC8 homodimers to bind and potentiate Ana2 oligomerization without sterically 
compromising coiled-coil formation.  
 Our data support a model in which LC8 stabilizes an Ana2 tetramer (Figure 5.7). An 
Ana2 tetramer may spatially arrange its conserved C-terminal STAN motifs to interact with 
Sas-6 and promote the Sas-6 oligomerization that underlies centriole cartwheel formation. 
Our SEC-MALS analysis of the Ana2M-LC8 complex reveals a stable, single-species 
complex consisting of four Ana2M molecules and eight LC8 molecules (Ana2M4-LC88). 
 This stable complex was purified over two successive sizing columns, demonstrating its 
ready formation, and yielded a similar experimental mass in two independent purifications 
and SEC-MALS assays. Mutating the first Ana2M LC8 bindin
SNAP tag to LC8 supported the Ana2M
               
 
FIGURE 5.7. A proposed model of LC8
indicate the formation of an LC8
role in centriole duplication by clustering multiple Sas
binding (gray ellipses) domains. Each LC8 homodimer locally mediates parallel dimerization 
of Ana2. The model, as presented, portrays the central, predicted 
domain. Whether this domain forms a tetrameric four
but it is presented as a parallel four
(below). 
 
  
 The Ana2-LC8 interactions that we characterized raise important questions about 
Ana2’s role in centriole duplication. Previous work has shown that Ana2’s C
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binds the N-terminus of Sas-6 in Drosophila (Stevens et al., 2010a), implicating a possible 
role for Ana2’s conserved STAN domain in Sas-6 binding. In our model, LC8 binds and 
stabilizes an Ana2 tetramer that may structurally organize four trans STAN domains at one 
end of a parallel tetramerization domain, or two trans STAN domains at either end of an 
antiparallel tetramerization domain (Figure 5.7). In either configuration, Ana2’s oligomeric 
state, coupled with its ability to bind Sas-6, is predicted to enhance Sas-6 oligomerization and 
cartwheel formation. This correlates with cellular studies in which Sas-6 and Ana2 dual 
overexpression was required for cartwheel formation, suggesting that Ana2 potentiates Sas-6 
cartwheel formation, potentially through oligomerization (Stevens et al., 2010b). Recent 
cryotomographic studies of nascent centriole architecture reveal auxiliary protein density 
connecting the Sas-6-based cartwheel to Sas-4 and the distal microtubule triplets (Guichard 
et al., 2013). Given Ana2’s integral role in Sas-6’s cartwheel formation as well as evidence 
that it binds both Sas-6 and Sas-4, Ana2 is a likely candidate for this density. More work is 
needed to determine if Ana2 can bridge Sas-6 and Sas-4, and whether the LC8-Ana2 
interaction plays a role in this Ana2 function, as it does in neuroblast asymmetric cell 
division. Our work outlines the structural basis of the LC8-Ana2 interaction, with 
implications for its role in Ana2 structure and function at the centriole. 
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TABLES 
Data Collection LC8-Ana2 Peptide 1 LC8-Ana2 Peptide 2/Apo LC8 
Wavelength (Å) 1.00000 1.07426 
Space group P212121 P1 
Cell dimensions (Å)   
       a 51.5 36.6     (α = 99.3) 
       b 77.9 44.8     (β = 103.0) 
       c 108.9 85.9     (γ = 91.8) 
Resolution (Å) 50.00-1.83 (1.90-1.83) 50.00-1.90 (1.97-1.90) 
Reflections   
       Measured 108,273 70,555 
       Unique 37,488 36,096 
Completeness (%) 95.1 (95.2) 87.5 (47.3) 
Mean redundancy 2.9 (2.5) 2.0 (1.8) 
I/σ 13.7 (2.4) 19.5 (7.0) 
Rsym* 0.08 (0.37) 0.04 (0.12) 
Refinement  
Resolution (Å) 45-1.83 (1.87-1.83) 36-1.90 (1.95-1.90) 
R/Rfree  (%) 17.6 (22.1)/20.7 (24.2) 18.5 (20.1)/23.6 (31.1) 
No. of reflections, R/Rfree 34,418/1,953 33,673/1,991 
Total atoms 3356 4580 
       Protein/Water 3046/310 4320/260 
Stereochemical ideality 
(Rmsd) 
  
       Bonds/angles (Å/°) 0.007/0.98 0.008/1.07 
Mean B-factors (Å2)   
       MC/SC/water 16.5/20.5/31.3 15.8/19.9/21.1 
B-factor Rmsd (Å2) 3.2 4.8 
Ramachandran analysis   
       Favored/allowed (%) 98.1/1.9 95.7/3.9 
 
Table 5.1. LC8-Ana2 Crystallographic Data, Phasing and Refinement. Values in 
parentheses are for the highest resolution shells unless otherwise denoted. *Rsym = ΣhΣi|Ii(h) − 
<I(h)>|/ΣhΣiIi(h), where Ii(h) is the ith measurement and <I(h)> is the mean of all 
measurements of I(h) for Miller indices h. 
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CHAPTER 6: DISCUSSION AND FUTURE WORK 
 
 
Plk4 employs an assemblage of Polo Box domains to license centriole duplication 
 Plk4 is a highly conserved serine/threonine kinase required for centriole duplication 
in nearly all animals, excluding higher plants and fungi (Bettencourt-Dias et al., 2005; 
Habedanck et al., 2005; Kleylein-Sohn et al., 2007; Rodrigues-Martins et al., 2007; Rogers et 
al., 2009; Cunha-Ferreira et al., 2009; Carvalho-Santos et al., 2010; Holland et al., 2010; 
Dzhindzhev et al., 2010). As a member of the Plk family of kinases, Plk4 contains an N-
terminal kinase domain and C-terminal “Polo Box” (PB) domains; however, the similarity 
between Plk4 and its family members stops there. Plk4’s kinase domain more closely 
resembles that of the Aurora family of kinases (personal communication, Yao Liang Wong 
and Karen Oegema) than the Plk family, indicating that different mechanisms of target 
recognition and/or kinase regulation may be in place for Plk4 than other Plks. Additionally, 
Plks 1-3 and 5 contain only two PB domains that are thought to form heterodimers in cis to 
allosterically downregulate the kinase domain (shown to be true for Plk1 in Xu et al., 2013). 
In contrast, our work has shown that Plk4 contains three PB domains (Slevin et al., 2012), 
indicating that Plk4 represents an architectural and evolutionary departure from the other Plk 
family members. Regardless, Plk4 remains a conserved core member of the centriole 
assembly pathway, for both canonical duplication mechanisms (Bettencourt-Dias et al., 2005; 
Habedanck et al., 2005; Pelletier et al., 2006) and de novo centriole formation (Rodrigues-
Martins et al., 2007; Peel et al., 2007; Eckerdt et al., 2011). 
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 Due to its essential role in regulating centriole biogenesis, Plk4 misregulation (as 
well of many of the other pathway elements) is associated with many diseases in humans, 
including male sterility, primary microcephaly, primordial dwarfism, and other ciliopathies 
(Nigg and Raff, 2009; Rosario et al., 2010; Bettencourt-Dias et al., 2011; Marthiens et al., 
2013; Chavali et al., 2014). Several mutations within specific centrosome components have 
been identified in these diseases; for instance, the human Ana2 homolog (known as STIL; 
Stevens et al., 2010a) contains a C-terminal TIM domain, which stands for “truncated in 
microcephaly” (Bennett et al., 2014). Most of the known mutations within these diseases give 
rise to centriole and basal body defects or reduced centriole numbers, leading to improper 
cilia formation required during development. However, some mutations lead to decreased 
centrosome numbers, mitotic delays, or deregulation of asymmetric cell division (Chavali et 
al., 2014). Conversely, it has been shown that overexpressed Plk4 in Drosophila is associated 
with multi-polar mitotic spindles, aneuploidy, and tumorigenesis (Basto et al., 2008), 
implicating a link between unregulated Plk4 levels and cancer. Indeed, Plk4 is now a target at 
the forefront of efforts to design new antiproliferative therapeutics. Though no Plk4-specific 
drugs are currently being tested in clinical trials, several labs within the last couple of years 
have published drugs said to specifically target Plk4’s catalytic activity and reduce 
centrosome number in tumorigenic cell lines (Laufer et al., 2013; Sampson et al., 2014; 
Godinho and Pellman, 2014). Much more work regarding Plk4’s role in tumorigenic 
transformation is forthcoming, with data pointing to concurrent mutations in both Plk4 and 
p53 leading to cancer (Li et al., 2005). It is an exciting time for both cell biologists and 
pharmacologists, as links between centriole duplication and cancer have revealed Plk4 as a 
prime target for novel therapeutics. 
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 Of course, Plk4 does not exert its effects on centriole number alone: in humans, Plk4 
binds both scaffolding proteins Cep152 (Asl in D.m.) and Cep192 (SPD-2 in C.e.) to attain 
centriole localization (Sonnen et al., 2013; Shimanovskaya et al., 2014). In human cells 
depleted of both Cep152 and Cep192, Plk4 is unable to localize to centrioles, underscoring 
the importance of the binding events between Plk4 and its scaffolding partners (Sonnen et al., 
2013). The requirement of binding partners for Plk4’s centriole localization is conserved 
throughout all animals studied; however, Plk4 exclusively uses Asl for its recruitment in 
D.m., or SPD-2 in C.e. (Dzhindzhev et al., 2010; Pelletier et al., 2006, respectively). Recent 
work from two labs (Park et al., 2014; Shimanovskaya et al., 2014) has uncovered the 
mechanism through which Plk4 binds its scaffolds: the Plk4 homodimer forms via lateral 
interactions formed between PB2-PB2 to create 12-stranded extended β-sheet (corresponding 
to a conformation shown in Figure 2.S1 B, Chapter 2). This is contrary to our published 
work, which claimed that PB1-PB2 forms a head-to-tail homodimer, with contributions to 
dimerization made by both PB1-PB1 interactions and PB2-PB2 interactions (Figure 2.2, 
Chapter 2). However, we presented our chosen dimerization interface (called the “X” dimer) 
as the most likely biologically relevant dimer due to its extended buried surface area and full 
use of both PB1-PB2 to create the interface; additionally, the head-to-tail dimerization is 
consistent with the current model of FL Plk4 dimerization to mediate self-regulation (Rogers 
et al., 2009). However, the dimerization interface presented in Shimanovskaya et al., 2014, 
and Park et al., 2014 (called the “Z” conformation) more likely represents the biological 
dimerization interface for several reasons: it creates a groove that allows for electrostatic 
interactions between Plk4 and its scaffolding partners, shown in a crystal structure in the 
Park manuscript; and it better fits a SAXS (small-angle x-ray scattering) envelope of PB1-
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PB2 in solution, as shown in the Shimanovskaya manuscript. Therefore, PB1-PB2 forms a Z-
dimer to interact with Cep152 and Cep192. Further crystal structures of Plk4 in complex with 
Asl/Cep152 or SPD-2/Cep192 will be essential in learning more about the mechanism 
through which Plk4 binds its partners, affording centriole localization. These crystallization 
targets are ongoing in the Slep lab as well as others. 
 Our work with Plk4’s Cryptic Polo Box (CPB) (presented here in Chapter 2 and in 
Slevin et al., 2012) established PB1-PB2 as bona fide tandem PB domains using structural 
biology. Despite labeling the seemingly incorrect interface as biological rather than a 
crystallographic artifact, we also showed that PB1-PB2 forms a dimer consistently in 
solution via both SEC-MALS and dynamic light scattering. Furthermore, our experiments in 
Drosophila S2 cells established that the entire PB1-PB2 cassette is required for robust 
centriole localization, and that removal of the cassette ablated Plk4 localization to centrioles. 
This work was confirmed using pull-down experiments, in which we established that Plk4 
employs PB1-PB2 to bind Asl in D.m. We also found that the homodimerization between 
PB1-PB2 plays a key role in dimerizing the FL Plk4 molecule, and therefore allows for the 
established trans autophosphorylation mechanism required to downregulate Plk4 levels to 
limit centriole duplication to a brief time period. Thus, Plk4 uses its central PB1-PB2 cassette 
for subcellular targeting, partner binding, and regulating the stability of the FL molecule. 
More work needs to be conducted to determine whether PB1-PB2 directly affects the 
catalytic activity of the kinase domain, as it commonly does in Plk1 homologs (Yun et al., 
2009; Xu et al., 2013). 
 Our work characterizing PB1-PB2 led to the observation that PB1-PB2 (whether in 
the X or Z dimer conformation) displays a “basic patch,” or a region with many positive 
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charges, that is conserved, surface-exposed, and not involved in dimer formation (Figure 6.1 
A). Thus, we initially postulated that this basic patch could be employed by PB1-PB2 to bind 
Asl or other negatively charged binding partners via electrostatic interactions (Slevin et al., 
2012). Though the experiments were not completed in time to be included in our 2012 
publication, we have since identified a series of residues within the PB1-PB2 basic patch that 
is responsible for PB1-PB2 subcellular localization (Figure 6.1 B). In our experiments 
(following the same protocols as outlined for the “Centriole Localization Assay” in Chapter 
2), site-directed mutagenesis was used to create charge reversals within targeted surface-
exposed basic residues within PB1-PB2 (Figure 6.1 A). We then assayed construct 
localization in Drosophila S2 cells using GFP-tagged mutant PB1-PB2 constructs and 
staining for D.m. D-PLP (pericentrin-like protein). We then identified the minimal set of 
mutants needed to reduce PB1-PB2 localization to centrioles: K510, R523, K529, and K539 
(highlighted in Figure 6.1 A; representative images shown in C). This corresponds very well 
to the set of mutants used in Shimanovskaya et al., 2014, in which they used in vitro pull-
downs and purified proteins to detect the residues important for the Plk4/Asl interaction. 
They identified Plk4 residues R490, K510, R523, and R594, which collectively overlaps with 
our identified minimal residue set. Additionally, a recent manuscript detailing the structure of 
human Plk4 PB1-PB2 in complex with a 60-residue fragment of Cep152 or 58-residue 
fragment of Cep192 confirmed the importance of electrostatic interactions between Plk4 and 
its scaffolding partners (Park et al., 2014). Further work is required to determine whether 
PB1-PB2 only binds scaffolding partners, or if other binding partners (including potential 
phosphorylation targets) interact with PB1-PB2.  
 Figure 6.1. Plk4 PB1-PB2 employs a basic patch to localize to centrioles.
conservation of PB1-PB2 shown in spherical representation, with 100% identical residues 
shown in green and 80% conserved residues shown in yellow. Right, an electrostatic map of 
PB1-PB2, displaying the basic patch formed within PB2. Bottom, a surface
the minimal four basic-to-acidic residue mutations (all to glutamic acid) required to ablate 
PB1-PB2 centriole localization. (B) A schematic of wt PB1
mapped onto the cassette. A total of six point mutations (
in different combinations. Shown in the bar graph are the localization results for three of the 
mutant constructs: ABCDEF (all six
R523E, K529E, and K539E set).
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 representation of 
-PB2 with specific mutations 
labeled A-F for clarity) were tested 
 residues), BCDEF, and CDEF (the minimal K510E, 
 All three constructs show a nearly complete disruption in 
 
 
 (A) Left, 
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centriole localization, indicating that PB1-PB2 requires its basic patch for proper 
localization. (C) Representative images of the centriole localization assay. The protocol is 
exactly the same as that detailed in Chapter 2, except instead of co-staining for D-PLP, we 
used a goat anti-Asl serum stained in Cy3 (provided by N. Rusan, NIH). Scale bar, 10 µm.  
 
 
 Additionally, the recent atomic structure of Plk4 bound to a Cep152/Cep192 peptide 
provides compelling evidence for a specific interaction that could potentially mark a new 
target for developing Plk4-based therapeutics. All of the cancer drugs targeting Plk4 to date 
have bound its kinase domain, which has many undesired off-target effects due to Plk4’s 
kinase domain sharing high levels of similarity with the Aurora kinases. Making use of new 
atomic information regarding a different, unique area of Plk4, as well as how it interacts with 
binding partners to attain localization and license centriole duplication, would be a powerful 
way to design new drugs with truly high Plk4 specificity levels.  
 Our work in Chapter 3 (unpublished) details the variation of PB3 structure and 
oligomerization among species. Interestingly, PB3 takes on both different folding patterns 
and oligomerization states in a species-dependent manner, indicating that it may not have a 
conserved role in Plk4 function. Current and future work regarding this divergent domain 
focuses on three aspects of PB3 function: 1) determining the role of PB3 in human HeLa 
cells, in which H.s. Plk4 either lacking PB3 or containing D.m. PB3 in its place is examined 
for centriole overduplication phenotypes; 2) using extensive sequence alignments among 
PB3 domain homologs to determine conservation and detect a possible evolutionary 
branching event; 3) collaborating with other labs to discover PB3-specific binding partners. 
These key experiments are crucial in understanding why Plk4, unlike all other Plk family 
members, contains three PB domains.  
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 While there is still much work to do to learn how Plk4 employs its array of PB 
domains to license centriole duplication, there is sure to be exciting implications for those 
findings. In addition to Plk4 being an important target to develop anti-cancer therapies, future 
work will focus on a seemingly basic and yet hotly debated topic within the field of centriole 
biology: what is Plk4’s phosphorylation target? Although we know that Plk4 phosphorylates 
itself (Rogers et al., 2009; Cunha-Ferreira et al., 2009; Holland et al., 2010; Sillibourne et al., 
2010), FBXW5 (Puklowski et al., 2011; Pagan and Pagano, 2011) and Chk2 (Petrinac et al., 
2009), we do not yet know if it has a direct target within the centriole assembly pathway 
(Lettman et al., 2013). More information at the structural level and at the cellular level as to 
the catalytic targets of Plk4, in addition to its binding partners, will be critical in 
understanding the mechanism of Plk4-dependent centriole biogenesis. It is also paramount to 
determine, through comparative alignments of Plk4 orthologs throughout all eukaryotic 
branches, the evolutionary branchpoints that created Plk4, a Plk unlike any other. This 
information will provide clues as to the presence of an additional PB (PB3), and help answer 
the ultimate question of how Plk4 employs its PBs collectively to license centriole 
duplication.  
 
LC8 potentiates Ana2 oligomerization, with potential implications for the role of Ana2 
in asymmetric cell division and centriole duplication 
 
 In addition to acting as a key downstream element of centriole duplication (Stevens 
et al., 2010a), Anastral-2 (Ana2) is an essential factor in maintaining correct spindle 
orientation in D.m. neuroblast asymmetric divisions (Wang et al., 2010; see Chapter 4). The 
initial discovery of the LC8/Ana2/Mud complex in D.m. NBs led the authors to postulate that 
LC8 (also known as Cutup, or Ctp) simultaneously binds Ana2 and/or Mud in addition to 
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dynein intermediate chain (DIC), which serves as an adaptor to dynein (Wang et al., 2010). 
However, research from several independent labs have converged to demonstrate that LC8 
does not simultaneously bind other dynein chains and its other varied targets, indicating that 
LC8 likely binds Ana2 and/or Mud independently of the cytoplasmic dynein motor complex 
(Benison et al., 2007).  
 Our work regarding the relationship between LC8 and Ana2 (presented in Chapter 5 
and in Slevin et al., 2014) identified two LC8 binding sites within Ana2, which very loosely 
conform to the binding motif K
-3X-2T-1Q0T1: Ana2 159-168 (A-3G-2T-1Q0T1D2, called Site (or 
Peptide) 1) and 237-246 (T
-3G-2T-1Q0C1D2, called Site (or Peptide) 2). We solved two 
independent structures of the LC8 homodimer bound to each of the Ana2 peptides and used 
ITC to characterize the binding of each peptide to LC8. We found that, similar to other 
known LC8 targets, each Ana2 site binds LC8 as a parallel dimer with affinities well within 
the range of known LC8 interactors. Importantly, the two LC8 binding sites that we 
determined flank a central predicted coiled-coil domain; furthermore, attempts in our lab to 
purify different portions of Ana2 were unsuccessful due to protein insolubility. However, we 
found that co-purification of a middle portion of Ana2 (Ana2M, residues 156-251) with LC8 
yielded a stable complex comprising 8 LC8 protomers and 4 Ana2M protomers (LC88-
Ana2M4, Figure 5.6). Thus, LC8 is an important factor that binds Ana2, promotes its 
stability, and mediates its oligomerization (Slevin et al., 2014). 
 This work has important implications for Ana2’s diverse roles in centriole 
duplication as well as asymmetric cell division. In the D.m. NB, Ana2 localizes preferentially 
to the daughter centrosome at the apical cortex, mirroring the apical localization of Mud. The 
additional presence of LC8 in the daughter centrosome suggests that LC8-mediated Ana2 
  151
oligomerization stabilizes it, allowing for enhanced centrosome maturation in an as-yet 
undetermined mechanism. Whether the stabilized Ana2 tetramer exerts control over spindle 
orientation via a Mud/Pins/Gαi, Mud/dynactin/dynein, or Mud/MT pathway is yet to be 
established, and discerning among these mechanisms is an important step in connecting 
centrosome asymmetry to spindle orientation control in ACDs. 
 The role of Ana2 in centriole duplication is much more opaque. While Ana2 is 
largely acknowledged to be one of few proteins actually required for centriole assembly (the 
main five consisting of Asl, Plk4, Sas-6, Ana2, and Sas-4; Goshima et al., 2007), it is very 
unclear as to how Ana2 affects centriole assembly. While Asl and Plk4 are considered to be 
scaffolding and signaling components, respectively, Sas-6 is the first molecule to make a 
stable structure within the nascent centriole: the 9-spoked cartwheel (van Breugel et al., 
2011; Kitagawa et al., 2011). However, biochemical evidence indicates that lateral Sas-6 
interactions are very weak, implying that other factors are needed in cells to faithfully build 
the 9-spoked cartwheel (Kitagawa et al., 2011). Indeed, Sas-6-based centriole amplification 
is only observed when Sas-6 is overexpressed in tandem with Plk4 and Ana2, suggesting that 
Sas-6 and Ana2 are both needed for cartwheel formation (Stevens et al., 2010a). 
Additionally, co-overexpressed Sas-6 and Ana2 form “tubules” in D.m., a phenomenon that 
requires Ana2 (Stevens et al., 2010b). Thus, while it is likely Ana2 plays a direct role in 
stabilizing Sas-6 oligomers, and ultimately cartwheel formation, it has not been definitively 
shown. Whether the LC8-mediated LC8 tetramer is necessary to build the Sas-6 higher-order 
structures is yet to be shown. LC8 is not strictly required for centriole duplication (Goshima 
et al., 2007); furthermore, our work has failed to show an LC8 requirement for centriole 
duplication in S2 cells (data not shown). However, LC8 is a ubiquitous protein, and its 
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depletion is expected to have many pleiotropic effects; therefore, it is difficult to dissect its 
role solely in centriole duplication without observing off-target effects. One of the next steps 
in the field of centriole biology is an enormous yet very important undertaking in 
understanding the molecular mechanisms underlying centriole assembly: to create entire 
centrioles in vitro. Now that we have a thorough understanding of the main components in 
centriole biogenesis, an in vitro system that allows for high-resolution visualization of 
centriole morphology is required to determine the effects of depleting individual proteins. 
This would be invaluable in determining the precise role of Ana2 in centriole formation. In 
the meantime, it would be very helpful to create different N- and C-terminal nanolabels (e.g. 
gold particle labeling) for Ana2 to visualize organization and localization of the FL molecule 
in the context of the centriole, via electron microscopy. Our lab is very interested in the 
outcome of these types of experiments to better understand the structural role of Ana2 in 
centriole assembly. 
 
Concluding remarks 
 Centrioles are fascinating structures. They form the basis of centrosomes and cilia, 
organelles responsible for nucleating polarized microtubule networks in eukaryotes. Despite 
the fact that flies lacking centrioles can develop to adulthood (Basto et al., 2006), centrioles 
remain highly conserved eukaryotic structures with a characteristic 9-fold symmetry. Mutant 
alleles for individual centriole components results in abnormal centriole number and/or 
morphology, and such mutations are implicated in human diseases such as microcephaly, 
male sterility, and cancer (Nigg and Raff, 2009; Basto et al., 2008), underlining the 
importance of regulating exact centriole number. The formation of the centriole, with its 
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inherent 9-fold radial symmetry, is an intricate and yet faithful process that has fascinated 
structural and cell biologists alike over the last decade or so. Many fundamental questions 
remain, including how does a cell detect its centriole number? What are the regulatory 
mechanisms preventing overduplication? Our work with both Plk4 and Ana2 has highlighted 
some of the structural-based mechanisms of centriole assembly and licensing thereof, though 
many questions remain. The future of the centriole biology field is bright, with newer high-
resolution techniques allowing for more and more questions to be addressed in situ, as we 
continue to uncover the conserved mechanisms of centriole duplication.  
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